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1.1 SCOPE OF THESIS  
 
The research in this thesis is aimed at the elucidation of the role of the glucocorticoid receptor 
(GR) in hippocampal neuroplasticity and functioning. To achieve this, we have developed a novel 
method to specifically knockdown GR in a discrete cell population of the mouse brain.  
In this thesis I report silencing of GR expression selectively in a population of neuronal progenitors 
and immature neurons of the dentate gyrus, using RNA-interference (RNAi) delivered by a 
lentiviral vector. Characterization of these cells resulted in the discovery that GR knockdown 
causes a striking modulation of hippocampal neurogenesis and remodelling of hippocampal 
circuitry. Functional studies further revealed consequences of GR knockdown for contextual 
memory performance and behavioural coping strategies during stressful conditions. The results 
demonstrate the feasibility to apply RNAi in discrete cell populations for study of the action 
mechanism of glucocorticoids underlying control of neuroplasticity and behaviour. 
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1.2 THE STRESS RESPONSE IN THE BRAIN  
 
The organism strives to maintain a physiological balance called homeostasis. When this balance is 
disrupted by a challenge (stressor), the organism responds by behavioural and physiological 
adaptations, resulting in coping and recovery 1-5. For example, an animal needs to react instantly 
when it is hunted by a predator and needs to decide on the best strategy for survival. This 
situation is often referred to as a “fight or flight” response and results in enhancement of systems 
that are directly crucial for survival, and repression of systems temporarily redundant 6. At the 
same time, physiological and behavioural adaptations are promoted in preparation for future 
events. This can imply for example, that the animal needs to learn about the situation to prevent 
its repeated exposure to the endangering environment. Together, these adaptations are called 
the stress response.  
The perception of the stressor is the key trigger that initiates the stress response. Central to the 
stress response therefore is the brain, because it determines what is threatening and, therefore, 
potentially stressful 7. Generally, stressors can be divided into two classes, physical stressors and 
psychological stressors. Physical stressors, such as e.g. infections, tissue damage, blood loss, are 
usually homeostatic challenges sensed by the somatic, visceral and circumventricular pathways 
which activate aminergic cells in the brain stem 8. Psychological stressors are external challenges 
that contain species- and individual- specific characteristics. They are processed by limbic brain 
areas, including the amygdala, hippocampus and prefrontal cortex 8;9. These limbic areas mediate 
the cognitive and emotional processing of psychological stressors, thereby appraising the 
challenge and assessing its stressfulness. Both the brain stem and the limbic brain areas 
communicate to the hypothalamus which integrates the stressor-specific information 10. 
 
1.2.1 The HPA axis 
Subsequently, the hypothalamus organizes the adaptive response and communicates to 
peripheral organs by 1) activating the sympathetic nervous system and subsequent secretion of 
catecholamine’s such as adrenalin. They are responsible for the immediate physiological changes. 
These include increased heart rate and cardiac output, diverting blood to the skeletal muscles and 
elevating blood glucose levels, processes crucial for the fight or flight response 6. On the other 
hand, the sympathic nervous system suppresses the reproductive and digestive systems which are 
at that time non-relevant to survival. 2) Activating the hypothalamo-pituitary-adrenal (HPA) axis 
and subsequent secretion of glucocorticoid hormones (GCs; cortisol in man and corticosterone in 
rodents) (for review see 3;11). This neuroendocrine system is responsible for more slow-acting 
adaptations which modulate and fine-tune the physiological changes initiated by the sympathetic 
nervous system. Physiological changes include inflammatory and immunity responses, 
metabolism and attention and information storage.  
Under basal (non-stressed) conditions, the HPA axis activity is limited, resulting in the pulsatile 
release of low amounts of GCs from the adrenal cortex. This ultradian pattern of secretion has 
pulses with larger amplitude which define the circadian rhythm 12. If activated by a(n acute) 
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stressor, the circadian rhythm is overridden and stress-induced HPA axis activity results in a rapid 
rise in hypothalamic corticotrophin releasing hormone (CRH) and vasopressin, activation of pro-
opiomelanocortin synthesis and release of adrenocorticotrophin (ACTH) from anterior pituitary 
corticotrophs, which ultimately -after several minutes- leads to the secretion of GCs into the 
bloodstream 13.  
 
1.2.2 Genomic and non-genomic actions of glucocorticoids  
The lipophilic glucocorticoid hormones enter target cells by penetrating across the cell 
membrane. At the cellular level, GCs control the stress response through binding to two types of 
steroid receptors: the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR or 
NR3C1: nuclear receptor subfamily 3, group C, member 1; encoded by a gene on chromosome 5 in 
humans and chromosome 18 in mice) 14;15. The steroid receptors belong to a superfamily of 
ligand-inducible, highly conserved nuclear hormone receptors.  
They have a  similar structural organization consisting of different domains that are implicated in 
their different action mechanisms (see Fig 1.1): A/B) an N-terminal regulatory region, (most 
unique part, only 4% homologous between GR and MR) and contains a ligand-independent 
activation function (AF-1) 16, C) a DNA binding domain (DBD), which has a homology of 94% with 
MR. It contains two zinc fingers of which the first is necessary for binding transcription factors 17. 
The second zinc finger domain encodes for receptor dimerization and GRE-mediated 
transactivation 18. The DNA binding domain further contains a nuclear localization signal (NLS1). 
D) A hinge region that is thought to link the DBD and the Ligand Binding Domain (LBD), E) a LBD. 
Along with the DBD, the LBD contributes to the dimerization interface of the receptor, and binds 
co-activator and co-repressor proteins. In addition, the LBD domain contains a second nuclear 
localization signal (NLS2) and a second ligand-dependent transcription activation function (AF-2). 
Both activation functions interact with co-regulator proteins and mediate the effects of the 
receptors on gene transcription. And F) the C-terminal part of the protein is about 60% 
homologous between GR and MR 16.  
MR and GR are localized in the cytosol bound to chaperone and co-chaperone proteins 19, and 
upon activation by binding GCs they undergo a conformational change and translocate without 
their chaperones to the nucleus. Here they control the expression of glucocorticoid-responsive-
genes. GCs are thought to influence about 20% of the expressed human genome by activating GR 
20. The genomic effects of GCs on these targets are noticeable within an hour after a pulse and last 
for days, weeks or even permanently 21. However, using micro- array analysis, responsive gene 
patterns were measured within a time window of 1-5 hours after GC pulse 22.  
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Figure 1.1 Structural organization of nuclear receptors like the GR. Top – Schematic 1D amino acid sequence of a 
nuclear receptor. Bottom – 3D structures of the DBD (bound to DNA) and LBD (bound to hormone) regions of the nuclear 
receptor. 
 
The GC actions are mediated through two major mechanisms: 1) both receptor types can function 
as a dimer, by directly binding DNA at either positive or negative glucocorticoid response 
elements (GREs), in the promoter region of target genes. This transactivation mechanism is 
prominent in GC control of energy metabolism and cognitive processes, and occurs 3-5 hours 
after receptor activation 22. Or 2) Only GR functions as a monomer, by modulating the activity of 
other transcription factors via protein-protein interactions and thereby inhibiting transcription 23-
26. This transrepression mechanism is prominent for glucocorticoid control of stress reactions and 
occurs predominantly during the first hour after GR activation 22.  
Besides the genomic effects of MR and GR, more recently there has also been a breakthrough 
with the discovery of non-genomic steroid actions 27-30. Di and Tasker (2003) discovered that in 
the PVN GR-like receptors mediate the release of endocannabinoids that block excitatory 
transmission towards CRH neurons. Karst and Joels (2005) demonstrated in the hippocampus 
rapid actions mediated by MR on the presysnaptic release of glutamate deducted from the 
enhanced mEPSCs 30-32. Non-genomic MR-mediated actions are thought to improve attention, 
vigilance and appraisal processes, in addition to rapid GR-mediated HPA negative feedback 21;33-35.  
 
1.2.3 Tissue-specific signalling pathways of GCs and their receptors  
As previously mentioned, GCs exert their pleiotropic functions on a variety of different organ 
systems. In fact, it appears that GC-responsive target genes are to a great extent cell type specific 
36. Therefore, in addition to the central control of GC secretion, mechanisms are necessary to 
regulate GC signalling in order to fine-tune their different physiological actions. These specific 
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modes of GC signalling are particularly apparent in the dynamic and complex environment of the 
brain, one of the prime targets of GCs. 
After secretion from the adrenals, bioavailability of GCs in the bloodstream can for example, be 
modulated by binding to plasma proteins, such as corticosteroid-binding globulin (CBG). In 
addition to regulating bioavailability and metabolic clearance of GCs in the bloodstream, CBGs 
have a role in tissue-specific GC release 37. Furthermore, at the level of the cell membrane, passive 
diffusion of lipophilic GC molecules or their active transport can influence uptake into the cell. 
This is particularly relevant in the brain, where GC entry is regulated by the blood-brain-barrier. In 
the blood-brain-barrier, the multidrug resistant P-glycoprotein plays an important role in 
exporting synthetic GCs. Within the cytoplasm of target cells, enzymatic processes called “pre-
receptor ligand metabolism” by 11β-hydroxysteroid dehydrogenase type 1 and 2 are yet another 
mechanism that can affect intracellular GC availability in a tissue- and cell type specific manner 
35;38.  
In addition to these pre-receptor regulation modes, the dual receptor system plays an important 
role in refining GC signalling. According to the MR:GR balance hypothesis, MR and GR function in 
complementary fashion and mediate genomic GC actions on distinct, yet overlapping sets of 
genes 3;11;39;40. These complementary and sometimes opposite effects serve to coordinate the 
basal functions in sleep-related and daily events (MR), and in coping with stressful events (GR) 11. 
There are several different possibilities how GC action through MR and GR can coordinate 
divergent functions under basal and stressful conditions. These can be divided into 3 groups.  
 
1) Receptor-specific characteristics. Both MR and GR are characterized by their difference in 
ligand-binding capacities. GR has a tenfold lower affinity for GCs (Kd cort ≈ 5 nM) than MRs and, as a 
consequence, the majority of GRs only become substantially occupied at elevated levels of 
hormone (i.e. at the ultradian and circadian peak or, following a stressor) 41-43. This difference is 
especially relevant when receptors are co-localized in the cell, as it results in a MR: GR ratio in 
which physiological fluctuations in GC level will range from a situation of predominant MR 
activation when the organism is at rest and at the circadian nadir, to concomitant MR and GR 
occupation after stress or at the ultradian and circadian peak 44-47. Another characteristic of both 
receptors is -when co-localized- their ability to homo- or hetero dimerize 48. This implies also that 
relative receptor concentrations determine the proportion of receptor dimerization 19. 
Homodimers are formed anytime and hetero-dimers are predominantly formed with high GC 
levels in response to stress. In addition, receptor expression levels (“Amount”, discussed below) 
and activity levels (“function”) are important for subtle differences in functioning. On the one 
hand, this is dependent on receptor-splice variant characteristics, as both MR and GR exist in 
several different isoforms due to mechanisms such as alternative mRNA splicing and further post 
transcriptional modifications 35;49;50. Different isoforms of receptors are not only expressed in 
tissue specific manner, they are also associated with different transcriptional efficacies 35;50. On 
the other hand, receptor expression and activity levels can also be influenced by GCs themselves. 
Overload of GCs for example can lead to a diminished expression of GR mRNA and protein, and 
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can even lead to receptor insensitivity, called “GR resistance” 8;51;52. In fact, recent evidence points 
to an effect of parental care on the epigenetic regulation of hippocampal GR mRNA and GR splice 
variant expression 53. 
 
2) Differential expression patterns of MR and GR. Although both receptors are constitutively 
expressed, the different localization of receptors naturally underlies differences in GC signalling. 
In fact, while GRs are almost ubiquitously expressed in the brain (but with very low levels in CA3, 
brainstem and suprachiasmatic nucleus), MRs are highly abundant expressed in the limbic system 
such as neurons in the hippocampus, amygdala, dorsolateral septum and parts of the prefrontal 
cortex. Even within the hippocampus, both steroid receptors are expressed heterogeneously in 
different subfields. While the MR is expressed in the entire cornu ammonis (CA1-4) and the 
Dentate Gyrus (DG), GR expression is predominantly in CA1, CA2 and the DG, with much lower 
levels in CA3 14;54;55.  
In addition to differential expression in tissues and anatomically determined areas, also between 
different cell types there can be differential MR: GR expression patterns. In contrast to the cornu 
ammonis, the DG, for example, is a highly heterogeneous subfield consisting of different cell types 
(see Box 2). In general, in the DG all mature cells, both neurons and astroglia, express GR but only 
granule neurons seem to express MR as well 56;57. The differences in expression between tissues 
and cell types can be explained by the expression of different splice variants of the steroid 
receptors 35;58. These splice variants or isoforms are associated with altered biological activity, 
which can play a role in its ligand-sensitivity 49.  
At even smaller scale, cell populations of specific origin or age can give rise to differences in MR 
and GR expression. Again, the DG is a prime example as it contains different cell populations that 
arise from both a different origin (embryonic vs adult neurogenesis) and a distinct age or 
developmental stage. For example, both neuronal progenitor cells and immature adult born 
granule neurons lack MR, while GR is expressed in about 50% of the cells (see Figure 1.2) 57. GR 
expression in adult born neurons develops in a dynamical pattern during the four-week 
maturation period. Also with increasing age of the mouse it seems that both GRs and MRs 
become expressed at higher levels in immature neurons with increasing age of the mouse, 
suggesting lifetime alterations in steroid sensitivity 57.  
For these differences in expression not only transcriptional processes may be responsible. 
Recently, microRNAs have been found that control levels of gene expression in the post-
transcriptional stage. For the GR, miRNA124a was observed to down-regulate GR protein levels in 
neural cells 59. Expression of miRNA124a is restricted to the brain. Endogenous miRNA124a up-
regulation during neuronal differentiation of a neural cell line in vitro was associated with a 
decreasing amount of GR protein levels. This observation may imply a potential role for miRNAs in 
the regulation of cell type-specific responsiveness to GCs, as may occur during critical periods of 
neuronal development. In two other studies, miRNA124a was indeed shown to regulate proper 
neuronal differentiation of neuronal progenitor cells in vitro and in vivo 60;61. 
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Figure 1.2 Proposed development of newborn neurons in the dentate gyrus. Six stages of neuronal development in the 
adult hippocampus can be readily identified on the basis of morphology, proliferative ability, and expression of markers 
such as nestin, GFAP, DCX, calretinin, calbindin and NeuN. Development originates from the putative stem cell (type-1 
cell; stage 1) that has radial glia and astrocytic properties. Neuronal development then progresses over three stages of 
putative transiently amplifying progenitor cells (type-2a, type-2b and type-3 cells; stages 2–4), which appear to be 
increasingly determined to the neuronal lineage because in vivo no overlap with any glial markers has been found in 
these cells, to an early post-mitotic stage (indicated by the ‘one-way’ sign). This transient early post-mitotic period is 
characterized by calretinin expression (stage 5). GR expression varies during the proposed stages of development during 
adult hippocampal neurogenesis. Distinction of cells as stem cells, transiently amplifying progenitor cells and lineage-
determined progenitor cells is hypothetical and remains to be proven in vivo. Figure modulated from references 57;62-64.  
 
3) Cellular context of MR and GR. Receptor signalling can be variably controlled by differential 
expression patterns of co-activators/ co-repressors 65. These transcriptional co-regulator proteins 
are enzymatically active proteins that reorganize the chromatin environment after recruitment by 
the ligand activated nuclear steroid receptor and thereby influence gene transcription. The ratio 
of co-activators and co-repressors expressed in the cell has been proposed to determine the 
nature and magnitude of the GR-mediated transcriptional response, particularly at sub-saturating 
levels of GCs 66. 
In addition, proteins that control the translocation of steroid receptors to the nucleus can 
influence gene transcription in a cell type specific manner. Recently, such a control mechanism 
has been described for GR signalling, involving the microtubule-associated protein DCL, a protein 
that is specifically expressed in neuronal precursor cells in the DG and crucial for GR translocation 
to the nucleus 67.  
Another type of cellular context in MR and GR signalling may be the differential sensitivity of GC-
responsive target genes for steroid-receptor mediated transcriptional regulation. Although both 
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steroid receptors recognize the same response elements, or GRE’s in the DNA, subtle differences 
in GRE- nucleotide sequence or number of GRE’s may lead to preferential MR- or GR- mediated 
transcriptional transactivation.  
Finally, there may be a higher order control of receptor interaction with the genome, relating to 
the spatial organization of the cell nucleus during cellular differentiation and growth 11;68. 
 
Taken together, pre-receptor differences in GC bio-availability, and the cellular context combined 
with the dual steroid receptor system enable a precise, balanced and coordinated regulation of a 
variety of tissue-specific GC functions 4;44;48. The role of GC receptors is particularly important in 
the local signalling pathways. GCs are a circulating ligand, and it therefore is the local receptors 
which ultimately initiate and translate the massage of GCs into actions in the specific cells and 
tissues. 
 
 
1.3 ROLE OF HIPPOCAMPAL GR  
 
A further understanding of brain mechanisms underlying the stress response and GC signalling 
requires identification of the processes occurring at multiple levels of complexity; from molecular, 
cellular and circuitry levels to the behavioural level. In the brain, GCs and several known 
glucocorticoid-responsive-genes influence these processes; including neurochemical processes, 
structural neuroplasticity, neurogenesis, motivation, emotions and cognitive performance. In 
addition, GCs target the HPA axis itself, exerting a negative feedback loop via their steroid 
receptors in the pituitary and the hypothalamus, with modulatory influences from the 
hippocampus, controlling HPA activity and preventing an overproduction of GCs  9;11;14;41;42;69.  
As both MRs and GRs are highly expressed in the hippocampus, this brain structure is sensitive to 
circulating GCs. In addition, a wealth of information is known about the function of this region at 
the multiple levels of complexity. In fact, recently the hippocampus is more and more 
acknowledged in the pathophysiology of a number of neurological disorders. Moreover, different 
subfields are highly accessible for pharmaca, which enables manipulation of GR. Therefore, in this 
thesis I decided to focus on the hippocampus and in following section I will further discuss GC 
signalling and GR function in the context of the hippocampus and its DG subfield.  
 
1.3.1 The hippocampus 
The mammalian hippocampus is phylogenetically one of the oldest parts of the cerebral cortex. 
This well preserved and complex structure can be divided into two major regions that are 
interlocked with each other; the DG subfield, and the cornu ammonis (Figure 1.3) 70. The cornu 
ammonis can be further subdivided into 4 pyramidal cell subfields that are designated as CA1, 
CA2, CA3 (and CA4 in humans).  
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Figure 1.3 Hippocampal neuroanatomy. Orientation of the dentate gyrus (black dots) and cornu ammonis (black 
triangles) and their connections with the trisynaptic circuit. Abbreviations: CA1-3 = cornu ammonis 1-3; DG = dentate 
gyrus; EC = entorhinal cortex; pp = perforant pathway; mf = mossy fibers; sc = Schaffer collaterals; ff = fimbria fornix. 
(Adapted from 71) 
 
The neurons of the different hippocampal subfields are interconnected via the excitatory 
trisynaptic circuit 72. The glutamatergic input from the superficial layers of the entorhinal cortex 
enters the hippocampus via the Perforant path to the DG. This connection is the first of the 
trisynaptic circuit. Next, between the DG and CA3 is the unidirectional Mossy fiber path. This path 
connects the axons of the dentate granule neurons with the dendrites of the CA3 pyramidal 
neurons. The third connection is the Schaffer collateral path between the CA3 and CA1. The 
processed information then is projected back from the CA1 to the deeper layers of the entorhinal 
cortex. The hippocampus also receives input from several other connections, for example, from 
its contralateral part and several other brain regions (e.g. limbic system, fore brain, PVN and 
pituitary). These connections are often characterized by their inhibitory features.  
Parallel with the central position of the DG in the trisynaptic circuit, is its unique neuroanatomy. 
This characteristic subfield consists of a trilaminar structure. The outer layer, the molecular layer, 
is relatively cell free. It comprises the dendrites of the dentate granule cells and axons originating 
from the performant path. The second layer or granule cell layer (GCL), is composed of densely 
packed granule cells, which have small spherical cell bodies (8-12 μm in diameter) and lack basal 
dendrites. The inner part, also referred to as polymorphic layer or hilus, contains besides the 
granule cell axons, also mossy cells, various types of interneurons, and astrocytes 70;73. The GCL 
consists of two parts: the suprapyramidal (upper) blade and the infrapyramidal (lower) blade. 
Although they differ slightly in granule cell morphology (dendritic length and spine number) 74;75, 
both can be subdivided into 3 layers; the outer third, lining the molecular layer, the middle third 
and the inner third 76. There is a fourth layer lining the inner third of the GCL and the hilus: the 
subgranular zone (SGZ). This two-nucleus-wide band contains neuronal progenitor cells (NPC’s). 
The NPC’s of the DG are, together with the NPC’s of the lateral ventricular wall, unique to the 
brain. They are able to divide- even in the adult brain and therefore underlie the phenomenon of 
adult neurogenesis (see box 1).  
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Box 1: Historical perspective of the study of adult neurogenesis  
“In the adult centres, the nerve paths are something fixed, ended and immutable. Everything may die, nothing may 
be regenerated”. This statement by Ramon y Cajal (1913) highlights what was one of the central dogma’s of 
neuroscience: that neurogenesis –the birth of new neurons- was restricted to prenatal and early postnatal 
development, and that the adult mammalian brain was unable to facilitate this process. However, in the 1960’s 
Joseph Altman and colleagues showed first evidence of the phenomenon in the brain of adult rats 77;78. Although 
these results were initially not accepted by the scientific community, results were repeated and proved the neuronal 
phenotype of dividing cells in the hippocampus 79.  
An important contribution to the study of neurogenesis is the increasing level of sophisticated tools and scientific 
methods. Cell division for example can be visualised using BrdU, a substance that incorporates into de DNA of 
dividing cells. By varying the paradigm and the examination time points after injection, this simple technique allows 
quantitative analysis of proliferation, differentiation and survival 80. Analysis of adult born neurons can since recently 
also be performed using retroviral genetic marking, since retroviruses also exclusively enter the target cell during 
mitosis. In combination with the analysis of the expression of specific cellular markers the result is more specific 81. 
Developing neurons express distinct markers during their maturation process 62. For example, for immature newborn 
neurons doublecortin (DCX) is regularly used, while for mature neurons the specific adult neuronal marker of nuclei 
NeuN is mostly used. 
It is now known that neurogenesis occurs in different species of rodents 82;83, primates 84 and even humans 85-87. 
Although newborn neurons have been observed to functionally integrate in the neuronal circuitry, their precise 
function remains still elusive. Multiple studies have linked adult neurogenesis with functions of the hippocampus, 
including cognition, emotion, and pattern separation, as well as with the development of psychopathology and 
recovery from brain damage 88-91. In addition, adult hippocampal neurogenesis has been found to be bi-directionally 
regulated by a wide array of factors such as stress, age, environment, hormones, neurochemicals and behaviour (see 
for an excellent review 80;92;93).  
 
 
Neurogenesis is the continuous process of development of new functional neurons from neural 
progenitors. The GCL of the DG therefore is built “from the inside out”. 
The process of neurogenesis takes about four weeks, during which newborn daughter cells 
mature through several stages including proliferation, selection, differentiation, migration and 
functional integration (see figure 1.2). These developmental stages have each their distinct 
physiological and morphological properties 94-97. It is important to keep in mind that following this 
definition not only cell proliferation, but also cell survival, neuronal cell fate determination 
(differentiation) and correct incorporation of the newborn neurons are equally important 
processes.  
It has been estimated that several thousands of new cells are generated daily 98-100, but only about 
50% of them will survive and ultimately functionally integrate into neuronal circuits. There they 
remain for several months 77, receiving synaptic inputs 101;102, expressing a neuronal marker 83, 
extending dendrites and axons 103 and exhibiting electrophysiological properties similar to mature 
dentate granule neurons 95;98;103-108.  
Recently, more and more evidence arises that these adult born granule cells may contribute to 
hippocampal function.  
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1.3.2 GC modulation of neurogenesis and neuroplasticity1  
As the hippocampus is involved in cognitive processes such as learning and memory, it 
continuously needs to deal with new stimuli, process them, store them and adapt to them. It is 
now generally accepted that this is facilitated at the cellular level by underlying plastic processes 
110. During such processes, cells, connections between cells and circuitry are remodelled. The 
connections between (groups of) cells can for example become strengthened or weakened in an 
activity- dependent way by long-term potentiation (LTP) or long term depression (LTD). Such 
processes prepare the neurons within a network for their repeated use and facilitate their efficacy 
in communication. Other forms of (structural) neuroplasticity include the remodelling of 
elaborate dendritic trees, formation of new synapses (synaptogenesis) and the growth of new 
neurons (neurogenesis) 111. 
GCs are able to modulate hippocampal neuroplasticity, thereby influencing hippocampal 
behavioural and neuroendocrine output 11;112;113. A conspicuous feature of GC actions on cellular 
activity in the hippocampus is the apparent lack of effect when neurons are studied under basal 
conditions: resting membrane potential and membrane resistance do not show steroid 
dependence 11. Only when neurons are shifted from their basal condition, e.g. by the actions of 
neurotransmitters, do GC effects become visible. This is illustrated by the way in which GCs affect 
neuronal excitability in the CA1 subfield. Calcium currents, accommodation and serotonin 
responses are large in both the absence of GCs (ADX) and when MRs and GRs are concomitantly 
activated. By contrast, these cell properties are small with a predominant MR activation, pointing 
to a U-shaped dose dependency. Due to these effects on CA1 excitability, hippocampal output is 
expected to be maintained in a relatively high tone with the predominant MR activation and 
reduced when GRs in addition to MRs are activated. 
Although GC effects for the DG do not seem to follow such a U-shaped dose dependency, the DG, 
more than any other area in the brain studied so far, requires GC hormone levels to be within in 
the physiological range 5;44;114;115. Full ablation of GCs by ADX results within 3 days in reduction of 
synaptic transmission by LTP 116;117, loss of neuronal integrity (Wossink et al., 2001) 118 and 
apoptosis of dentate granule cells 119. Substitution with low doses of GCs, which preferentially 
occupies MR, can at least fully prevent apoptosis 117. MR occupation is associated therefore with a 
neuroprotective effect and an enhanced excitability. However, less clear is the role of the GR in 
DG physiology. Acute stress and a single injection with high dose dexamethasone (agonist) result 
in increased apoptosis 120;121. The effects of acute stress though, are largely normalized within 24 h 
121, indicating that the impact of a single stressor is probably limited. Prolonged exposure of 
animals to high GC concentrations presumably makes dentate granule cells more vulnerable to 
delayed cell death by excitotoxicity 5. 
In line with their growth inhibiting functions, GCs have also been shown to inhibit the 
proliferation and differentiation of neuronal progenitors, and also the survival of young neurons 
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122;123. As neuronal progenitor cells (NPCs) have been found predominantly in the direct vicinity of 
blood vessels 124, they are easily reached and influenced by circulating GCs. GC effects in NPCs are 
likely to be mediated directly through GR and also indirectly through MR or affecting other 
mediators of neurogenesis 5, such as growth factors 125-128, cell cycle inhibitors 129;130 and altered 
glutamate signalling 89;131-136.  
The context, time course, duration, and concentration of GCs and the exposure to stressors are 
essential factors affecting neurogenesis. Removal of circulating GCs following adrenalectomy 
(ADX) increases cell proliferation and neurogenesis in young adult and aged rodents 82;133;137;138. 
This can be reversed by treating ADX animals with a low dose replacement of corticosterone 
139;140. Similar effects on increased cell proliferation and adult neurogenesis were found using 
other methods of inhibiting HPA axis activity, such as blockade of CRF-1 and V1b receptors 89;141. 
In contrast, excess levels of GCs, due to stress or treatment with exogenous GCs, results in 
structural changes in the hippocampus and a decrease in cell proliferation and neurogenesis both 
in vitro and in vivo 11;13;142-147. These changes, including cell proliferation, cell survival and neuronal 
cell fate, can all be reversed after brief treatment with GR antagonists like mifepristone 148-151. 
In addition to the concentrations of GCs, also the duration and time frame are influencing its 
effects on cell proliferation and neurogenesis. Temporarily increased levels of GCs after a single 
stressor in adult rats only mildly and reversibly suppresses proliferation 121, while repeated or 
chronic stress leads to a more prominent and sustained suppression of neurogenesis 121;152;153. 
These experiments typically involve exposure of animals to a variety of mild stressors over a 
period of several weeks. Stressors include food and water deprivation, temperature changes, 
restraint and tail suspension 154-156. 
However, severe, repeated or chronic stress during sensitive developmental stages leads to a 
more prominent and sustained suppression of neurogenesis 121;152;153 and can even persist 
permanently into adulthood beyond restoration of basal HPA axis activity 139;157-159. Given the 
differences in the developing and adult brain, an increase in GCs during early postnatal life may 
therefore have profoundly different effects from those in adulthood and might even lead to an 
increased sensitivity to GCs. 
Furthermore, the nature of the stressor and also the context in which the stressor operates are 
crucial in determining the effects on neurogenesis. Because under certain circumstances such as 
learning 160, exposure to an enriched environment 161;162, or voluntary physical exercise such as 
running 47;163-167, elevated GC levels are associated with enhanced neurogenesis 89;168-170. 
Intriguingly, if animals were housed in isolation, the effects of stress and exercise on neurogenesis 
would be worse than if animals were socially housed 21;171;172. This so-called glucocorticoid 
paradox is also shown in rodents where elevated GC levels due to caloric restriction causes 
increased longevity, whereas elevated corticosterone due to chronic stress does the opposite and 
enhances vulnerability to disease 21;173. 
Thus, in addition to the intensity and duration of the stressor, the nature and context of exposure 
to the stressor determine whether the outcome is positive or negative. While these observations 
appear contradictory, a possible explanation of this glucocorticoid paradox may be the manner in 
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which an organism perceives the specific contexts as stressful, neutral or even pleasurable. It is 
thought that psychological variables such as predictability and controllability can determine the 
impact that otherwise identical stressors have on the organism, and are known to lessen or even 
protect against the negative consequences of stress on brain, body and neurogenesis 174-178. 
Although the precise mechanism behind this phenomenon is still unknown, it may partly be 
explained by the processing of psychological but not physical stressors by the hippocampus (see 
paragraph 1.2) 8;179.  
 
1.3.3 GC modulation of cognitive performance  
Half a century ago, first indications of hippocampal function were observed by physicians studying 
patients like “patient H.M.”. In patient H.M., large part of his medial temporal lobes, including the 
majority of his hippocampus, were removed in an attempt to stop his severe epileptic seizures. 
This resulted in severe anterograde amnesia 180. The patient could not form long-term memory of 
new events while other types of memory and his general intelligence were intact. Later, studies in 
both animals 181 and humans 182 have revealed the involvement of the hippocampus in spatial and 
declarative memory. Since then, much more research on the intriguing functions of the 
hippocampus has revealed a wealth of information.  
It is now known that hippocampal-dependent spatial learning and memory can be separated into 
distinct phases 183. Based on lesion studies, computational modelling and physiological evidence, 
these phases have been attributed to the different hippocampal subfields. It is thought that the 
CA1 subfield plays a role in consolidation and retrieval processes, and cue related memory, 
whereas the DG is thought to be more important in the encoding of contextual and spatial 
information: spatial pattern separation 73;184-188. The CA3 area plays a crucial role in rapid learning 
and pattern completion 187. 
The hippocampus is particularly involved in the appreciation of (novel) experiences, labelling of 
declarative memories in respect to context and time and in the organisms’ reaction to novelty and 
its spatial environment. The hippocampus exerts this function by integrating and processing 
spatial and contextual information of an organisms’ environment, with information about the 
motivational, emotional and autonomic state of the organism 189. This is in line with the theory 
that the hippocampus processes psychological stressors. In fact, the ventral part of the 
hippocampus is tightly linked to the amygdala, a limbic brain structure with a function in 
organizing fear related behaviours and anxiety. This may explain why emotionally arousing 
memories are among the strongest 190. As a consequence, hippocampal function can also be 
tested in emotional tasks such as contextual fear conditioning 191;192.  
There is profound evidence that GCs modulate the memories for these events 113;193;194. Therefore 
I will focus here on how GCs and their receptors affect the cognitive functions of the 
hippocampus. The effects of GCs on hippocampal functioning are dependent on the 
concentration, timeframe, duration, and context of GCs and stressor modality.  
As explained in paragraph 1.2.3, the concentration of GCs determines which receptor is activated. 
Basal GC levels activate predominantly the MR, which is involved in the acquisition and retrieval 
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phases of memory. MR activation is also important for reaction to novel information as well as 
determination of behavioural strategy 195;196. Experimental removal of even basal levels of GCs by 
adrenalectomy results in a time-dependent impairment of acquisition of spatial learning and 
contextual fear conditioning 149;197-199. This is thought to be contributed to – at least in part- by the 
DG, as lack of circulating GCs causes loss of dentate granule neurons  (see paragraph 1.3.2) 5;119. In 
general, a reduction of GR expression or function is associated with decreased memory 
consolidation 149;200.  The cognitive deficit can be reversed with replacement corticosterone 
therapy 149;201, although this is only effective if the DG is not completely disappeared 149;202.  
In contrast, higher levels of GCs activate the GR, which is required for the consolidation of spatial 
memory 203-206. After acquisition, administration of GCs facilitate memory consolidation in MWM 
under low stress (25° C water) but not high stress (19° C water or predator exposure) conditions, 
suggesting that moderate stress levels of GCs are beneficial 207;208. In general, stress- mediated 
activation and over-expression of GRs are associated with enhanced memory consolidation 149;209. 
This is a beneficial situation, as a mild/acute stressor for example, can create a situation of 
increased arousal, enhanced cognitive capacities and emotional salience enabling the organism to 
appropriately respond to the stressor and ensure survival. 
Chronic stressors, excess of GCs and continuous GR activation are correlated -just as lack of GCs 
and GR activation- with maladaptive effects on emotion and cognitive performance 2;149;210. Age-
related increases of GCs in humans also are correlated with cognitive decline 211. The detrimental 
effects on spatial memory in mice can be reversed by the application of selective and competitive 
GR antagonists 149;212. This can also explain the improvement in neurocognitive function and mood 
following antiglucocorticoid treatment of patients suffering from psychotic depression 213;214 and 
age-related cognitive decline secondary to elevated GCs 211. 
Strikingly, high levels of GCs and stress seem to improve the memory of the fearful event in 
contextual fear conditioning 149;209. Although this is dependent on genotype 194;215, and probably 
also of hippocampal region 216. However, for these “beneficial” effects not only the concentration 
but also the timeframe in which they occur is essential. Only when high levels of GCs are present 
during or immediately following the aversive event, they enhance long-term retention of learning. 
But when stress and high GCs are applied before the cognitive tasks they have been shown to 
impair acquisition, consolidation and retrieval 183. In addition, GCs augment consolidation of fear 
memory extinction rather than decreasing retrieval or consolidation 149;217.  
It seems thus that the timeframe and concentration of GC exposure determine a healthy adaptive 
stress response. GR-mediated transactivation enhances the storage of newly acquired 
information, while facilitating extinction of behaviour that is no longer relevant 44;149;149;218-221 .  
Duration is also an important parameter. A short duration of alterations in GC concentration is 
generally overcome more or less easily. In fact, a rapid onset of stress-induced GC rise is 
characteristic for a healthy individual, as long as the GC response is turned off effectively. More 
chronic elevations or chronic stress therefore are regarded as detrimental. This becomes 
especially clear in sensitive periods during development. Early life stressors are associated with 
long-term changes in brain function and behaviour, which can even remain into adulthood, a 
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phenomenon called developmental programming 222. 
The impact of GCs further also depends on the context and the stressor modality. For example, 
GR activation within the learning context is required for consolidation of spatial information 223;224, 
whereas GR activation or additional stressors applied before acquisition training or retention 
testing and which are not related to the learning context may impair rather than improve 
acquisition and retrieval of spatial memory 218;225. In respect to stressor modality, it is known that 
hippocampal lesions cause a prolonged stress response to psychological stressors 8;51;226;227, but 
not to physical stressors 8;227. This is explained in the ways these different types of stressors are 
processed in the different brain regions (see paragraph 1.2) 8;179.  
 
Thus, GCs and their receptors clearly play a vital role in modulating an array of cellular processes. 
These are underlying the functions of the hippocampus in emotion and cognitive performance.  
 
 
1.4 GCS IN (PATHO-) PHYSIOLOGY: IMPLICATIONS FOR HIPPOCAMPAL FUNCTION 
 
The hippocampus not only has an important function in emotion, cognitive performance and 
behavioural adaptation to stress. Recently there is growing evidence that the hippocampus is also 
a key structure in the pathology and course of several neuropsychiatric diseases and other 
neurological disorders. There are indications that the structure of the hippocampus is affected as 
well as hippocampal function. In depression 228;229 and in post traumatic stress disorder (PTSD) 
3;230-233, a reduction in hippocampal volume, associated with disturbances in mood, cognition, and 
behaviour are commonly reported. Typically, the frequency and the duration of the untreated 
illness, instead of the age of subjects, predicts a progressive reduction in volume of the 
hippocampus 234;235. In addition, malfunctioning of the hippocampus is observed in aging and 
dementia 236, and a variety of other diseases such as Cushing’s disease, diabetes, schizophrenia 
and epilepsy 111.  
In the following section, I will review the current evidence of how hippocampal dysfunction is 
associated with disease and how the stress system might be involved. To this end, I will illustrate 
two mechanisms or theories; 1) the stress theory, and 2) the neuroplasticity theory2. 
 
1.4.1 The stress theory 
In previous paragraphs I have shed light on the functions of GCs and their receptors in 
neuroplasticity and hippocampal function. It was illustrated how GCs and their receptors function 
-with respect to adaptation- in a U-shaped-dose relation. This implies that too high levels of GCs 
are as detrimental as lack of GC signalling, and that there is a certain optimum in the middle, 
where levels of GCs are contributing to cellular integrity and stable excitability in the 
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hippocampus favourable for behavioural adaptation 237. Although lack or excess of GCs are not 
directly life threatening, on the long run these conditions can have serious consequences. There is 
strong evidence that in genetically predisposed or otherwise vulnerable individuals, chronic 
stress, HPA axis hyperactivity is a primary, causal factor in the pathogenesis of neuropsychiatric 
disorders, such as depression 4;232;238-240.  
Depression is a serious multifactorial disorder with a complex clinical nature 241. The symptoms of 
depression fall into three primary categories, including changes in mood/ emotion (e.g. sadness, 
anhedonia, irritability), basic drives (e.g. eating, sleeping), and cognitive disturbances (e.g. 
memory loss, indecisiveness, guilt) 242. The diversity of symptoms suggests that multiple neuronal 
(limbic) circuits are likely to be involved, such as the prefrontal cortex, hippocampus,  amygdala, 
and nucleus accumbens 3;11;13;41;243. All these structures are modulated by GCs 244;245 but in 
investigations of the neural substrates, especially the hippocampus received a lot of attention. It 
is connected to multiple other brain regions and underlying several of the emotional and cognitive 
symptoms seen in neuropsychiatric disorders 246. In addition it is very sensitive to GCs. In fact, the 
disturbances in mood, cognition, behaviour and hippocampal atrophy coincide with abnormal 
levels of GCs in both humans 7;90;247. Vice versa, chronic stress and elevated GCs in animals lead to 
hippocampal dysfunction and other symptoms of depression 6;154;155;248. Major stressful or 
traumatic events seem to precede or even trigger depressive episodes, and about 50% of the 
depressive patients display hypercortisolemia, which appears to exist prior to the onset of clinical 
symptoms of depression 4;231;249.  
Typical observations done in depressed patients with a hyperactive HPA axis are: reduced GR 
function as tested in the dexamethasone (DEX) suppression or the DEX-CRH test 230, elevated 
amplitudes of cortisol secretory periods 250;251, an increased frequency of adrenocorticotropic 
hormone (ACTH) secretory episodes 252, and several other aberrations at different levels of the 
neuroendocrine system 230;233;253;254.  
There appears to be a direct correlation between the severity of symptoms and circulating cortisol 
levels 255;256. This conclusion is strengthened by observations in patients receiving exogenous GCs, 
such as prednisolone. Particularly when given at high doses for extended periods of time, these 
produce symptoms that include depression, hypomania, insomnia, cognitive deficits and 
psychosis 257;258. Also, patients suffering from elevated GC levels secondary to Cushing’s disease 
illustrate the link between GCs and depression as they often suffer from anxiety and depression 
and in some cases from psychosis and suicidal thoughts 259.  
These symptoms of HPA hyperactivity can typically be reversed with antidepressant (AD) 
treatment in both humans and animal models 260. Moreover, some ADs have direct effects on the 
GR 261 and potential novel ADs, as galanin, modulate HPA axis activity and enhance GC secretion, 
suggesting a tight interaction with the GR/GC system 262;263. Interestingly, short-term treatment (4 
days) with GR antagonist mifepristone has been successfully applied to treat/ameliorate 
depression with psychotic features in clinical trials. It was found that mifepristone reduced 
depressive symptoms in a subset of severely depressed patients with highly elevated GC levels 
254;260. However, only high doses of mifepristone are effective 255, and these doses are often 
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associated with adverse drug effects, although not uniformly across patient populations. These 
adverse effects include fatigue, anorexia and nausea. 
 
In spite of all the evidence, a direct causality in between HPA axis hyperactivity, hippocampal 
dysfunction and depression is still circumstantial. Also unclear is the underlying mechanism. Still, 
GR function seems altered in depression. There are two theories for a possible mechanism. 
 
1) The glucocorticoid cascade hypothesis explains how a tightly regulated system -the HPA axis- 
can spin out of control through a cascade of events and eventually leads to disease. Chronically 
raised levels of GCs, as for example occurs during chronic stress, can trigger this cascade and 
become maladaptive as the continuous stress response becomes more damaging than the initial 
stressor itself. Energy resources become depleted, oxidative damage increases, immune 
responses are suppressed, physiological and behavioural adaptations become compromised and 
then inevitably enhanced vulnerability to additional challenges and disease is produced 6;111;264;265. 
Since the elevated GC concentrations downregulate the GR in central feedback sites leading to 
further disinhibition of the HPA axis, the condition is further aggravated in a feedforward vicious 
cycle. 
 
2) The MR:GR balance hypothesis focuses on aberrant receptor functions as the primary cause of 
enhanced vulnerability or resilience. It is proposed that once the balance in actions mediated by 
the MR and the GR is disturbed, the individual is compromised in the ability to maintain 
homeostasis if challenged, for example by experiencing an adverse life event. This may lead to a 
condition of neuroendocrine dysregulation and impaired behavioural adaptation as risk factor for 
the precipitation of depression 3;11;39. While GR over-expression or enhanced receptor function is 
correlated with post traumatic stress disorder (PTSD) 266, several lines of evidence have suggested 
that impaired GR function, is a primary, causal factor in the pathogenesis of depression 230;267.  
The MR:GR balance hypothesis refers to the limbic circuitry e.g. hippocampus, and amygdala 
frontoparietal cortex, where both receptor types are abundantly expressed 8;11;14;39;51;52. In this 
limbic circuitry psychosocial stressors are processed. Via limbic MR, GCs modulate appraisal of 
novel experiences and influence the selection of the appropriate behavioural response. If during 
the stress response the rising GC concentrations activate GR, the storage of the experience is 
promoted in preparation for the future. MR therefore organizes the stress response, which is 
terminated via GR. The rapid effects are mediated by the membrane MR, while the genomic MR 
variant is crucial for integrity of the hippocampus and a stable excitatory transmission in the 
limbic circuitry, which is suppressed via GR, if transiently raised by stressors 237;268. 
 
The MR:GR balance can be altered by (1) genetic predisposition, resulting in a vulnerable 
phenotype with an altered behavioural pattern and altered HPA axis response to stressors 11;269. 
Hence, GR variants exist that provide either higher sensitivity or resistance to the GR 270. Recently, 
also MR gene variants were identified that enhance the expression of this receptor in 
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hippocampus and are associated with resistance to depression 271. (2) it has been shown that early 
life experiences themselves also can interfere with long lasting changes in steroid receptor 
expression by an epigenetic mechanism 21;272-274. Of particular importance is the quality of 
maternal care. Offspring of high licking and grooming mothers invariably has a high GR and MR 
expression in hippocampus. In addition to genetic predisposition and the impact of stressful early 
life events, the susceptibility to the disease state is further enhanced by (3) a subsequent 
challenge, such as a later life psychological stressors which are particularly potent if occurring in a 
repeated fashion under conditions that there is no prediction and no control possible over the 
psychosocial challenge 268;275.  
 
Thus, the cumulative exposure to genetic and adverse early cognitive inputs leaves a signature in 
developmental programming of limbic (and hippocampal circuitry) in anticipation of later life 
conditions. This signature is characterized by dysregulation of the neuropeptides CRH, vasopressin 
and opioids as well as the GC hormones and its receptors. If these later life conditions do not 
match with the expectancy, vulnerability to disease is increased 222. Therefore, the condition of 
uncontrollable, repeated stressors supposedly has the most devastating effect in well-groomed 
pups. The brain effects of genetic input combined with the effect of factors released by early and 
later life experiences is often called the “three hit hypothesis” 21. 
 
1.4.2 The neuroplasticity theory  
The neuroplasticity theory explains how hippocampal dysfunction, due to changes in 
neuroplasticity and neurogenesis, is underlying disease. According to this theory, a decrease in 
hippocampal neurogenesis is related to the pathophysiology of depression while enhanced 
neurogenesis is necessary for the treatment of depression 90;91;247;276-279. However, thus far there is 
no evidence that the reduction of neurogenesis is causally related to the aetiology of depression 
245;280, rather in rodents neurogenesis appears induced by chronic antidepressant treatment (see 
below). 
Nevertheless, decreased neurogenesis could affect neuronal function in the hippocampus in 
different ways 244. One way in which impaired neurogenesis could lead to depression is by 
weakening the mossy fibre pathway in the hippocampus. As the mossy fiber synapses are involved 
in controlling the dynamics of excitation and inhibition within CA3 281, a decreased dentate gyrus-
CA3 connectivity could result in a downward spiral leading to impaired learning and decreased 
possibility of coping with a complex environment, further impairing neurogenesis. In fact, this 
hypothesis is strikingly similar to what is observed in depressive patients: they show aversion to 
novelty and withdrawal from activities and challenges which traps them in a vicious circle 
244;245;278;282. 
Less speculative are the preclinical indications that adult hippocampal neurogenesis is necessary 
for mediating some of the behavioural effects of antidepressants. Remarkably, the delayed 
therapeutic actions of all major classes of marketed ADs (which take two to four weeks to 
develop) 283 coincides with the timescale of hippocampal neurogenesis and neuroplasticity 242;284. 
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It is notable that the induction of cell proliferation and neurogenesis is contingent upon chronic 
but not sub-chronic (acute) SSRI treatment 248;285-289. Moreover, the unique physiological 
properties of adult-born dentate granule neurons, in terms of their location within the 
hippocampal neuronal circuitry and their functional plasticity, suggests adult neurogenesis as a 
potential common pathway associated with the functional effects of antidepressants 94;245. 
Mature adult-born neurons may also contribute to the behavioural effects of SSRIs. This is in line 
with the observations that enhancing neurogenesis is necessary to exert antidepressant-like 
effects in animal models 280;287;290-292.  
 
1.4.3 GCs, neuroplasticity, and hippocampal function in health and disease: A convergence of 
mechanisms?  
The above described hypotheses are not mutually exclusive, nor do either of them completely fit 
reality. The stress theory of depression for example does not fit all patients, as only 50% of them 
suffer from HPA hyperactivity. On the other hand, the neurogenesis theory has a flaw as well as 
some studies point out that AD- behavioural effects can also be achieved in the absence of 
neurogenesis 293;294. 
Depression is of course a very complex disorder and it is certain that factors other than stress and 
neurogenesis are involved. However, it is likely that stress and neurogenesis interacting together 
in modulating hippocampal function and underlying disease is a more appropriate hypothesis to 
model the situation, rather than either of the theories alone. 
There are several lines of evidence for this hypothesis. As outlined in paragraph 1.4.1, several 
classes of ADs, with distinct modes of action, often restore HPA function in both humans 4 and 
animal models 43 while also boosting neurogenesis 295;296. A recent study has shown that from a 
group of rats exposed to chronic stress, only a subset responded behaviourally to treatment with 
the antidepressant SSRI 297. Interestingly, neurogenesis was restored to normal levels only in the 
behaviourally identified responders. In fact, the correlation between HPA axis functioning and AD 
effects is reinforced by the observation that distorted HPA axis diurnal rhythms prevented ADs to 
stimulate cell proliferation and hippocampal neurogenesis in rats 298. These consistent 
observations support the possibility that reducing stress/ HPA activity and increasing 
neurogenesis is a common pathway through which ADs exert their behavioural and therapeutic 
effects on depressive symptoms 152;245;299;300.  
Although the precise mechanism is not clear 244, it is thought that stress, GCs and their receptors 
are involved by the regulation of neurogenesis and neuronal plasticity and thereby affecting 
hippocampal function 282;301-303. This hypothesis needs further study, since it is mainly based on 
rodent studies.  
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Box 2 Context of GR research in animal models 
Since in vivo expression and functional studies are not feasible in humans, and the possibilities with in silico and in vitro 
studies are restricted, research has focused on experimental animals. Of course, with the use of experimental animals 
the complexity of human nature cannot completely be mimicked. The advantages however, are twofold. On the one 
hand, the similarity of rodents to humans in for instance “the stress response” makes it possible to investigate the 
function of specific genes by manipulating them artificially. This gives also fundamental information for the human 
situation.  
Apart from these fundamental objectives, animal models can also be used as disease models which reflect core features 
of the respective human disorders. This enables to investigate the underlying mechanisms of human diseases and 
validation of possible drug targets for these diseases. A better understanding could allow the design of better treatment 
strategies with specific molecular target sites and fewer side effects. For this purpose, the human benefits are weighed 
against the animals’ suffering by ethical committees. 
As for a number of neurological and behavioural disorders/ syndromes, there is not a single gene responsible, but a 
complex multi-genetic background. This is especially true for stress-related neuropsychiatric diseases. Therefore mouse 
models based on single gene manipulations unlikely can be expected for truly mimicking this phenotype. However, such 
models can be used to study parts of it, such as specific symptoms or traits, so called “endo-phenotypes” 299;304;305. This 
type of research is often performed in mice (Figure 1.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 A fearless mouse... A mouse model in which the smell was impaired by genetic manipulation, lost its display 
of anxiety behaviour to its predator (only when the cat is silent) 306. 
 
 
 
1.5 THE GLUCOCORTICOID RECEPTOR AS SUBJECT OF RESEARCH: ANIMAL 
MODELS 
 
As discussed previously, the GR is a key regulator of the HPA axis, neuroplasticity, hippocampal 
function and also implicated in the pathogenesis and course of stress-related-disorders. In 
addition, drugs targeting the GR are used widely in clinic. GR agonists such as prednisolone are 
applied because of their powerful anti-inflammatory and immunosuppressive effects, while mixed 
progesterone- and GR antagonists such as mifepristone are used for example for abortion. 
Because of this important role, the GR has been a subject of research for decades. Most of this 
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research has been done in animals. By selective breeding for example, several strains of mice and 
rats have been generated with different stress-responsiveness, neuroendocrine, neurogenic, 
physical and behavioural phenotypes that are heritable and stable 307. However, often the 
underlying molecular mechanisms leading to the differential phenotypes are complex and poorly 
understood. Another approach is therefore selectively targeting the different known elements 
and genes of the stress system and investigating the consequences. By manipulating GR in vivo -
either pharmacologically or genetically-, the capacity to stress adaptation and sensitivity for 
stress-related-disorders can be investigated at the level of neurophysiology, cognition, emotion 
and motivation. In this section, I will describe the various animal models for the study of GR and 
then summarize their major cellular, HPA axis and behavioural changes (see for review: 113).  
 
1.5.1 Pharmacological models  
As previously described (see paragraph 1.3) the HPA axis can be activated in rodents to different 
degrees; ranging from mild (e.g. handling, needle stick, novel environment) to moderate (e.g. 
swimming in MWM) to severe stressors (e.g. acute or chronic restraint). In addition, a distinction 
can be made between different types of stressors: physical or psychological stressors. The last 
condition is most severe as the individual has no control over the situation, prediction of an 
upcoming event, uncertainty and fear. Using these different types of stressors, investigators have 
been able to dissect the role of the GR in stress- associated HPA axis functioning 113. For example, 
as tested during the conditioned emotional response (fear conditioning).  
 
A more precise way of controlling stress-associated GC levels is in classical pharmacological 
substitution experiments. By adrenalectomy, the endogenous source of GCs is removed and 
hormone levels can be accurately manipulated by substitution with exogenous ones. Because 
some mice still have a residual GC secretion after adrenalectomy due to accessory adrenal tissue, 
their MR rather than GR is occupied. This is therefore a good model for investigating GR in the 
context of basal MR activation. Subsequent alterations in GC dose can for example be achieved by 
the implantation of corticosterone pellets 308, systemic injections 207 or local injections in the brain 
309. In such animal models, different types of stressors can be applied to see how it reacts. 
However, hormone depletion by adrenalectomy has some disadvantages. Apart from leading to 
GC depletion, it also results in the removal of mineralocortioids and catecholamines and the 
replacement of GCs only allows a crude assumption of receptor occupancy 310. In addition, 
agonists and antagonists may have a certain level of unspecificity, and therefore they may also 
target other nuclear receptors. Moreover, they often poorly penetrate the brain as they are not 
able to pass the blood brain barrier. RU38486 for example, needs therefore to be administered in 
106 higher dose systematically than in the brain to achieve the desired effect 149. 
 
1.5.2 Genetic models  
Another approach to correlate altered steroid signalling and stress with physiological and 
behavioural changes involves the use of animals with a genetic GR manipulation. Several mouse 
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lines have been generated in which GR expression or function is altered throughout the body (see 
for reviews 23;113;266;311): 1) GR antisense mice, 2) two different conventional knockout approaches, 
3) partial knockouts, 4) mice with disrupted GR dimerisation, 5) mice with a chimeric ER/GR 
receptor, 6) GR over-expression mice, and 7) Polymorphic GR mice. 
 
1) GR antisense mice (AGR mouse line). The first published genetic model of glucocorticoid 
disruption involved the introduction of antisense GR cDNA into the mouse genome and is known 
as the antisense GR mouse 312;313. A 1.8 kb fragment of the GR cDNA was inverted and placed 
under the control of the neurofilament promotor. This strategy was designed to reduce 
expression of endogenous GR in the nervous system. However, inconsistent expression of the 
transgene induced differing amounts of reduced GR expression in neural (e.g. 50–70% decrease in 
the GR expression) and non-neural (e.g. 30–50% reduction in liver and kidney) tissue, limiting the 
interpretation of the data. GR reduction in these mice resulted in changes in energy balance and 
lipid metabolism. Similar to the human situation, GR antisense mice show an impaired negative 
feedback loop of the HPA axis with a blunted circadian rhythm and lack of response to the 
Dexamethasone Suppression Test. The HPA hyperactivity becomes apparent under stressful 
conditions 313;314, but can be reversed by antidepressant treatment 315;316. At the behavioural level, 
the GR antisense mice were intensively studied 316 and found to present a reduced anxiety 
behaviour as well as several cognitive deficits for hippocampus-dependent memory tasks, such as 
the Morris Water Maze.  
 
2) Conventional GR knockouts. To investigate the effects of loss-of-function for the GR, two 
conventional knockout animals have been produced: Exon 2 targeted GRHypo; 317 and Exon 3 
targeted GRNull; 318. The GRHypo mice were developed by inserting a PGK-Neo cassette into Exon 2 
of the GR gene, a region involved in transactivation, while the GRNull mice were developed using 
mutant mice containing loxP sites surrounding Exon 3, a region involved in DNA binding. It has 
been reported that most of the GRHypo mice and all of the homozygous GRNull mice died in the first 
hours of life from severe lung atelectasis 317;319, demonstrating an essential function of the 
receptor for survival. The surviving fraction of mice, 5-10%, display the characteristic insensitivity 
to GCs and an impaired negative feedback regulation of the HPA axis leading to extreme 
elevations in both plasma-ACTH (15-fold) and -corticosterone (2.5 fold) levels 317;320. At the 
behavioural level, these mice displayed hippocampus- dependent memory deficits in several 
tasks. These mice were further investigated for the presence of aberrantly truncated GR proteins 
to explain the phenotype of the survivors. Analysis showed that GRHypo mice on an outbred strain 
have a truncated GR with a ligand-binding domain that can bind the synthetic glucocorticoid 
dexamethasone 320. So, GRHypo mice may have some remaining GR function that could limit 
interpretation of findings, particularly when differences in action are not found.  
 
3) Partial knockouts. Heterozygotes of both conventional GR knockout models survive into 
adulthood and have been convenient as these mice models aimed to model human disorders, 
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may mimic more naturally the situation of patients with affective and stress-related disorders as 
receptor expression reduction is more likely than a full knock out 321. Heterozygotes have a ~50% 
reduction of GR protein expression in the brain and have been used to study a variety of 
physiological, endocrine and behavioural factors 318;322. Typically, these mice under normal 
circumstances resemble wild type controls 318. Only when subjected to stress, GR +/- mice show a 
genetic predisposition for depressive-like behaviours and depression-like neuroendocrinological 
abnormalities. Importantly, these mice show hippocampus- dependent deficits in spatial memory 
when tested in the Morris Water Maze. 
 
4) Mice with disrupted GR dimerization. As described in paragraph 1.2.2, glucocorticoid binding to 
GR can induce cellular changes through dimerization-dependent and independent actions. To 
investigate these two types of GR activity on a variety of cellular processes, a GR mutant with a 
point mutation in Exon 4 was developed (GRDim/Dim) 323. Using a knock-in strategy replacing the 
endogenous GR gene, a point mutation (A458T) was introduced in the dimerization domains of 
the gene. A458T, had previously been shown to disrupt D loop formation causing a loss of GR 
dimerization and direct DNA binding 26. Interestingly, the resulting GRDim/Dim homozygous mice are 
born at the normal Mendelian ratios from heterozygote to heterozygote pairings and did not 
show signs of increased mortality. Consequently, GRDim/Dim mice are unable to control GRE-driven 
genes by direct, cooperative binding of the receptor to the DNA, but able to indirectly influence 
gene transcription by modulation of other transcription factors via protein-protein interactions. 
As these mice did not die after birth, it appears that the transrepression mechanism is important 
for survival. In addition, based on their neuroendocrine profile, it appears that the mechanism of 
protein-protein interactions is important to some but not all aspects of GR-mediated negative 
HPA axis feedback at the level of the hypothalamus 324. On the behavioural level, these mutant 
animals displayed selective GC-dependent deficits in spatial memory in the Morris water maze 
(MWM; a hippocampus- dependent task) 325, but no alterations in anxiety-related behaviour.  
 
5) Mice with a chimeric ER/GR receptor 208. In this transgenic mouse line the DNA-binding domain 
of the GR gene is replaced by the homologous part of the estrogen receptor. The gene still 
contains the GR-ligand-binding domain. As a result ER/GR transduces deleterious GC signals into 
beneficial estrogenic ones as estrogen is associated with enhanced hippocampus-dependent 
spatial memory performance which can counteract the deleterious effects of GCs.  
 
6) GR over-expression mice. To complement the loss-of-function studies, an YGR mouse model 
has been generated in which GR is over-expressed. This was achieved by introducing two 
additional copies of the full length GR gene using a yeast artificial chromosome 326. These mice 
over-express GR mRNA by 25% and GR protein by 50%. Phenotypically, they display a strong 
suppression of the HPA axis which reflects an increased GR negative feedback control in the HPA 
system 318;326. These over-expressing mutants provide an interesting framework to study the 
effects of increased GR activation on stress-mediated adaptations.  
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7) Polymorphic GR mice. This mouse model (GRQn) was generated by divergent genetic selection 
of two strains of mice 327. High Stress and Low Stress strains with different allele frequencies of GR 
were selected for an altered corticosterone response to stress. These mice, when tested, showed 
an altered stress-response and increased anxiety-type behaviours. 
The above described mouse models with systemically altered GR expression, clearly demonstrate 
the pronounced effects on the HPA axis and behaviour, but one disadvantage is that they are not 
very specific for the brain. In fact, these systemic mutants have a number of peripheral changes in 
metabolism and immune function. Although, not fully characterized, these peripheral changes 
make it more difficult to derive specific correlative conclusions about the role of GR in stress and 
nervous system function. Therefore more refined animal models are necessary with targeted GR 
expression in the brain. 
 
1.5.3 Brain-specific genetic modifications 
Instead of a constitutive loss or gain of genetic function, new advanced techniques allow temporal 
and spatial control of gene expression in the adult central nervous system (CNS). These 
innovations allow conditional gene disruption in specific anatomical regions at chosen time 
points. For example, the Cre/Lox recombination system enables the selective disruption of a gene 
conditionally induced by tamoxifen 328. These approaches can also be used to investigate GR in 
specific cell types without affecting its activity in other cells of the organism. In addition to the 
“confounder” of gene effects in respective other cells, this allows investigating gene function in 
adult animals without the drawback of developmental illnesses and genetic compensation/ 
adaptation mechanisms. To more precisely define the role of GR in the CNS, several mouse 
models have been generated (see for reviews 23;113;266;311): 1) The nervous system specific GR 
knockout mouse, 2) the forebrain-specific GR knockout, 3) the forebrain-specific inducible GR 
knockout, and 4) the forebrain-specific GR over-expression mouse. 
 
1) The nervous system specific GR knockout (GRNesCre) 319. In these mice GR expression is deleted 
specifically throughout the nervous system in both neurons and glia. The Cre-loxP model starts 
with two types of genetically altered mice. In one, the exon 3 of the GR gene is flanked with loxP 
sites. Mating these mice with second type containing nestin- Cre recombinase, results in offspring 
with deletion of GR in all CNS neurons and glial cells. GRNesCre mice have normal survival but 
exhibit a Cushing’s syndrome-like phenotype. These mice have altered fat deposition with 
lowered weight gain, osteoporosis, and immunological abnormalities. At neuroendocrine level 
GRNesCre display a strong activation of the HPA system with markedly elevated levels of circulating 
corticosteroids following a preserved but blunted circadian rhythm due to the lack of the negative 
feedback normally exerted at the level of the hypothalamus via GR. Investigation of GR 
downstream MAPK targets revealed a down-regulation of p-ERK1/2, Ras, Raf-1 and Egr-1 with 
potential implications for stress responsiveness and fear-based learning and memory 329. Indeed, 
inactivation of brain-GR reduced anxiety behaviour in two tests. In cognitive studies, the absence 
of GR signalling in the brain of the GRNesCre mice exhibited a mild memory deficit in the MWM task, 
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therefore these mice possibly have some cognitive deficits 319;330. Unfortunately in GRNesCre mice 
GR is deleted in the PVN, a site of major negative feedback inhibition of the HPA axis, leading to 
severe hypercorticism and wasting, confounding behavioural analysis. Furthermore, in the GRNesCre 
mice, and all the above described systemic GR mouse models, GR is deleted early in development. 
This makes it difficult to separate effects resulting from alterations that occur during development 
from those resulting from an acute requirement for GR.  
 
2) The forebrain-specific GR knockout (FBGRKO). To test the effects of acquired GR disruption in 
adult mice, Boyle et al (2005) developed forebrain-specific GR knockout (FBGRKO) mice 331. This 
mouse model was again produced by mating two types of mice: mice containing a floxed GR Exon 
1C through 2, with mice containing Cre recombinase expressed selectively in the CamKII 
promoter. Using this strategy, promoter elements at the normal translation start sites for GR are 
deleted  progressively from the age of 3 weeks till 6 months in neurons (and glia?) of the 
forebrain. This results in GR knockout in regions as hippocampus, cortex, basolateral nucleus of 
the amygdala (BLA) and nucleus accumbens, but intact GR expression in the PVN, thalamus and 
central nucleus of the amygdala (CeA) 332. Truncated GR were not detected 333. 
Mice exhibited hyperactivity of the HPA axis, impaired negative feedback of the HPA axis upon 
acute psychogenic but not physical or unpredictable chronic stressors, increased depression-like 
behaviour, and decreased anxiety-like behaviours in specific tests 8;331;332. In this mouse model, the 
depression-like behaviours, but not the anxiety-like behaviour can be reversed by chronic 
antidepressant treatment (tricyclic imipramine).  
The additional spatial specificity (i.e. forebrain only) and temporal aspects of deletion (i.e. 
deletion after 3 months of age) make the FBGRKO mice a particularly interesting model to 
investigate the role of extra-hypothalamic sites of GR on basal and stress-induced HPA axis 
activity as well as the role of GR in limbic modification of behaviour in the absence of non-specific 
developmental changes. 
 
3) The forebrain-specific inducible GR knockout (CaMKCreERT2) 328. To achieve cell-type specific GR 
gene inactivation, this mouse model was produced by mating brain-specific Cre mice with GRflox 
mice. Subsequently, in offspring the Cre/ LoxP receombination system was advanced by the 
tamoxifen-inducible protein consisting of the Cre recombinase and the mutated ligand binding 
domain of the human oestrogen receptor to achieve ligand-dependent Cre activity. The 
unliganded form of the CreERRT2 fusion protein resides in the cytoplasm and, upon tamoxifen 
binding, translocates into the nucleus and mediates site-specific recombination of the LoxP-
flanked DNA sequence. Phenotypically, these mice showed spatially restricted loss of GR protein 
expression in neurons of the adult forebrain, including the hippocampus, upon tamoxifen 
treatment. Also, it was observed that these mice display an increase in basal morning 
corticosterone levels 6 weeks after tamoxifen treatment 328. 
 
CHAPTER 1: GENERAL INTRODUCTION 
36 
 
4) Forebrain GR over-expression mouse 334. In this mouse model (GROv), GR was over-expressed by 
introducing a transgene containing the CamKII promoter driving expression of the GR cDNA. GROv 
mice exhibit about 78% over-expression of GR in the forebrain (including the cortex, 
hippocampus, CeA, BLA and nucleus accumbens) as well as the PVN, and possibly includes ectopic 
expression of GR within groups of neurons not normally expressing GR in the CNS such as the 
suprachiasmatic nucleus (SCN) 335. Importantly, GR over-expression excludes the cerebellum, 
thalamus and anterior pituitary gland as well as all peripheral organs. GROv mice show increases in 
CRHmRNA in the CeA and in expression of various neurotransmitter transporters 334. GROv mice 
offer the opportunity to investigate the role of increased GR in important limbic areas with the 
caveat that PVN over-expression of GR might make it difficult to disentangle hypothalamic vs. 
extra-hypothalamic GR modulation of HPA axis drive. Phenotypically, these mice presented 
increased levels of anxiety and despair in a number of specific tests. 
 
The above discussed variety of mouse models give clear insights into GR functioning in the CNS 
and brain. GR seems indeed implicated in emotion and cognitive performance. However, the 
diverse models have gained conflicting results regarding their role in hippocampal functioning. 
And still, there is not much known about the function of GRs in individual cells and discrete 
locations of the brain. This requires studies in more detail. With the advancement of refined 
molecular tools, it has become now possible creating animal models in which the functions of 
genes can be investigated in discrete brain regions and cell types. Therefore, the aim of my PhD 
project was to investigate the function of the GR specifically in the adult born dentate granule 
neurons of the hippocampus in respect to stress- related behaviour, neuronal networks and 
neurogenesis. The strategy of choice was an animal model in which GR expression could be 
reduced both selectively in place as well as time. 
 
 
1.6 RNA-INTERFERENCE TECHNOLOGY 
 
1.6.1 Biological function  
RNA-interference (RNAi, see Box 1.3) is a natural process triggered by double stranded RNAs 
(dsRNAs) 336 that cells use to turn down, or silence, the activity of specific genes. The 
phenomenon is highly conserved, as it is thought to have evolved about a billion years ago, before 
plants and animals diverged. The process exists in a wide variety of organisms, including single-
celled organisms, fungi, plants 337, worms 338, mammals 339 and even humans 340. In cells, RNAi has 
been implicated in temporal and spatially restricted gene regulation, imparting roles in brain 
morphogenesis and neuronal cell fate (reviewed in Davidson et al., 2007) 341. 
 
 
 
CHAPTER 1: GENERAL INTRODUCTION 
37 
 
Box 3 Discovery of RNA-interference  
The first discovery of the RNA-interference (RNAi) mechanism was by a lucky accident and occurred in petunias. Dutch 
researchers aimed to deepen the purple colour of petunias, by injecting the gene responsible into the flowers. But they 
were surprised by the results. Instead of a darker flower, the petunias were either variegated or completely white 
(Figure 1.5)! This phenomenon was termed co-suppression, since both the expression of the existing gene (the initial 
purple colour), and the introduced gene (to deepen the purple) were suppressed. Co-suppression has since been found 
in many other plant, fungi and animal species. It is now known that double stranded RNA is responsible for this effect: 
RNA interference. In 2006, Fire and Mellow were awarded the Nobel Prize for describing the phenomenon which is 
among one of the major discoveries in cell biology. Currently, this biological mechanism is applied as scientific tool for 
investigating the function of genes. This has become even more important since the sequenced human genome has 
revealed the presence of a staggering number of 30.000 genes. In addition, RNAi is being tested for possible 
applications in gene therapy. By the ability to knock down the expression of disease genes, RNAi is a promising new 
cure for a number of diseases previously no treatment was available for, such as cancer, viral infections, prion diseases 
and neurodegenerative disorders like ALS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Discovery of RNAi phenomenon in purple petunias. A variegated petunia, upon injection of the gene 
responsible for the purple colouring in petunias, the flowers became variegated or white rather than deeper purple as 
was expected. 
 
 
In addition to functioning in endogenous gene regulation (for example as an epigenetic 
mechanism during development), RNAi may originally have evolved to prevent or control genetic 
instability by silencing repetitive genes and transposons. Transposons are genetic elements in a 
double stranded RNA form, which can wreak havoc in the DNA by jumping from spot to spot on a 
genome, sometimes causing mutations that can lead to cancer or other diseases. The RNAi 
mechanism is triggered by the transposons and mediating their break down. Adding up to these 
cellular functions of RNAi, it is highly likely that RNAi has also evolved as a cellular defence 
mechanism against invaders such as RNA viruses. When they replicate, RNA viruses temporarily 
exist in a double-stranded form. Like transposons, this double-stranded intermediate would 
trigger RNAi and inactivate the virus’ genes, preventing an infection 342. 
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Figure 1.6. Mechanism of RNA-interference. Upon entering a cell, the double-stranded RNA molecules that trigger RNAi 
are cut into small fragments by the RNAse called Dicer. The small fragments then serve as guides, leading the cell’s RNAi 
machinery to mRNAs that match the genetic sequence of the fragments. The machinery then slices these cellular 
mRNAs, effectively destroying their messages and shutting off the protein expression of the corresponding gene. Figure 
by 343. 
 
1.6.2 Mechanism of gene knockdown 
RNAi works in highly specific fashion by destroying the molecular messengers (mRNAs) that carry 
information coded in genes to the cell’s protein factories (figure 1.6). In mammalian cells, the 
process starts when small interfering RNAs (siRNAs) are produced by enzymatic processing from 
double stranded RNAs (dsRNAs) by the RNase III class endoribonuclease Dicer. The newly formed 
siRNAs, usually about 21 base pairs in length, associate with Dicer, and other factors to form the 
RNA-induced silencing complex (RISC). As only one strand of the RNA is needed, once RISC has 
been associated, the non-functional “passenger strand” is discarded, whereas the other “guide 
strand” is retained and further directs the sequence specific gene silencing by disintegrating the 
mRNA of the target. 
The cellular RNAi machinery can be triggered endogenously by a variety of dsRNA sources, such as 
micro RNAs (miRNAs), transposons or viruses. It can also be triggered exogenously by the delivery 
of short hairpin RNAs (shRNAs, basically processed pre-miRNAs) or short interfering RNAs (siRNAs, 
or “mature” miRNAs) which can be made homologous to the target mRNA and then guide its 
sequence specific degradation (by the hydrolysis of complementary strands).  
The inhibitory RNAs can be designed specifically against the sequence of the target gene mRNA by 
a set of “design rules”. For reliable results, the specificity of RNAi must therefore be well 
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considered for its applications as a biological or therapeutical tool. The silencing can sometimes 
be non-specific or resulting in off-target effects on other genes, when siRNAs bind to and regulate 
unintended mRNA targets. Engineered siRNAs, shRNAs and miRNAs utilize endogenous RNAi 
machinery and can therefore at high doses cause toxicity independent of the sequence 341. Also, 
dsRNAs can, when introduced into mammalian cells, lead to an interferon response resulting in 
cell death and global gene silencing, but this can be circumvented by directly delivering siRNAs 339. 
 
1.6.3 Application of RNAi in functional genetic analysis and gene therapy  
After its discovery, the RNAi mechanism was rapidly used as a tool to investigate gene function 
(functional genetic analysis). The strength of RNAi as a research tool has an enormous potential 
impact on medicine. Knocking down a gene’s activity yields a wealth of information about its 
functions in cellular pathways and could lead to new therapy targets. But prior to the discovery of 
RNAi, the process was laborious and could take months, especially in transgenic (knockout) 
animal models, of which the development is laborious, costly and cumbersome.  
Investigating genes optimally requires control over gene expression in place and time. Place, 
because for example genes may have different functions in different cell types or tissues, and 
time because genes may have different functions in development. Careful control over gene 
expression may therefore limit unwanted side effects and compensation mechanisms. Use of 
RNAi -together with a suitable delivery approach- enables this and therefore is preferred over 
other strategies of gene manipulation (see Table 1.1).  
 
Pharmacological: (ant-) agonists 
+ Rapid action 
+ Systemic or local delivery 
+ In almost any model organism 
± Short term, reversible approach 
± More or less selective ligands available 
-  Slow development 
Immunological: antibodies 
+ Rapid action 
+ highly specific 
+ In almost any model organism 
± Systemic delivery only 
± Short term, reversible approach 
-  Slow development 
Genetical: transgene and  
gene targeting approaches  
+  Long term effect, irreversible 
+  Inducible, reversible systems possible 
-   Involves removal of part of the genes      
    on both alleles 
-  Developmental disruptions, side effects 
-   Confounding compensation   
    mechanisms and adaptations 
-  Time consuming and costly  
-  Preferably in mouse 
Post-transcriptional: RNAi  
+  Highly sequence (even allele) specific  
+  Time, location and cell specific delivery 
+  Inducible and transgenesis systems possible 
+  Relative fast and easy technique 
+  Reversible and irreversible approaches 
+  In almost any model organism 
±  Partial knockdown gene function 
 -  Only inhibition of gene expression possible 
 -  Possible off-target effects 
 
Table 1.1. Comparison of different techniques for the manipulation of the GR gene, its mRNA and protein products. 
See for in vivo applications of the pharmacological and genetical approaches for GR also §1.5. 
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Other advantages of the technique are its superb sequence specificity (even alleles), the 
possibility of inducible, reversible and permanent approaches and the partial knockdown of gene 
function, which mimics natural circumstances more than in full knockout approaches. In fact, 
partial inhibition of target gene function is also closely mimicking the approach of 
pharmacological inhibition for validating genes by antagonists 344. 
RNAi can be used as a research tool to silence selected genes quickly and easily, investigating their 
function and possibly this may lead to new drug targets. An effective knockdown of exogenous as 
well as endogenous genes has been demonstrated in several mammalian organs (e.g. liver, lung, 
spleen, kidney, brain, pancreas and skeletal muscle; reviewed in 344). Moreover, RNAi has been 
applied in cultured cell systems, organotypic slice cultures and different animal models. In animal 
models, knocking down genes underlying disease can for example induce a disease phenotype, in 
which the underlying molecular aspects can be studied.  
Another line of research implementing the RNAi phenomenon characterizes endogenous miRNAs 
expression patterns as they in fact could be underlying the molecular basis of disease. MiRNAs are 
involved in translational repression or mRNA degradation and can thereby lead to subtle 
(individual) differences in gene expression at protein level. The group of Uchida for example, has 
shown that the differential expression pattern in specific brain regions of miRNA-18a targeting the 
GR at protein level, are underlying the phenotypic differences in stress vulnerability in two rat 
strains; Fisher 344 rats and Sprague-Dawley rats 307.  
In addition to the application of RNAi as a research tool, RNAi can be used as a gene therapy in 
medicine. Diseases that can be blocked by down regulating the activity of one or several 
responsible genes are the most promising targets for RNAi-based therapies. Cancer, for example, 
is often caused by overactive mutations in onco-genes, and quelling their activity could halt the 
disease. Several pharmaceutical companies are currently testing RNAi-based therapies for various 
forms of cancer 345. 
Viral infections are important potential targets for RNAi-based therapies as well. Reducing the 
activity of key viral genes would cripple the virus, and numerous studies have already hinted at 
the promise of RNAi for treating viral infections. In laboratory-grown human cells, investigators 
have stopped the growth of HIV, polio, hepatitis C, and other viruses. RNAi-based therapies 
against HIV and other viruses are expected to soon enter clinical trials 346.  
Recently, the RNAi technology has also been used to limit prion-disease like scrapies 347-349. This 
was tested using lentiviral-mediated delivery in the oocytes of both goats and cows. Also in a 
mouse model of scrapies, successful lentiviral-mediated RNAi knockdown of the diseasing prion 
protein was obtained. Mice not only survived longer, but also their behavioural deficits and 
neuronal damage could be reduced using RNAi as treatment 347. As the strategy was successful, in 
future it could be used to generate transgenic prion-disease resistant live hood stocks.  
However, one of the most promising and appealing applications of RNAi in therapy is probably in 
neurodegenerative disorders; severe diseases where previously no cure for existed. Engineered 
RNAi molecules for example have been tested as novel therapeutics for treating these 
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neurological disorders in mouse models for Huntington’s disease, Alzheimer’s, Spinocerebellar 
ataxia type I, and Amyotrophic lateral sclerosis, among others (see for a review 341;342;350-352). 
 
Thus, in relatively short time, RNAi has proven to be a very potent and selective research tool with 
lots of possibilities, applications, and advantages. We therefore selected this technology for 
knocking down GR protein expression in adult born dentate granule cells of the hippocampus of 
adult mice. 
 
 
1.7 DELIVERY OF RNAI IN THE BRAIN 
 
As discussed in the previous paragraph, spatial and temporal control of gene expression is the 
approach for studying gene function properly in animal models. RNAi enables this, and has several 
advantages over the more classical pharmacological and genetic approaches. However, effective 
delivery of RNAi molecules (miRNA, shRNA, siRNA) into target cells and tissues is critical for 
successful RNAi application. In this section I will describe the difficulties associated with siRNA 
delivery in the brain and an approach to target the GR in such a way that its protein expression 
may be manipulated in a cell type specific manner. 
 
1.7.1 Delivery difficulties 
A major difficulty in targeting genes by RNAi is the delivery. Delivery of compounds such as siRNA 
molecules needs to be performed in such a way that tissue damage is prevented, while the 
compounds can reach their target. Especially delivery into the brain is complex. The brains 
intricate anatomical divisions, molecular complexity and the fragile nature of its cellular 
populations make interventions very complicated 342. In addition, the brain is inaccessible for 
compounds (> 500 dalton, without lipid solubility or transport systems) such as siRNA molecules 
because of the Blood-Brain-Barrier (BBB). This neuroprotective, membranic structure acts 
primarily to protect the brain from chemicals in the blood, while still allowing essential metabolic 
function.  
Overcoming this delivery hurdle, mechanisms for siRNA delivery in the brain involve going either 
"through" or "behind" the BBB. For RNAi delivery locally in the brain, the last strategy is most 
optimal. Strategies for siRNA delivery behind the BBB include for example the application of 
naked or chemically modified RNAi molecules, plasmid transfection and viral transduction by local 
intra-cerebral injection using a stereotact (Fig 1.7). Using the stereotactic injection-strategy it is 
possible to deliver RNAi molecules or their vectors at any target site in the brain as small as a 
hippocampal subfield, such as the DG, with a minimum of damage 94;208;347;353. Using cannulae/ 
implanted pumps even continuous injections can be given 354. 
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Figure 1.7 Stereotactic delivery in the mouse brain. Using a stereotact, precise and localized injections can be placed in 
the brain. Using the frame, the injection needle can be placed at the specified coordinates with a precision of 0.05 mm. 
 
Another difficulty is the short, temporary, timeframe of RNAi induced by transient transfection of 
naked siRNAs requesting continuous or repeated delivery. Moreover, the high doses that are 
needed to achieve the knockdown in the brain go together with the off-target and non-specific 
side effects. Chemically modified or plasmid-based RNAi is often insufficient as well. These 
problems can be circumvented using viral vectors that genomically express shRNAs. Long-term 
RNAi may for instance be achieved with lentiviruses 355-357, adenoviruses 358 and adeno-associated 
viruses 359-362. 
 
1.7.2 Lentiviral transgenesis 
Viral vectors are a well established means for (long-term) delivery of shRNAs into the brain. In 
general, viral vectors are commonly used to deliver genetic material into cells both in vitro and in 
vivo without severely affecting cell viability and physiology. Especially lentiviral vectors can deliver 
a significant amount of genetic information such as transgenes or shRNAs, into the DNA of the 
host cell 363, without inducing an immune response or cytotoxicity 364. Moreover, lentiviral vectors 
are able to transfect cells that are normally difficult to manipulate 355 and are generally simple and 
inexpensive to produce. In addition, the stable integration of transgenes into the genome of the 
target cells can be -depending of course on research questions and experimental set up- a 
convenient characteristic. It results in a model of long term and irreversible transgene expression, 
and as the genes are incorporated into the DNA, the transgenes are passed on to the progeny 
when the cell divides. Because of this feature, combined with the many other advantages, 
lentiviral vectors have been intensely used in both in vitro and in vivo research models. 
Lentiviral vectors are derived from Human Immunodeficiency Virus 1 (HIV-1), which belong to the 
Retroviridae family, and are characterized by a long incubation period. Because they originate 
from pathogenic viruses, the major emphasis in the construction of these vectors has been on 
their safety. The general strategy has been to use as few genetic elements of the lentiviral 
genome as possible by deleting specific genes (required for replication and pathogenic properties) 
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and to make them replication incompetent and self-inactivating, while still enabling strong 
transduction efficiencies.  
Another safety concern characteristically for retroviruses is their unpredictable, random 
integration site of their RNA-based genome into the DNA. The site of integration may cause 
problems, when the provirus disturbs the function of cellular genes and lead to activation of onco-
genes. This can promote the development of cancer and leukemia. This however is unlikely to 
happen during the short duration of animal experiments.  
 
1.7.3 Transduction of adult born dentate granule neurons  
Although the dentate gyrus has been shown to be the most susceptible brain region to the gene 
knockdown effect of intracerebal-ventricular delivery of naked siRNAs 344, cell type specific 
delivery in the brain is a challenge. With the advancement of technology, only recently a few 
animal models with more or less cell type specific delivery have been described. Most of these 
models use gene targeting strategies in which the targeted genes are expressed or suppressed 
under de control of a cell type specific promoter 98;365;366. In these transgenic animals, the genes 
are targeted from embryonic development. Other recent strategies have used retroviral labelling 
of dividing NPCs in adult animals 95;103;367;368. 
A major advantage of lentiviral-based shRNA delivery systems is that they, in contrast to other 
retroviral vectors, such as MMLV, can efficiently infect both actively dividing, non-dividing post-
mitotic, and terminally differentiated cells such as neurons and muscle cells 353;355;369;370. Lentiviral 
vectors are therefore valuable tools for permanent and stable gene silencing in neurons at 
different stages of development, such as differentiating adult born dentate granule neurons. 
In order to deliver shRNA molecules in adult born dentate granule neurons, we have chosen for a 
third generation lentivirus. This delivery system contains two expression cassettes. On cassette 
contains a hairpin sequence encoding siRNA precursor. This typically uses the type III class of RNA 
polymerase III promotor sequences, such as e.g. H1, to drive constitutive expression of the 
hairpin. The other cassette is a RNA polymerase II transcription unit directing stable expression of 
a marker protein such as green fluorescent protein (GFP). This marker is widely used to 
permanently label living cells in vitro and in vivo. This makes it possible to track transduced cells 
and their progeny for analysis of gene knockdown.  
 
 
1.8 RATIONALE AND OBJECTIVES  
 
In the previous sections I have described the stress response and the effects of GCs on the 
different tissues and cell types of the brain. I focused on the profound effects of GCs in 
modulating cellular properties, circuitry and behaviour in the hippocampus. Subsequently, I briefly 
laid out the present evidence for the possible role of GCs and hippocampal GRs in health and 
disease. Based on recent evidence suggesting that 1) neurogenesis may be a substrate for certain 
types of hippocampal function (see Box 1), and 2) adult born dentate granule neurons express GR 
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(see paragraph 1.2.3) this culminated in the hypothesis that 
 
hippocampal GRs may affect hippocampal function by modulating 
neurogenesis. 
 
The underlying mechanism is not clear and needs thorough investigation. This not only will gain 
fundamental information about the biology and cellular processes involved; knowledge of the 
pathogenic mechanisms underlying disease may provide novel targets for therapy. In the case of 
stress-related-diseases this is particularly important as chronic stress and all its associated 
pathologies play an ever increasing role in Western society. In addition, current therapies 
targeting the HPA axis are not very specific as they affect all cells of the body. More knowledge 
about the cell type specific functions of HPA axis parts may be the basis for the development of 
more specific and refined drugs with fewer side effects. 
 
Therefore, the main objective of this thesis was investigating the role of the GR in adult born 
dentate granule neurons of the hippocampus in relation to neuroplasticity and cognitive 
performance.  
 
In the last sections of this chapter, I explained that although GR has already been thoroughly 
investigated in a variety of animal models, thus far there has been a lack of cell type specific 
models for GR. I reasoned that this was caused by a lack of refined techniques. I introduced then 
the new RNAi technology and proposed a lentivirus-mediated cell type-specific delivery strategy 
for targeting adult born dentate granule neurons in the hippocampus.  
 
Therefore, the second objective of my PhD project was to investigate the applicability of such a 
new, precise method: lentiviral-shRNA injections in the dentate gyrus.  
 
 
1.9 CHAPTER OVERVIEW 
 
Chapter two is the first experimental chapter. In this chapter I will show the results of the 
optimization phase of the experiments. shRNAs directed against the GR (shGR) were designed, 
tested and selected in an in vitro system. A neuronal cell line was used for testing of different 
types and doses of shRNA constructs and their controls. Then a selected shGR construct and its 
mismatch control was further optimized by dose-response tests and tests for the time frame of 
the GR knockdown. Finally, these constructs were successful built into a lentiviral vector.  
In chapter three, the results of optimization of delivery in the mouse hippocampus by different 
types of lentiviral vectors are shown. We investigated the transduction efficiency and GFP 
expression patterns of neuron-specific and non-cell type specific viruses. We show for the first 
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time that the lentivirus transduces a specific subpopulation of DCX+ neuronal progenitor cells and 
immature, adult born dentate granule neurons. This observation is fundamental for the in vivo 
study of genes in a cell type-specific manner. 
In chapter four, the functional effects of LV-shRNA mediated GR knockdown in the DG are 
described in several experiments at the cellular level. One week after GR knockdown, we 
observed altered differentiation and migration of newborn dentate granule neurons. These 
observations were strengthened by evidence for altered structural plasticity and physiological 
properties of matured dentate granule neurons 5 weeks after GR knockdown. This evidence 
points to a critical role of GR in the fate determination of newborn dentate granule neurons. 
In chapter five, the functional effects of LV-shRNA mediated GR knockdown in the DG are 
described at the behavioural level. In this experiment, 5 weeks after LV-shRNA treatment, mice 
were subjected to a context and cue fear conditioning test to measure their fear-related memory 
capacities and coping strategies. In GR knockdown mice we observed a specific memory 
consolidation impairment. In addition, we found plasma corticosterone concentrations were 
similar between GR knockdown and control mice.  
This thesis will end with chapter six. In this final chapter a synopsis of all major findings is given. 
The application of lentiviral-mediated RNAi for the generation of new and more selective animal 
models is discussed. In addition, the outcome of GR knockdown for the fate of newborn dentate 
granule neurons is evaluated to assess the role of GR in modulating neurogenesis and 
hippocampal functioning. Furthermore I will discuss the possible consequences and implications 
of the new insights gained in the present study.  
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IN VITRO VALIDATION OF 
GLUCOCORTICOID RECEPTOR SILENCING  
BY RNA-INTERFERENCE 
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ABSTRACT  
 
In this study we describe the design and optimization of effective RNA-interfering constructs 
targeting the glucocorticoid receptor (GR). To achieve potent knockdown of the GR, we have 
designed four different sequence-specific short interfering RNA constructs. These constructs were 
cloned into pSuper vector in a short hairpin format. Subsequently, pSuper-shRNA constructs were 
transfected into a neuronal cell line and assessed for their potency to down-regulate GR protein 
levels. Using Western Blot analysis we determined the efficacy of the different constructs 
compared to sham, empty vector and corresponding mismatch shRNA. We found four effective 
pm- shRNAs, one (pm-GR3) with high potency to yield more than 90% GR protein knockdown, 
whereas the 3 others were less potent (pm-GR2 ~ 60%, pm-GR1 ~ 46% and pm-GR4 ~ 25% 
respectively). Pm-GR3 was subsequently cloned into a lentiviral vector and its potency was 
verified, gaining > 70% GR protein knockdown. Using shRNA constructs it was possible to 
specifically down regulate GR expression both via plasmid- and lentiviral vectors in a neuronal cell 
line. Therefore, this lentiviral vector may be a useful tool to knockdown GR in specific cell 
populations in the brain.  
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INTRODUCTION 
 
Glucocorticoid receptors (GRs) mediate a wide array of cellular and physiological processes and 
are central in adaptation to stress and maintaining homeostasis 11. They exert these functions by 
regulating the expression of numerous downstream glucocorticoid-responsive genes, thereby 
mediating a wide array of cellular and physiological processes. This fundamental role has made 
GR a target in many studies of functional genomic analysis. However, although ubiquitously and 
constitutively expressed, GR’s tissue- and cell type specific actions have thus far been difficult to 
unravel 35. This is particularly true in the central nervous system, where its complex anatomical 
organization underlies the pleiotropic actions of glucocorticoids 44;371. 
Abrogating gene function is still one of the primary means of examining the physiological 
significance of a given gene product 344. However, traditional pharmacological and transgenic 
animal models generally do not have enough resolution to investigate gene function at the level 
of a small brain region. We therefore chose to apply a new strategy: RNA-interference (RNAi), to 
investigate the function of the GR in specific neuronal subfields. RNAi is able to knockdown gene 
expression by degrading mRNAs of target genes. This phenomenon has since its discovery in 
purple petunias (see also CHAPTER 1, box 3) 337 and Caenorhabditis elegans 338, been observed in a 
variety of other organisms, including mammals 339. Initially acknowledged as a cellular surveillance 
system, RNAi rapidly became a powerful tool to investigate gene function.  
Gene silencing by RNAi is triggered by the cytoplasmatic presence of small double stranded RNAs. 
These small non-coding RNAs are enzymatically processed by RNase III class endoribonuclease 
Dicer, yielding ~ 21 pb short interfering (si) RNAs. Newly produced small duplex siRNAs then 
associate with Dicer and other factors, and compose the RNA-induced silencing complex (RISC). 
Once RISC has been associated, the non-functional “passenger strand” is discarded, whereas the 
other “guide strand” is retained. The guide strand anneals to fully complementary target mRNA 
and further directs the sequence-specific gene-silencing. 
Dependent on the sequence complimentarity of the small non coding RNAs, RNAi results either in 
translational arrest or full mRNA degradation. MessengerRNA degradation by hydrolysis of the 
target sequence is typically caused by full complementary short interfering and short hairpin RNAs 
(siRNAs, shRNAs respectively) of exogenous (viral) origin 372. In contrast, endogenously originating 
microRNAs (miRNAs) generally have lower sequence compatibility, leading to translational arrest. 
Although RNAi is a natural occurring process of gene regulation, in recent years it was noticed, 
that the varying levels of sequence complimentarity can have different effects. In fact, 
semicomplimentary RNAi sequences could underlie not only different levels target gene silencing, 
but also render RNAi ineffective or even underlying interference with other genes, resulting in off-
target effects. 
Much attention therefore has focused on understanding how precisely the sequence of short RNA 
duplexes determines the efficiency and specificity with which RISC degrades mRNA 373;374. The 
effectiveness of gene silencing appears to depend on the sequence specific and thermodynamic 
properties of siRNA 375. This not only determines compatibility with the target but also loading of 
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the appropriate guide strand into the RISC complex. Based on this, a set of empirically based and 
rational “design rules” has been developed (See Figure 2.1) 373;374;376.  
In this study we have applied these rules to design several RNAi constructs and their controls for 
GR knockdown. Towards this end, we optimized and selected potent and efficient shRNA 
constructs for functionally silencing GR at both mRNA and protein level. In addition, we 
incorporated these shRNA constructs in lentiviral vectors for effective neuronal delivery.   
 
 
MATERIALS AND METHODS 
 
Experimental setup  
In this study we designed several perfect match (pm) short hairpin RNAs (shRNAs) constructs 
against the GR and their non-specific, mismatch (mm) constructs bearing two point mutations. 
The efficiency for downregulation of GR expression was subsequently assessed in vitro. Firstly, we 
tested the efficiency of shRNA constructs to knockdown endogenous GR in the rat Neuroscreen-1 
(Ns-1) PC12 cell line. GR protein knockdown was assessed by Western Blot analysis. Selection of 
the most optimal shRNA construct involved dose-response curves and time course studies in 
comparison with mm-shRNA, empty vector, and mock transfection as controls. Selected shRNA 
constructs were checked for functional GR knockdown in a reporter gene assay and subsequently 
cloned into lentiviral vectors. These lentiviruses were then verified for their ability to knockdown 
GR protein expression. 
 
Design of short hairpin RNA constructs 
Four different pm-shRNA constructs (named pm-GR1-GR4) and their 2 nt-mismatch controls 
(named mm-GR1-GR4) directed against a consensus sequence of the mouse (mus musculus; GR1-
4), rat (rattus norvegicus; GR1-4) and human (homo sapiens; GR3-4) glucocorticoid receptor 
(Nr3C1 at chromosome 18) 377 were designed from the Ensemble genome browser/ database 
(www.ensembl.org; gene ID: ENSMUSG00000024431 and transcript ID: ENSMUST00000025300). 
The design was done according to the 9 critera of Ui-Tei et al and Reynolds et al (Figure 2.1 and 
Table 2.1A-B) 373;374. These pm sequences of GR- targeting shRNAs (NM_008173) were checked for 
theoretical specificity against the mouse transcriptome. BLAST search indicated perfect sequence 
homology with NR3C1 (GR) and limited sequence homology with a Zink finger gene (pm-GR2; 15/ 
19 nucleotide homology), TATA box gene (pm-GR3; 15/ 19 nucleotide homology) or 
synaptotagmin (pm-GR4; 16/ 19 nucleotide homology). However, according to the design rules, 
our pm-shRNA constructs are expected not to influence expression of these genes as there is only 
partial overlap. In addition, none of the pm-shRNA sequences overlap with seed regions of any 
mRNA. To get insight into which extent a guide strand binding site is accessible, we inspected 
prediction of secondary structures by Sfold software 378 of the GR mRNA. Mismatch sequences 
were used as negative controls for pm-shRNAs to account for non-sequence specific effects. 
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Oligonucleotides were obtained from Isogen (Isogen Life Science, De Meern, The Netherlands) 
(See Table 2.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 General criteria to design efficient shRNAs and their mismatch duplexes. The criteria are based on guide 
(sense) strand. PM). pm-siRNA design rules. The design rules can be divided into two categories; 1) Rules attributing the 
thermodynamic properties of the shRNAs, important for initial shRNA-RISC recognition; such as I) Use 21-nt RNA 
duplexes, II) 2-nt overhangs, III) No G/C rich regions (longer than 9 bp); G/C content 30-52%, IV) A/T richness in the 3’ 
end of the Sense strand (last 7 bp), V) lack of internal repeats. 2) Rules that may affect critical shRNA-protein 
interactions, such as VI) T/A in position 19 of the Sense strand, VII) A in position 3 of the Sense strand, VIII) T in position 
10 of the Sense strand, IX) No G in position 13 of the Sense strand, X) G/C at the 5’ end of the Sense strand 373;374. MM). 
Mismatch design rules 376. Indicated areas give tolerance for the mismatch point mutation. Best positions for point 
mutation are 5-11. To generate effective point mutations, nucleotide substitutions should be A to C; T to A/G; G to T/C 
and C to A/G.  
 
Cell cultures  
Ns-1 PC12 rat pheochromocytoma cells (Cellomics Europe) were used for Western blotting 
experiments and express GR endogenously. Ns-1 PC12 cells, were cultured at 37 °C at 5% CO2 in 
Roswell Park Memorial Institute (RPMI) 1640 medium, supplemented with 5% fetal bovine serum 
(FBS), 10% horse serum, penicillin (20 U/mL), and streptomycin (20 μg/mL; all Invitrogen, 
Carlsbad, CA). The N1E-115 mouse neuroblastoma cell line was previously shown to express GR 
endogenously as well 67. This cell line was used for reporter assay experiments. N1E 115 cells were 
cultured at 37 °C at 5% CO2 in DMEM medium (4500 mg/l glucose, Invitrogen Life Technologies, 
Carlsbad, CA, USA), supplemented with Glutamine, penicillin (20 U/mL) and 2% FBS. 
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A. 
Name       
pm-
shRNA 
construct 
pm design rules according to thermodynamic properties 
I 
Length 21 
nt 
II 
2 nt 
overhangs 
III 
%GC=30-52 
IV 
Last 7≥5A/T 
V 
Lack of repeats 
pm-GR1 Y Y Y (48%) N (4) Y 
pm-GR2 Y Y Y (48%) N (4) Y 
pm-GR3* Y Y Y (38%) N (4) Y 
pm-GR4 Y Y Y (38%) N (3) Y 
 
B. 
Name       
pm-
shRNA 
construct 
pm design rules according to nucleotide type and position 
VI 
19=A/T 
VII 
3=A 
VIII 
10=T 
IX 
13≠G 
X 
1=G/C 
pm-GR1 Y N N Y Y 
pm-GR2 Y Y N Y Y 
pm-GR3* Y Y N Y Y 
pm-GR4 N Y N Y N 
 
C. 
Name       
mm-
shRNA 
construct 
mm design rules according to nucleotide type and position 
Point mutation 1 
nucleotide type 
Point mutation 1 
position 
Point mutation 2 
Nucleotide type 
Point mutation 2 
position 
mm-GR1 G  T 3 T  G 13 
mm-GR2 A  C 3 T  G 13 
mm-
GR3* 
A  C 3 A  C 13 
mm-GR4 A  C 3 A  C 13 
 
Table 2.1 Overview of the application of shRNA design rules to the four constructs (see also figure 1). A) Design rules 
for pm-shRNA constructs according to thermodynamic properties. B) Design rules for pm-shRNA constructs according to 
nucleotide type and position, affecting shRNA-protein interactions. Y(es): design rule is applied, N(o): design rule is not 
applied. The four pm-siRNA constructs apply to 6-8 out of 10 design rules. * Selected for in vivo studies (see results 
section). C) Design rules for mm-siRNA constructs. Rules for both nucleotide mutations and nucleotide position have 
been applied. For both mm-siRNA and pm-siRNA constructs two additional rules are followed for length of the construct 
(19-25 bp) and the presence of a 3’ dinucleotide overhang (reviewed in  379). 
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name 
construct 
flankin
g 
region 
shRNA sequence 
 
hairpin shRNA sequence 
reverse  
flanking region 
pm-GR1 
sense 
5’ 
gatcccc 
cagactttcggcttctgga 
passenger 
ttcaagag
a 
tccagaagccgaaagtctg 
guide 
tttttggaaa 3’ 
pm-GR1 
antisense 
3’ ggg gtctgaaagccgaagacct 
guide 
aagttctct aggtcttcggctttcagac 
passenger 
aaaaaccttttcga 
5’ 
mm-GR1 
sense 
5’ 
gatcccc 
caTactttcggcGtctgga 
passenger 
ttcaagag
a 
tccagaCgccgaaagtAtg 
guide 
tttttggaaa 3’ 
mm-GR1 
antisense 
3’ ggg gtAtgaaagccgCagacct 
guide 
aagttctct aggtctGcggctttcaTac 
passenger 
aaaaaccttttcga 
5’ 
pm-GR2 
sense 
5’ 
gatcccc 
gcagcagaggattctcctt 
passenger 
ttcaagag
a 
aaggagaatcctctgctgc 
guide 
tttttggaaa 3’ 
pm-GR2 
antisense 
3’ ggg cgtcgtctcctaagaggaa 
guide 
aagttctct ttcctcttaggagacgacg 
passenger 
aaaaaccttttcga 
5’ 
mm-GR2 
sense 
5’ 
gatcccc 
gcCgcagaggatGctcctt 
passenger 
ttcaagag
a 
aaggagCatcctctgcGgc 
guide 
tttttggaaa 3’ 
mm-GR2 
antisense 
3’ ggg cgGcgtctcctaCgaggaa 
guide 
aagttctct ttcctcGtaggagacgCcg 
passenger 
aaaaaccttttcga 
5’ 
pm-GR3* 
sense 
5’ 
gatcccc 
gaaagcattgcaaacctca 
passenger 
ttcaagag
a 
tgaggtttgcaatgctttc 
guide 
tttttggaaa 3’ 
pm-GR3* 
antisense 
3’ ggg ctttcgtaacgtttggagt 
guide 
aagttctct actccaaacgttacgaaag 
passenger 
aaaaaccttttcga 
5’ 
mm-GR3* 
sense 
5’ 
gatcccc 
gaCagcattgcaCacctca 
passenger 
ttcaagag
a 
tgaggtGtgcaatgctGtc 
guide 
tttttggaaa 3’ 
mm-GR3* 
antisense 
3’ ggg ctGtcgtaacgtGtggaGt 
guide 
aagttctct actccaCacgttacgaCag 
passenger 
aaaaaccttttcga 
5’ 
pm-GR4 
sense 
5’ 
gatcccc 
ttaagcaagagaaactggg 
passenger 
ttcaagag
a 
cccagtttctcttgcttaa 
guide 
tttttggaaa 3’ 
pm-GR4 
antisense 
3’ ggg aattcgttctctttgaccc 
guide 
aagttctct gggtcaaagagaacgaatt 
passenger 
aaaaaccttttcga 
5’ 
mm-GR4 
sense 
5’ 
gatcccc 
ttCagcaagagaCactggg 
passenger 
ttcaagag
a 
cccagtGtctcttgctGaa 
guide 
tttttggaaa 3’ 
mm-GR4 
antisense 
3’ ggg aaGtcgttctctGtgaccc 
guide 
aagttctct gggtcaCagagaacgaCtt 
passenger 
aaaaaccttttcga 
5’ 
 
Table 2.2 Sequences siRNA constructs and complete short hairpin format against GR. In this table the four different 64- 
oligonucleotide constructs for perfect match and mismatch shRNA against GR are shown. Passenger shRNA sequences 
are comparable to the target GR mRNA sequences. The guide shRNA sequence is complementary to the passenger and 
incorporated in RISC. Capitals in mm-shRNA sequence indicate point mutation compared to pm-shRNA sequence. * 
Selected constructs for in vivo studies.  
 
Plasmid-shRNA transfections 
The sense and antisense oligonucleotides of 64 bp long were annealed and cloned in between 
BglII and HindIII sites of the plasmid p-Super (The Netherlands Cancer Institute, Amsterdam, The 
Netherlands) 375. Insertion of the oligonucleotides was confirmed by sequence analysis and 
positive clones were stored at -80°C. A day prior to transfection, 3x104 cells per well were plated 
in a 24 well plate, and then incubated under normal growth conditions (37°C and 5% CO2). For 
each well, the cells were transfected with 3 μg plasmid using using 6 μl Superfect transfection 
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reagent (Promega Corp. Madison, WI, USA). After transfection, cells were kept in DMEM 
containing 5% stripped FBS overnight. For the dose-response experiment, different total 
concentrations of DNA were kept constant using empty vector p-Super.  
 
Protein extraction and Western blot analysis 
Western Blot analysis was performed to verify shRNA-mediated GR protein knockdown in NS-1 
PC12 cells. For this purpose, cells from two separate culture dishes per experimental group, were 
lysed in ice cold 0.5× radioimmunoprecipitation assay (RIPA) buffer (20 mM triethanolamine, 0.14 
M NaCl, 0.05% deoxycetant, 0.05% SDS, 0.05% Triton X-100) substituted with protease inhibitors 
(complete Protease Inhibitor Cocktail tablets; Roche Applied Science, Penzberg, Germany). 
Subsequently, the cell lysates were centrifuged for 30 minutes at 13.000 rpm at 4°C after which 
the supernatants were collected. Protein content was quantified using the BCATM Protein Asay 
(Pierce Biotechnology, Rockefort, IL, USA) and from each sample, 25 μg was loaded onto a 10% 
SDS-PAGE gel 380. After electrophoresis, the samples were blotted overnight onto an Immobilon P 
membrane (Millipore Corp., MA, USA) and processed as described (Vreugdenhil et al., 2007) 381. 
Blots were blocked in 10 mm Tris-HCl (pH 8.0), 150 mm NaCl, and 0.05% Tween 20 containing 5% 
nonfat dried milk powder. GR was subsequently detected using the M-20 GR antibody (1:500, 
Santa-Cruz Biotechnology, Santa Cruz, CA, USA) as a primary antibody and goat-anti-rabbit IgA 
conjugated with horse raddish peroxidase (1:5000- 1:10.000, Jackson ImmunoResearch 
Laboratories, PA, USA) as a secondary antibody. Tubulin (monoclonal anti-α-tubulin antibody; 
Sigma, 1:1000- 1:5000) expression levels were used for normalization. Luminol sodium salt 
(Sigma®) substituted with p-Coumaric acid (Sigma®) was used as substrate for the peroxidase 
reaction. Western blot experiments contained two biological samples per treatment group. Grey 
levels of immunopositive bands were determined by analyzing relative optical densities using 
Image J software (NIH, Bethesda, MD).  
 
Dual luciferase reporter assay 
Construct pm- and mm-GR3 were screened for its functional in vitro knockdown efficiency in a 
luciferase reporter assay. In this assay, GR-dependent transcriptional activity was measured in 
transfected N1E-115 cells by using a Dual Luciferase (Promega Corp. Madison, WI)- based GC 
response element reporter gene assay as previously described 67. Cells were co-transfected with 
either pm-GR3- or mm-GR3- p-Super plasmid, TAT3 (containing 3 different GRE’s controlling the 
firefly luciferase expression) and PCMV (containing Renilla luciferase as internal control), as 
described above. 24 h after transfection, cells were treated for another 24 h with 1x10-7 M 
dexamethasone, a potent GR agonist. Results are expressed as mean GR transcriptional activity 
±SEM of three independent experiments performed in duplicate.  
 
Lentiviral vectors 
p-Super vector GR pm-shRNA and corresponding mm-shRNA constructs were sub-cloned into a 
vesicular stomatitis virus G glycoprotein (VSV-G)-pseudotyped advanced generation lentiviral 
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vector (Invitrogen BV, Breda, The Netherlands) downstream of the H1 promotor (see figure 2.2). 
In addition, the lentiviral vector contained an EGFP transgene downstream of a cytomegalovirus 
(CMV) promoter 382. Lentiviral vectors were produced in 293FT cells using the ViraPower Lentiviral 
Expression System following the manufacturer’s instructions (Invitrogen BV, Breda, The 
Netherlands). Virus containing supernatant was harvested 48 hr after transfection. Lentiviral 
constructs were concentrated by two rounds of ultracentrifugation. The titers were measured by 
rt-PCR and verified by EGFP expression as previously described 67. Titers of both viruses were 
comparable and ranged between 1x108 and 1x109 transducing U/ml. Virus suspensions were 
stored at -80°C until further use and were briefly centrifuged and kept on ice immediately before 
transduction of Ns-1 PC12 cells. 
 
 
 
 
Figure 2.2 Schematic representation of the Lentiviral vector for shRNA delivery. The lentivirus contains the shRNA 
construct expressed from a H1 promotor and in addition a visual marker; enhanced green fluorescent protein (EGFP), 
expressed from a CMV promoter. 
 
Statistics 
Overall statistical analysis was performed using unpaired t test (two groups) or one-way ANOVA 
(three or more groups) using SPSS 15.0 and statistical significance was determined with Tukey’s 
multiple comparison tests with P < 0.05. 
 
 
RESULTS 
 
Design of multiple shRNA constructs against the glucocorticoid receptor 
In this study, we aimed to characterize efficient shRNA constructs targeting the glucocorticoid 
receptor. Firstly, we designed four different 21 nt long oligonucleotide sequences, targeting the 
murine GR and incorporated them into DNA vectors (see Table 2.2). As the GR gene consists of 
areas that are highly homologous to other members of the nuclear receptor subfamily 3, we 
selected a less conserved domain of the GR gene. As exon 2 contains unique sequences for the GR 
gene, we designed all the pm-shRNA sequences (and their mismatch controls) against this region 
(see figure 2.3).  
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Figure 2.3 Schematic representation of the glucocorticoid receptor transcript and its shRNA targets. Numbers indicate 
exons and abbreviations functional domains of GR: N) N-terminal domain including a ligand-independent transcription 
activation function-1, D) DNA-binding domain, H) hinge region, L) Ligand-binding domain, and C) C-terminus. Arrows 
indicate sequence areas of shRNA constructs targeting the murine transcript (according to Ensemble; ENSMUS&25300); 
sequence area GR1 (nt) 519-537; GR2 289-307; GR3 539-557; GR4 1041-1060. 
 
Testing of constructs 
Plasmid delivery of shRNAs is a relatively easy strategy to introduce shRNA molecules into cells. 
We assessed therefore the efficiency of plasmid-based pm-shRNAs for GR protein knockdown in a 
Ns-1 PC12 cell line. These neuronal cells express GR endogenously and constitutively, and are in 
that sense comparable to the in vivo situation. Firstly, the four different plasmid-shRNA constructs 
were assessed for their potency to knockdown GR at the protein level. To this end, different 
plates of Ns-1 PC 12 cells were transfected with 3 μg of plasmids containing the different pm-
shRNA constructs and two mm-shRNA controls. As a pilot experiment, two, four and six days after 
plasmid transfection, GR protein levels were determined by Western Blot analysis (data not 
shown). We observed that pm-GR3 is able to down-regulate GR protein levels by more than 70 % 
at an optimal time point of four days. Other constructs were less potent; pm-GR1 46%, pm-GR2 
60% and pm-GR4 25% respectively (data not shown). These initial observations for pm-GR3 were 
strengthened by a similar experiment in triplo. Four days after shRNA-plasmid transfection, GR 
protein was significantly down-regulated by 95% (4.7% ± 1,8 STD, p=0.000), as compared to 
controls. In fact, mm-shRNA control did not differ from both mock transfection and empty vector 
pSuper controls (see Figure 2.4A). Therefore we selected pm-GR3 for further experimentation. 
In a subsequent experiment, we optimized the transfection dose. From three different doses of 
pm-GR3; 1, 2, and 3 μg, efficiency for GR protein knockdown was measured in duplo four days 
after transfection. This resulted in GR protein knockdown of 63% ± 18.4, 83% ± 0.6, and 90% ± 9.3 
respectively (Figure 2.4B). Although statistically not significant, a clear trend is observed 
suggesting a dose-response relationship in which the highest dose of pm-GR3 gave the highest GR 
protein knockdown. Actually, GR protein knockdown was significantly down-regulated at all pm-
GR3 shRNA-plasmid doses compared to the three controls used (P= 0.000). Again, the mm-shRNA 
control proved an appropriate control as compared to both mock transfection and empty vector 
pSuper controls.  
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Figure 2.4. Selection of potent pm-shRNA constructs. A) pm-GR3 was tested for its efficiency to knockdown endogenous 
GR protein in Ns-1 PC12 cells. Relative GR protein levels four days after treatment with 3 μg pm-GR3 in comparison with 
different controls (mm-GR3, mock transfection (-) and pSuper). Data were normalized by measuring α-tubilin levels. 
Asterisk indicates p=0,000. Representative Western blots are depicted on top of the graph. B) Dose response curve for 
plasmid-shRNAs. Relative pm-GR3-mediated GR knockdown in Ns-1 PC12 cells, as determined by Western Blot. Data 
were normalized by measuring α- tubilin levels. Asterisk indicates p=0,000. Representative Western blots are depicted on 
top of the graph. For further details: see Materials and Methods and text. 
 
In addition to assessing GR knockdown at protein level, we measured whether pm-GR3 could 
affect GR transactivation properties by performing a Dual luciferase reporter assay. In this assay, 
luciferase expression is driven by multiple GREs and luciferase activity is a measurement for GR 
trans-activitation properties. Dexamethasone (DEX)-activated GR was assessed for its capacity to 
induce transcription of a luciferase reporter gene. Inactive, non-ligand bound GR and mm-GR3 
conditions were used as negative controls. As expected, four days after mm-GR3 treatment a 
robust DEX- dependent activation of luciferase expression (0.194 ± 0.016 L.U.) was observed 
(Figure 2.5). In contrast, pm-GR3 treatment did not show such a DEX-dependent luciferase 
expression (0.016 ± 0.003 L.U.). In fact, compared to mm-GR3/+DEX treatment this lack of 
luciferase induction corresponds to a significant 92% (p= 0.000) reduction of GR trans-activation 
properties. Moreover, RNAi-mediated inactivation of ligand-bound GR transactivation properties 
was comparable to non-ligand bound GR function (-DEX; see figure 2.5). 
These results indicate that plasmid-based expression of pm-GR3 is effective at both 
downregulation of GR protein levels as well as ligand-activated downregulation of GR trans-
activation properties. 
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Figure 2.5 GR transactivation properties in a dual luciferase assay. pm-GR3 was tested for its ability to knockdown GR 
transactivation properties in a dual luciferase reporter assay. Dexamethasone was used to assess binding of ligand-
activated GR to GRE’s resulting in luciferase expression. Luciferase expression was controlled by renilla expression. 
Asterisk indicates p<0,05. For further details: see Materials and Methods and text. 
 
Effective lentiviral-shRNA-mediated GR knockdown 
Lentiviral vectors are a well established means for long-term delivery of genetic information in a 
wide variety of cell types both in vitro and in vivo 383;384. To investigate the efficiency of viral-
expressed shRNA (see figure 2.2), we measured relative GR protein levels in Ns-1 PC12 cells four 
and six days after transduction. We observed pm-GR3-mediated downregulation of GR after four 
days (46% ± 1,70), albeit not significant (see Figure 2.6). However, six days after lentiviral 
transduction we observed a significant knockdown of GR protein as determined by Western Blot 
analysis (71%, p= 0.022). This indicates that pm-GR3 is a potent and selective shRNA for GR down-
regulation after both plasmid and lentiviral delivery. 
 
 
Figure 2.6 Lentiviral-mediated knockdown of the GR in Ns-1 PC12 cells. Time-dependent down regulation of GR protein 
after LV-pm-GR3 transduction of Ns-1 PC12 cells. Western blot: Data were normalized by measuring α-Tubilin levels. 
Asterisk indicates p= 0.022. Representative Western blots are depicted on top of the graph (for each representative bar 
in duplo). For further details: see Materials and Methods and text. 
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DISCUSSION 
 
In this study we have designed, selected and optimized shRNA constructs against the GR. The 
results of the experiments reported here show that we generated a potent pm-shRNA construct. 
In fact, construct pm-GR3 was capable of mediating GR knockdown in the Ns-1 PC12 cell culture 
by 70- 95% within 6 days after plasmid delivery. This GR protein knockdown was also potent 
enough to down-regulate ligand-activated GR transcription in a dual luciferase reporter assay. In 
addition to transient plasmid delivery, we showed that long lasting lentiviral- mediated delivery of 
shRNAs in vitro was successful as well to knockdown GR protein levels efficiently.   
 
GR knockdown 
Other studies have shown comparable levels of shRNA-mediated protein knockdown in vitro 
344;354;362;385. This partial knockdown is typical of RNAi, and is also occurring endogenously in most 
eukaryotic cells. Initially, RNAi leads to downregulation of target mRNAs, while protein 
downregulation follows gradually. Protein downregulation is dependent on the stability and half-
life time of the corresponding proteins. In our study, GR protein knockdown was found optimal 
four days after plasmid delivery and six day after lentiviral delivery. This pattern is in line with the 
known half-life time of GR proteins. Although dependent on cellular conditions, the GR protein 
was found to degrade with a half-life of approximately 24 hours 386. After four days this entails a 
95% reduction of GR protein. In the presence of its ligand the GR half-life is even shorter 45 and 
thus optimal RNAi-mediated GR knockdown may be achieved sooner. The two days delay after 
lentiviral delivery can be explained by the fact that shRNAs from lentivirus are incorporated in the 
DNA of the host cell first and then transcribed from there. In contrast, shRNAs from plasmids are 
directly transcribed which may explain the shorter period needed to knockdown the GR protein 
levels by plasmid delivery. An alternative explanation for the 2 days delay with lentiviral 
transduction could be a probable difference in shRNA copy number expression, delivered by the 
two methods.  
The extent of protein down-regulation further depends on the availability of splice variants and 
isoforms. The GR gene is host to two GR splice variants, GR-α and GR-β, transcripts which are 
generated by alternative splicing of the 3’ UTR part 35;49;50;58;387. These two splice variants share 
identical N-termini encoded by exons 2-8 and are distinguished only by their unique C-terminal 
ligand binding domain. Similar isoforms are known to be produced from alternative translation 
initiation sites and differ in their N-terminal region 35;49;50;58;387. These GR-isoforms are expressed in 
various tissues of the mouse, and are underlying the tissue- specific functions of GR 18;24;35. 
Because not much is known yet about the tissue-specific functions of these isoforms in the 
hippocampus, we chose to target the full-length GR mRNA -and thereby all splice variants and 
isoforms- by targeting exon 2 of the GR mRNA.  
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Effectivity of designed shRNA constructs 
From the four different constructs initially designed, efficiency in GR knockdown was variable. 
Two pm-shRNAs (pm-GR2 and GR3) showed more than 50% GR knockdown, while two other 
constructs were less potent in silencing GR. This variability was expected, as the design and 
selection of efficient RNAi constructs is an empirically determined process requiring testing of 
multiple constructs. There are two possible explanations for this. The siRNA efficacy can depend 
on either siRNA-specific properties or on target mRNA properties. 
Firstly, it is well known that the effectiveness of gene silencing depends on the sequence-specific 
and thermodynamic properties of RNAi constructs and their targets. Such properties can partly be 
estimated by theoretical design rules (See Fig 2.1 and Table 2.1a,b) 374-376. The pm-shRNA 
constructs designed by us were, although 100% sequence compatible to the target mRNA, not 
completely in line with the design rules. In fact, constructs applied to only 6-8 out of 10 rules (see 
table 1a). A clear relationship can be observed between the effectiveness of the pm-shRNA 
construct and the extent to which these rules were applied.  
Interestingly, both effective shRNAs; pm-GR2 and -GR3 shared the highest number of applied 
rules, i.e. 8 out of 10 (see table 1, figure 2.7), versus 6-7 out of 10 design rules for the less 
effective constructs (pm-GR1 and- GR4; see table 2.1, figure 2.7). Less effective shRNAs may 
therefore have a lower chance of being built into the RISC, as imposed by the design rules.  
A second explanation for the observed variability may lie in the tertiary structure and accessibility 
of target mRNA. An open tertiary structure facilitates binding of shRNAs, while a closed, double-
stranded structure shields shRNA binding sites and renders the targeted transcript inaccessible 341. 
In line with the expectation, the target sequence in the GR mRNA of the least potent shRNA, pm-
GR4, had the predicted most closed structure (10 out of 21), while pm-GR3, the most potent, has 
a more predicted open tertiary structure with only 8nt bound (see figure 2.7).  
 
Specificity and controls 
In RNAi studies, several types of controls have been used; 1) Scrambled shRNA with a random 
sequence 354;360;388;389, 2) Non-coding, random shRNA, without any (known) biological activity 390-392 
3) Non-specific shRNAs directed against a different (trans)gene (e.g. GFP or housekeeping genes) 
393;394, and 4) Mismatch-shRNAs, bearing a few point mutations from the perfect match 356;395. Of 
these different types of controls, mismatch-shRNAs are the most similar to the perfect match as 
they entail a complete sequence homology with the pm-shRNA constructs, except for two 
nucleotides. As RNAi can tolerate a few sequence mismatches, it is important to design these in 
the vicinity of the middle cleavage site 343. We therefore applied this design rule at position 13 of 
the siRNA sequence.  
Because of their similarity to perfect match sequences, mismatch-shRNAs may have similar seed 
regions and this should result in similar side effects. The differences observed between mismatch 
and perfect match treatment, are therefore plausible effects resulting from specific GR 
knockdown. This is the main reason why we chose for mismatch-shRNA constructs as negative 
controls in our experiments. As shown in this study, RNA-interference is a highly specific 
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mechanism as two nucleotides can make the difference between target mRNA degradation or 
control situation. Thus, RNA-interference is highly sequence specific. In fact, many experiments 
have shown that RNAi is capable of causing specific degradation of target mRNAs with as little as 
one base pair difference to other transcripts 339;342;396.  
 
  
 
  
  
  
 
Figure 2.7 Theoretical model of mRNA tertiary structures and binding sites for different guide strand shRNA 
constructs. Positions marked by a line indicate bases predicted to be involved in RNA binding.
 
 
 
pm-GR1 
Design rules: 7/10 
Bases involved in dsRNA: 7 
Down-regulation: ~ 46% 
pm-GR2 
Design rules: 8/10 
Bases involved in dsRNA: 9 
Down-regulation: ~ 60% 
pm-GR3 
Design rules: 8/10 
Bases involved in dsRNA: 8 
Down-regulation: ~ 95% 
pm-GR4 
Design rules: 6/10 
Bases involved in dsRNA: 10 
Down-regulation: ~ 25% 
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Off target effects 
The use of RNAi as tool to manipulate gene expression in mammalian cells might result in side-
effects. There are three types of these so-called off-target effects.  
A first type of off-target effect is associated with an incomplete binding of shRNA molecules to 
other mRNA molecules potentially resulting in non-specific silencing of genes other than the 
specific target. It is thought that such binding occurs when parts of the 5’ prime end of the guide-
shRNA strands are similar to 7-8 nt long seed regions of endogenously expressed miRNAs 341;397;398. 
Incomplete seed-region binding within the 3’ untranslated region of an mRNA then results in 
translational arrest. The presence of seed regions is difficult to avoid given the small degree of 
similarity implicated in off-target gene regulation (Jackson et al., 2003) 398. Whether or not the 
pm-shRNA constructs designed in our study are underlying such off-target effects is presently 
unknown and cumbersome to investigate. Possible approaches are bio-informatic analysis of 
potential seed regions, microarray analysis of non-specific gene silencing, and the application of 
multiple effective pm-shRNA constructs to exclude off-target effects 341. 
However, in the design of the shRNA constructs we have used exon 2 of the GR transcript as 
target. Although GR belongs to a family of highly similar and evolutionary conserved nuclear 
steroid receptors (see also CHAPTER 1.2.2), exon 2 is known as the most unique part. BLASTing of 
passenger shRNAs confirmed a lack of any sequence complementarity to other nuclear receptors 
such as MR. In fact, BLASTing showed a limited sequence complementarity to a few other genes. 
As described above, RNAi is so sequence specific that such a partial sequence overlap is not 
expected to result in gene knockdown any other than the target. In addition to in silico 
predictions, it is also essential to use appropriate controls to rule out off-target effects while 
circumventing “more cumbersome” approaches. Therefore in our studies we used the mismatch-
shRNA construct as a control. This construct is essentially similar to the perfect match-shRNA 
construct except for two nucleotides. Therefore it is expected that all differential effects observed 
from mm- and pm-shRNAs are due to specific GR knockdown only.  
A second potential off-target effect associated with shRNAs and dsRNA > 30 nucleotides in length 
is an immune response (see for review 399). These are typically characterized by PKR and Toll-like-
receptor (TLR)- mediated interferon activation, infiltrations of granulocytes and increased 
apoptosis. These complex processes are part of the cellular defense system, which is capable of 
sensing and destroying exogenous particles of possibly pathogenic origin. It appears that these 
processes are also induced by delivery of shRNAs. Viral delivery, expression of shRNAs from pol III 
promoters and certain immunostimulatory sequence motifs have in some instances been 
associated with the innate immune response 341;397;399;400.   
Although we did not test for the presence of an innate immune response after shRNA delivery, we 
avoided the presence of immunostimulatory sequence motifs during the design of the shRNAs. In 
fact, beyond viral delivery, genomicly incorporated shRNAs become endogenously expressed, 
which should circumvent the mammalian innate immunity 399. Twenty-one base pair siRNAs, 
processed from shRNAs, are also known to circumvent the mammalian immune response 
339;372;397.  
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During experimentation we also used specifically the mm-shRNAs to exclude this type of off-
target effects. Moreover, it is unlikely that there are off-target effects due to immune responses 
in Ns-1 PC12 cells, as neurons are known to lack most types of TLRs (e.g. 1, 2, 4-10) 399. Therefore 
this makes the possibility unlikely that Pol III and immunogenic shRNA sequences induce a TLR-
mediated interferon response. Moreover, we used a lentiviral vector in our study. This type of 
vector is lacking its original genes and therefore not expected to express viral-dsRNAs, which are 
known to activate the single present TLR3 in neurons 399. 
A third type of off-target effect is cellular stress caused by an overshooting RNAi response. 
Engineered shRNAs utilize the endogenous RNAi machinery and therefore can cause at high doses 
cytotoxicity independent of sequence 341. Although not a primary aim, in our studies for GR 
protein knockdown we also have indirectly tested for cellular homeostasis by measuring the 
expression of the housekeeping gene α-tubilin. As expected, we did not find any changes in its 
expression relative to basal condition (sham), empty vector delivery and mm-shRNA treatment. 
Therefore it is plausible that the basal cellular machinery is not disrupted. Also in this situation 
our mismatch shRNAs are a proper control, as they are expressed from the same H1 promotor in 
comparable levels. 
 
Delivery of shRNAs 
Beyond the specificity and effectivity of shRNAs; delivery of shRNAs into target cells is an 
important hurdle. This is especially difficult in the mammalian nervous system as it consists of 
terminally differentiated cells. As neurons are also extremely sensitive to external influences, they 
are -in vivo- well protected by the blood-brain-barrier, again making delivery even more 
complicated. Therefore good shRNA delivery strategies are essential. In this study, we have shown 
extensive GR knockdown after both plasmid and lentiviral delivery in a neuronal cell line. Both 
approaches have their benefits and drawbacks. Short hairpin RNAs expressed from plasmids are 
transient in nature and therefore the knockdown effect is temporary. This may be an insufficient 
strategy for (long term) functional studies. Depending on the research question, long term viral-
mediated shRNA expression can be an effective strategy for functional studies. The use of 
lentiviral delivery of shRNAs in the nervous system has already been described in vivo (see for 
review 341). 
Expression of shRNAs from the delivery vectors occurs by transcription from specific promoters. In 
our study and in most others studies, RNA polymerase III promoters have been used for shRNA 
expression. This type of promoters is relatively small while highly active and therefore ideal for 
continuous shRNA expression in a variety of cell types. shRNAs themselves have the advantage of 
being more stable than siRNAs 401. 
 
Conclusion 
In conclusion, we have identified a very potent shRNA construct: pm-GR3, to knockdown GR 
protein levels in vitro. Expressing this construct by both plasmid-based delivery and lentiviral 
delivery resulted in efficient GR knockdown in a mammalian neuronal cell line. This construct led 
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to GR protein knockdown as well as strong impairment of GR transactivation properties. Using the 
2 nt- mismatch-shRNA as a specific control, we likely minimized off-target effects and differences 
in phenotypes may therefore be due to specific knockdown of the GR. The pm- and mm-GR3 
lentiviral constructs may form excellent tools to study GR function in discrete neuronal cell 
populations in the brain.  
  
 65 
 
3 
LENTIVIRUS-MEDIATED TRANSGENE 
DELIVERY TO THE HIPPOCAMPUS REVEALS 
SUB-FIELD SPECIFIC DIFFERENCES IN 
EXPRESSION 
 
L.W.A. van Hooijdonk, M. Ichwan, T.F. Dijkmans, T.G. Schouten, M.W.A. de Backer1, R.A.H. 
Adan1, F.J. Verbeek2, E. Vreugdenhil, C.P. Fitzsimons 
 
BMC Neuroscience 2009, 10:2 
 
CHAPTER 3: TARGETTING NPCs IN VIVO 
66 
 
ABSTRACT  
 
Background In the adult hippocampus, the granule cell layer of the dentate gyrus is a 
heterogeneous structure formed by neurons of different ages, morphologies and 
electrophysiological properties. Retroviral vectors have been extensively used to transduce cells 
of the granule cell layer and study their inherent properties in an intact brain environment. In 
addition, lentivirus-based vectors have been used to deliver transgenes to replicative and non-
replicative cells as well, such as post mitotic neurons of the CNS. However, only few studies have 
been dedicated to address the applicability of these widespread used vectors to hippocampal cells 
in vivo. Therefore, the aim of this study was to extensively characterize the cell types that are 
effectively transduced in vivo by Vesicular Stomatitis Virus G glycoprotein-pseudotyped lentivirus-
based vectors in the hippocampus dentate gyrus.  
Results In the present study we used Vesicular Stomatitis Virus G glycoprotein-pseudotyped 
lentivirual vectors to express EGFP from three different promoters in the mouse hippocampus. In 
contrast to lentiviral transduction of pyramidal cells in CA1, we identified sub-field specific 
differences in transgene expression in the granule cell layer of the dentate gyrus. Furthermore, 
we characterized the cell types transduced by these lentiviral vectors, showing that they target 
primarily neuronal progenitor cells and immature neurons present in the sub-granular zone and 
more immature layers of the granule cell layer. 
Conclusions Our observations suggest the existence of intrinsic differences in the permissiveness 
to lentiviral transduction among various hippocampal cell types. In particular, we show for the 
first time that mature neurons of the granule cell layer do not express lentivirus-delivered 
transgenes, despite successful expression in other hippocampal cell types. Therefore, amongst 
hippocampal granule cells, only adult-generated neurons are target for lentivirus-mediated 
transgene delivery. These properties make lentiviral vectors excellent systems for over-expression 
or knockdown of genes in neuronal progenitor cells, immature neurons and adult-generated 
neurons of the mouse hippocampus in vivo.  
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INTRODUCTION  
 
The hippocampus is a brain structure that forms part of the limbic system and is involved in 
memory formation and spatial navigation. The Dentate Gyrus (DG) field, despite of being 
composed mainly by granule cells, is an heterogeneous structure 402. Moreover, the subgranular 
zone (SGZ) of the DG, along with few other few areas of the adult brain, is characterized by the 
existence of ongoing neuronal generation known as adult neurogenesis 403;404. All in all, these and 
other important observations have called for extensive attention on the study of the adult DG and 
its functions. 
In this respect, one challenging task is to identify and employ genes and molecular mechanisms 
directly involved in hippocampal functions, such as neuronal plasticity and neurogenesis 405;406. 
The ability to manipulate the genotype in vivo provides major opportunities for studying gene 
function in the mammalian nervous system and for developing novel therapeutic strategies 369.  
Viral-mediated single-cell gene manipulation has proven to be one of the most successful 
approaches to study molecular mechanisms involved in adult neurogenesis in an intact brain 
environment 367;368. With this aim, retroviral vectors have been extensively used in the study of 
neurogenesis due to their ability to transduce only replicative cells 103;367. Also, lentiviral vectors 
have been extensively used to deliver transgenes to replicative and non-replicative cells, such as 
post-mitotic neurons of the CNS 383;384. Among lentiviral vectors, Vesicular Stomatitis Virus G 
glycoprotein (VSV-G)-pseudotyped are the most widely used due to their very broad tropism and 
stability of the resulting pseudotypes. Moreover, they have received considerable attention since 
they have recently entered human clinical applications 384. Interestingly, numerous reports have 
described on the use of lentiviral vectors on hippocampal neurons in vivo 357;363;369;407-411. 
Aiming to demonstrate the usefulness of modified lentiviral vectors to deliver transgenes to the 
adult mouse hippocampus and extensively characterize the cell types that are effectively 
transduced in vivo, we used a previously described VSV-G-pseudotyped advanced generation 
lentiviral vector (AGLV) to express the enhanced green fluorescent protein (EGFP) under the 
control of the cytomegalovirus (CMV) promoter 67.  
EGFP expression was analyzed one and five weeks after stereotactic injection to the mouse 
hippocampus and the local distribution of EGFP+ cells within different hippocampal sub-fields was 
compared. We identified the different cell types transduced in the DG using cell-lineage specific 
markers 62;295. The distribution and location of EGFP+ cells were also analyzed and quantified in 
the DG and Cornu Ammonis 1 (CA1) fields for comparison.  
We report that lentivirus-mediated transgene expression in the DG is restricted to a 
subpopulation of NPC and immature neurons present in the inner granule cell layer (GCL), while 
presumably more mature granule cells located in the outer layers are resistant to transgene 
expression. 
These results reveal for the first time the existence of hippocampus sub-field and cell-type specific 
differences in lentivirus-mediated transgene expression. These properties make lentiviral vectors 
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excellent delivery systems for studies aiming to characterize the functions of hippocampal NPC 
and immature neurons, where in vivo gene manipulation is requested. 
 
 
METHODS 
 
Experimental setup 
We investigated expression of EGFP and cell-type specific markers in hippocampal cells after 
transduction with AGLV 412. In these vectors, EGFP expression was under the control of three 
different Polymerase II promoters, as described in the Results section 67;383. Hereto, animals were 
divided into experimental groups of 5 animals each and intra-hippocampally injected into the DG 
or SR with one of the three types of lentivirus. One or five weeks after injection, brain tissue was 
processed for immunohistochemistry. 
 
Cloning and Lentiviral vector production 
Replication incompetent and self-inactivating Advanced Generation lentiviral vectors were 
produced and titrated as previously described 67. All lentivirus batches used for experiments had 
comparable titers ranging from 1x108 to 1x109 transducing U/ml. Virus suspensions were stored at 
-80 °C until use and were briefly centrifuged and kept on ice immediately before injection.  
 
Animals 
Male C57Bl/6J mice (seven weeks old at injection, Janvier Biosciences, France) were housed 
5/cage for one week before surgery as acclimatization. Thereafter, mice were single housed in 
filtertop cages, in a temperature and humidity controlled room with 12:12 dark- light cycle (light 
on at 08:00 A.M.). Mice had free access to food pellets and water. All efforts were made to 
minimize animal suffering and the number of animals used. All experiments were approved by the 
committee of Animal Health and Care, Leiden University, the Netherlands and the Netherlands 
ministry of VROM and performed in strict compliance with the European Union recommendations 
for the care and use of laboratory animals. 
 
Stereotactic surgery 
Stereotactic injections were performed essentially following previously described methods 367. 
Animals were deeply anaesthetized by a mixture of Hypnorm (0.5 mg/kg/ml) and Dormicum (5 
mg/kg/ml) and Milli-Q purified water (Millipore, Amsterdam, The Netherlands) at volume ratio of 
1:1:2 (10 ul/g).  Bilateral injections of lentiviral vectors into the Dentate Gyrus (AP: -2.00 mm, ML: 
+/-1.50 mm, DV: -1.90 mm, relative to Bregma) or the Stratum Radiatum (AP: -2.00 mm, ML: +/-
1.50 mm, DV: -1.50 mm, relative to Bregma), were conducted using a small animal stereotact (900 
series, David Kopf Instruments, Tujunga, CA) and an injection pump (Harvard Apparatus, Holliston, 
MA) with injection volume=1 l, rate=0.4 l/ min, connected to a Hamilton needle (5 l, 30 
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gauche), and customized borosilicate glass micro-capillar tips of approximately 100 m. After 
surgery animals were placed under a heating lamp until awakening and further monitored and 
weighted daily. 
 
Immunohistochemistry 
One or five weeks after injection, animals were sacrificed and brains were fixed by transcardial 
perfusion. Before the procedure the animals were deeply anaesthetized by IP injection of sodium 
pentobarbital (Nembutal 60 mg/ml, 0.1 ml). Animals were transcardialy perfused with 0.1M PBS 
for 10 minutes. Brains were removed and kept in 25 ml 4% PFA for one hour.  Then, they were 
washed in 0.1M PBS and immersed in 15% and subsequently 30% sucrose solution for 3-4 days. 
Brains were blotted dry and snap-frozen for 10 sec in isopentane on dry ice and stored at -80˚ C 
until sectioning. 
Serial coronal 20 μm-thick sections were obtained using a cryostat (Leica CM 1900, Leica 
Microsystems, Rijswijk, The Netherlands). All brain sections containing the hippocampus were 
collected and thaw-mounted on SuperFrost microscope slides and stored at -80˚ C until further 
use.  
Immunofluorescent double and triple labelling was performed as described 381. Primary antibody 
were from: Santa Cruz Biotechnology, Inc; Heidelberg, Germany (Doublecortin (C-18), used 1:200; 
Ki67 (M-19), used 1:100; GFAP, mouse monoclonal, used 1:1000); Chemicon-Millipore 
International BV, Amsterdam, The Netherlands (NeuN (A60), used 1:200), BD Biosciences, Breda, 
The Netherlands (Nestin, (556309), used 1:200) or Molecular Probes/Invitrogen, Breda, The 
Netherlands (GFP, chicken polyclonal, used 1:500). After 24 h incubation at 4 C with continuous 
stirring, sections were incubated with correspondent Alexa488 or Alexa594-conjugated secondary 
antibodies (1:400, Molecular Probes/Invitrogen) for 2 hrs at RT in 100 l 1xPBS/0.3% TritonX-100. 
Sections were counterstained with Hoechst 33342 when indicated, as previously described 381. 
Sections were embedded with Aqua-Poly/Mount (Polysciences Europe, Eppelheim, Baden-
Württemberg, Germany). Similar samples were processed in parallel excluding primary antibodies 
and used for comparison as negative controls (not shown). 
 
Organotypic hippocampal slice cultures 
Early postnatal rat hippocampal slices were produced an cultured as previously described 67. 
Briefly, slice cultures were prepared from 4- to 6-day-old male Wistar rats (Charles River 
Laboratories, Inc., Frankfurt, Germany) using the modified interface culture method. At the time 
of the first medium change (day in vitro (DIV) 1), hippocampal slices were inoculated with 10 l of 
the CMV-EGFP lentiviral vector stock. Slices were fixed 4 days later with 4% paraformaldehyde for 
1 h at 4 C and used for immunofluorescence studies. 
 
In situ hybridization for EGFP mRNA 
Perfused mouse brain sections were used for in situ hybridization with a 720 base pair long 
digoxigenin (DIG)-labelled EGFP riboprobe (antisense to NCBI gene ID DQ768212). The in situ 
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hybridization was performed essentially as described by Schaeren-Wiemers and Gerfin-Moser 413, 
with small modifications. Briefly, sections were fixed in 4% paraformaldehyde (PFA) for 5 minutes, 
treated for 10 minutes with 10 ug/ml proteinase K and 0.1% Triton-X100 in phosphate buffered 
saline (PBS, pH 7.4), followed by 10 minutes extra fixation with 4% PFA. Thereafter, sections were 
rinsed 3 times in PBS for 3 minutes. After acetylation for 10 minutes (0.25% acetic anhydride in 
0.1 M triethanolamine), sections were washed 3 times in PBS for 5 minutes and prehybridized for 
2 hours at room temperature in hybridization solution, containing 50% deionized formamide, 5x 
SSC, 5x Denhardt’s solution, 250 μg/ml tRNA Baker’s yeast and 500 μg/ml sonicated salmon 
sperm DNA. 150 l of hybridization mixture containing 400 ng/ml DIG-labeled riboprobe was 
applied per slide, covered with Nescofilm and hybridized overnight at 68°C. The next morning 
slides were quickly washed in 2x SSC followed by 0.2x SSC for 2 hours, both at 68°C. DIG was 
detected with an alkaline phosphatase labelled antibody (1:5000, Roche, Mannheim) using 
NBT/BCIP as a substrate. After DIG in situ hybridization, slides were counterstained with 0.5% 
methyl green, quickly dehydrated in ethanol, cleared in xylene and mounted using Entellan. 
 
Histological analyses and confocal microscopy 
Quantification of EGFP+ cells and quantitative analysis of different classes of neuronal cells in the 
hippocampus of treated animals were performed using the optical fractionator sampling method, 
as described by Encinas and Enikolopov 81. Briefly, every tenth hippocampal section was collected 
starting at the DG following the fractionator scheme, to ensure that each slice is 200 nm apart 
from the next slice within each collected set of approximately 11 slices (Fitzsimons et al., 2008) 67. 
For quantification of EGFP+ cells, three sets of slices from at least three independently injected 
animals from each experimental group were used. Sections surrounding the injection site were 
routinely discarded. For quantitative analysis of neuronal cell-types other three sets of slices from 
at least three independently injected animals from each experimental group were used. Confocal 
images were acquired using a Nikon C1si Spectral confocal microscope, as described 67. Expression 
of markers and cell-localization analyses were done counting more than 50 EGFP+ cells per 
animal. Co-localization was assessed through the entire z-axis of each cell, using an optical slice of 
0.3–0.6 μm. Morphology was analyzed from three-dimensional reconstructions of series of 
sequential confocal images taken at 0.3–0.6 μm intervals in EGFP+ cells. 
 
Image analysis 
For EGFP+ cell-localization analyses within the DG or CA1 sub-fields, maximum intensity z-axis 
projections of series of sequential confocal images were constructed using ImageJ, as described 67. 
Using these projections, EGFP+ cells were automatically identified and counted using Cell Profiler 
(http://www.cellprofiler.org) 414. This procedure was validated by comparison to manual counting 
performed by an experienced operator using the optical fractionator method sampling scheme 
and unbiased stereology estimation of cell numbers as described by West and co-workers 415. The 
“pipeline” used to automate cell counting was composed of the following Cell Profiler’s modules, 
in the specified order: LoadSingleImage, ColorToGray, CorrectIllumination_Calculate, 
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CorrectIllumination_Apply, IdentifyPrimAutomatic. By using this pipeline we routinely found a 
strong correlation between the manual unbiased stereology method and the automated 
procedure (r=0.985, Pearson’s correlation test performed with GraphPad Prism 4, GraphPad 
Software, Inc., La Jolla, CA). EGFP+ cells were individually pseudo-coloured to facilitated 
visualization and cell-localization maps were generated using Cell Profiler. Subsequently, based on 
a previously described manual method to study granule cell location within the GCL 416 the GCL 
was subdivided in four 2-cell-body-wide sub-layers using ImageJ (http://rsb.info.nih.gov/ij/) to 
generate a superimposed grid, guided by Hoechst 33342 staining of cell nucleus. These sub-layers 
were denominated: sub-granular zone (SGZ) and granule cell layer (GCL) 1 to 3, as described by 
others 76;94;368. Then, the pseudo-coloured cell-localization maps generated with Cell Profiler were 
used to manually assign and count individual EGFP+ cells to the 4 sub-layers of the GCL of the DG. 
In all cases, EGFP+ cells present in the apex of the DG were excluded from the analyses. A similar 
procedure was used in experiments comprising EGFP+ cells in CA1. 
For quantification of different cell-type markers in EGFP+ cells, total EGFP+ cells were 
automatically identified and counted using Cell Profiler from z-projected confocal images. From 
the same images, cells positive for each individual co-stained marker were also automatically 
identified and counted with Cell Profiler using the corresponding confocal channel. Cells positive 
for each marker analyzed were expressed as percentage of total EGFP+ cells. All image analyses 
procedures were performed in hippocampal slices from at least three independently injected 
animals as described above. In all cases, image analyses were performed by an operator blind to 
treatment. 
 
Dendrite tracing and three-dimensional reconstructions. 
Three-dimensional reconstructions of dendritic arbors and spine density analysis were performed 
using TDR3D software package (http://bioimaging.liacs.nl/tdr3dbase.html), using a simulated 
fluorescence process-based algorithm 417;418. Briefly, three-dimensional reconstructions for 
morphological analyses were generated from series of confocal images of EGFP+ neurons taken at 
0.3–0.6 μm intervals from at least three independently injected animals. All cells used for 
morphological analyses were positive for the neuronal marker NeuN (not shown). Quantification 
of dendritic protrusions and dendritic length was done with ImageJ (NeuronJ plugin). 
 
 
RESULTS  
 
Lentivirus-mediated EGFP delivery to the DG 
In order to transduce cells present in the DG of the mouse hippocampus, we used a previously 
described AGLV system where the CMV promoter controls EGFP expression 67, further referred 
here as CMV-EGFP. This vector was infused by stereotactic injection into the DG (Figure 3.1). 
Under these experimental conditions we observed a marked restriction of EGFP expression to the 
hilar region and the SGZ and only few EGFP+ cells present in the GCL one week after injection 
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(Figure 3.1A). This spatial distribution is reminiscent of previous observations with murine 
Maloney Leukemia virus (MMLV)-derived retroviruses, transducing only dividing cells 95;103. 
Notably, increased EGFP expression from higher lentiviral vector delivery titers did not result in a 
substantially increased proportion of EGFP+ cells located in the GCL, while the total numbers of 
EGFP+ cells were drastically increased, resulting in massive EGFP expression in the hilar region and 
the SGZ (Figure 3.1B). 
 
 
 
 Figure 3.1  Lentivirus-mediated EGFP delivery to the DG. Lentivirus-mediated delivery by stereotactic injections to the 
hilar region of the hippocampus does not results in substantial EGFP expression in the GCL, despite low (A) or high (B) 
EGFP expression, 1 week after injection. Each image shown is representative of 5 animals independently injected. Right 
panels represent the boxed area in the left panels of the figure. Scale bars: left panels 100 μm; right panels 20 μm. 
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Spatial distribution of EGFP+ cells in the GCL after CMV-EGFP injection. 
In order to account for the spatial distribution of the EGFP+ cells in the GCL of the DG, we 
subdivided the GCL in 4 different two-nucleus-wide regions, following the method described by 
Kempermann et al., and extensively used by others 76;94;368(Figure 3.2). These four regions were 
designated SGZ, GCL1, 2 and 3 (Figure 3.2C). Thereafter, we applied semi-automated, software 
assisted, quantification of the percentage of total EGFP+ cells present in each of these regions. 
Although the numbers of total EGFP+ were variable among different injections, as described for 
MMLV-based retroviral vectors 103, the relative percentages of cells present in the different 
subdivisions of the DG were consistently reproducible. We found that one week after stereotactic 
injection, a large percentage of the cells reside in the SGZ (57±1 %, n=5 animals) and the 
innermost layer of the GCL, GCL1 (32±2 %, n=5 animals; Figure 3.2A, C and D). When the number 
of EGFP+ cells was assessed five weeks after stereotactic injection, we found that the larger 
percentage of EGFP+ cells still resided in the SGZ (27±4 %, n=5 animals) and the GCL1 (42±3 %, 
n=5 animals) with a significantly higher percentage of EGFP+ cells located into the intermediate 
third of the GCL (GCL2, 26±3 vs. 9±4 %, 5 and 1 weeks respectively, p<0.05 Student t test, n=5 
animals each; Figure 3.2B and E). Notably, EGFP+ cells rarely reached the outer third of the GCL 
(GCL3) and the percentage of cells located in the GCL3 was not significantly different from the one 
observed one week after injection (5±3 vs. 2±2 %, 5 and 1 weeks respectively, n=5 animals each; 
Figure 3.2D and E). 
 
Spatial distribution of EGFP+ cells in the GCL after CaMKII-EGFP injection 
In order to assess the possibility that the distribution of EGFP+ cells in the GCL after lentivirus 
transduction may depend on the promoter used to control EGFP expression, we used two other 
previously described lentiviral vectors where EGFP expression is controlled by neuron-specific 
promoters, the Synapsin I (denoted here Syn-EGFP) and the CamKII (denoted here CaMKII-EGFP) 
promoters. These vectors promote different levels of EGFP expression in mature post-mitotic 
cortical neurons, presumably due promoter’s specificity for different neuronal developmental 
stages 383. All lentiviral constructs were produced with the same packaging system and 
pseudotyped with VSV-G protein to avoid possible differences in cell-type targeting due to the use 
of different pseudotyping proteins 419. When the spatial distribution of EGFP+ cells was assessed 
one week after CaMKII-EGFP injection, we observed that this distribution was significantly 
different from that observed one week after CMV-EGFP injection (Figure 3.3). Injection of CaMKII-
EGFP resulted in a significantly smaller percentage of EGFP+ cells present in the SGZ (12±2 vs. 
57±1 %, CaMKII-EGFP and CMV-EGFP respectively, p<0.05 Student t test, n=5 animals each) and a 
concomitant larger percentage present in GCL1 (45±4 %, n= 5 animals) and GCL2 (36±3 %, n=5 
animals). Nevertheless, GCL3 was still the layer with fewer cells, with only 7±2 % of the EGFP+ 
cells present in this particular layer (Figure 3.3 A-B). 
These results suggested that, although the promoter used to control EGFP expression is relevant 
to obtain cell type specific (neuronal) expression, the outer neuronal layer of the GCL (GCL3) is not 
easily transduced by (VSV-G pseudotyped) lentiviral vectors. 
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Figure 3.2  EGFP+ cell location after injection with CMV-EGFP in the DG. Distribution of EGFP+ cells in the gcl 1 (A) or 5 
(B) weeks after stereotactic injection of CMV-EGFP. The central panels represent the split confocal channels shown 
merged in left panels. Right panels depict pseudo-colored cell-localization maps, used for quantitative image analyses, 
generated with cell profiler showing the automatically identified EGFP+ and total cells. Scale bars: 20 μm. Each image 
shown is representative of 5 animals independently injected. C) schematic diagram depicting the subdivisions of the GCL 
used for quantitative image analyses, reproduced from 94, with permission from the authors. Distribution of EGFP+ cells 
within the GCL 1 (D) or 5 (E) weeks after the stereotactic injection, normalized to the total number of EGFP+ cells. Each 
portion of the pie diagrams represents the mean percentage of EGFP+ within internal subdivisions shown in (C), 
indicating the distribution across the GCL, color-coded according to (C). 
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Figure 3.3, EGFP+ cell location after injection with CamKII-EGFP in the DG. See legend on the next page. 
 
 
Figure 3.4  EGFP+ cell location in CA1 after injection with CMV-EGFP in the SR. See legend on the next page. 
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 Figure 3.3  EGFP+ cell location after injection with CamKII-EGFP in the DG. A) Distribution of EGFP+ cells in the GCL, 
1 week after stereotactic injection with CamKII-EGFP. Right panels represent the boxed area in the left panel of the 
figure. Scale bars: left panel 100 μm; right panels 20 μm. Each image shown is representative of 5 animals independently 
injected.  B) Distribution of EGFP+ cells within the GCL 1 week after the stereotactic injection, normalized to the total 
number of EGFP+ cells. Each portion of the pie diagram represents the mean percentage of EGFP+ within internal 
subdivisions of the GCL, color-coded according to (3.2C). 
 
 Figure 3.4  EGFP+ cell location in CA1 after injection with CMV-EGFP in the SR. A) Distribution of EGFP+ cells in CA1, 
1 week after stereotactic injection of CMV-EGFP to the SR. Right panels represent the boxed area in the left panel of the 
figure. Scale bars: left panel 100 μm; right panels 20 μm. Each image shown is representative of 5 animals independently 
injected. B) Distribution of EGFP+ cells within the CA1, 1 week after the stereotactic injection, normalized to the total 
number of EGFP+ cells. Each portion of the pie diagram represents the mean percentage of EGFP+ within each internal 
subdivision of the CA1. SR: Stratum Radiatum; CA1: Cornu Ammonis 1; ML: Molecular layer; DG: Dentate Gyrus. 
 
To test this hypothesis, we utilized a lentiviral vector where the expression of EGFP was controlled 
by the Synapsin promoter (Syn-EGFP). This promoter has been shown to drive EGFP expression in 
earlier, presumably more immature, stages during neuronal development 383. EGFP expression 
controlled by the Synapsin I promoter led to a pattern of distribution of EGFP+ cells in the GCL 
very similar to that obtained with CMV-EGFP, confirming that the promoter controlling EGFP is of 
relevance for the spatial distribution of EGFP+ cells in the GCL (Table 3.1). Nevertheless, a very 
small percentage of the EGFP+ was found to be in the GCL3, as observed with the other lentiviral 
vectors used in this study (Table 3.1).  
 
 CMV-EGFP Syn-EGFP CaMKII-EGFP 
SGZ 57 ± 1% 45 ± 1% 12 ± 3% 
GCL1 32 ± 2% 41 ± 1% 45 ± 4% 
GCL2 9 ± 1% 12 ± 2% 36 ± 2% 
GCL3 2 ± 1% 2 ± 1% 7 ± 2% * 
 
Table 3.1. Distribution of EGFP+ cells in the DG of animals transduced with three different lentivirus-based vectors. 
Distribution of EGFP+ cells, expressed as percentage of total EGFP+ cells, with their soma within different domains of the 
DG (as defined in materials and methods) at 1 week post infection. Values represent mean ± SEM (n = 5 animals; *: 
significantly different vs CMV-EGFP; p<0.05, Student t-test). 
 
Spatial distribution of EGFP+ cells in the CA1 after CMV-EGFP injection. 
These observations prompted us to speculate that the CMV promoter may not be highly 
expressed in mature neurons. To test this hypothesis we delivered CMV-EGFP to the CA1 region of 
the adult mouse hippocampus. One week after virus injection, we observed a strong expression of 
EGFP+ in the CA1 field. Typically, EGFP+ cells presented their somata in the CA1 region and 
extended long dendrites into the Stratum radiatum (SR), phenotypically resembling CA1 pyramidal 
cells (Figure 3.4A). These results confirmed that the CMV is capable of driving EGFP expression in 
mature post-mitotic neurons, as previously shown by others 420. 
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In analogy to the procedure applied for the GCL, we arbitrarily subdivided the CA1 layer in three 
identical width regions (CA1-1, CA1-2 and CA1-3) and accounted the distribution of EGFP+ cells in 
them. EGFP+ cells were homogeneously distributed across the CA1 layer of pyramidal neurons 
(Figure 3.4B), indicating that the irregular distribution of EGFP+ cells observed in the GCL of the 
DG reflects an inherent difference among granule cells in their permissiveness for lentivirus 
transduction. 
To challenge this hypothesis we directed the stereotactic injection to the SR of the hippocampus 
(Figure 3.5), arguing that by doing so granule cells present in the outer layers (GCL3) will be 
directly exposed to the lentivirus, bypassing any possible physical barrier that may obstruct the 
free diffusion of the lentiviral suspension through the GCL when injected into the hilus. If the 
CMV-EGFP lentivirus would be able to transduce granule cells present in the outer shell of the DG, 
we should observe EGFP+ cells in the GCL3. Interestingly, we observed strong EGFP expression in 
cells present in the Molecular Layer (ML) and CA1 and even some EGFP+ positive cells in the GCL2 
but none in the GCL3 (Figure 3.5A). Increased EGFP expression from higher lentiviral vector 
delivery titers did not result in a substantially increased proportion of EGFP+ cells located in the 
GCL, while the total numbers of EGFP+ cells were drastically increased (Figure 3.5B). These 
observations strengthened our conclusion that cells present in the GCL3 have inherent properties 
that make them less permissive to lentivirus-delivered transgene expression. 
 
Transduction pattern of the CMV-EGFP lentivirus vector in the DG 
In order to verify our hypothesis that the lack of transduction of GCL3 neurons is a consequence 
of inherent cellular properties and not of technical limitations of our delivery strategy we 
performed a series of experiments, presented collectively in Figure 3.6. 
Correlational studies have demonstrated a large degree of discrepancy among transcript (mRNA) 
and protein expression levels in the mouse hippocampus 421. Previous studies have used in situ 
hybridization to detect with high sensitivity the expression of lentivirus-delivered transgenes in 
the DG 363. Therefore, we decided to use this technique to assess EGFP expression levels in the DG 
upon CMV-EGFP lentivirus delivery. As shown in Figure 3.6A, in agreement with our previous 
observations on protein expression using EGFP native fluorescence, one week after injection the 
EGFP in situ hybridization signal was mostly restricted to the hilus and the SGZ, demonstrating 
that the lack of EGP expression in the outer layers of the GCL is not a consequence of possible 
post-transcriptional regulation but more likely of lack of transgene expression. 
To substantiate this conclusion we should be able to show that there are no major physical 
obstacles to reach the DG by stereotactic injection into the SR. To achieve this goal we used a 
fluorescently labelled transferrin-derived peptide (T12-Cy5, Prosensa BV, Leiden, The 
Netherlands) delivered by stereotactic injection into the SR (1 l; 30 M). Transferrin-derived 
peptides have been shown to increase delivery efficiency of molecular cargos to neuronal cells in 
vivo 422;423. Following this approach, 48 h after injection we observed fluorescence distributed 
across the SR and ML fields, reaching the CA1 and DG (Figure 3.6B). A closer observation of the DG 
clearly displayed a fluorescence pattern with maximal intensity in the ML and gradually diffusing  
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Figure 3.5  Lentivirus-mediated EGFP delivery to the SR. See legend on the next page. 
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Figure 3.6  Transduction pattern of the CMV-EGFP lentivirus vector in the DG after delivery to the SR. A) In situ 
hybridization for EGFP mRNA in the GCL, 1 week after stereotactic injection of CMV-EGFP to the SR. Inset: higher 
magnification view of the boxed area. Arrowheads indicate positive EGFP expression in the hilus and SGZ. B) Stereotactic 
injection to the SR of a fluorescently labeled transferrin-derived peptide (T12-Cy5, pseudocolored green). NeuN+ cells are 
shown in red. Inset: higher magnification view of the boxed area. Arrowheads indicate NeuN+ cells in the outer GCL 
positively transduced with the fluorescent peptide (yellow). Animals were sacrificed 48 h after the injection. (C): Higher 
magnification confocal image showing co-localization (yellow) of T12-Cy5 (red) and NeuN (green) in cells located across 
the supra-pyramidal blade (top) hilus and infra-pyramidal blade (bottom) of the DG. The orthogonal projection on the y-
z axis shows a gradient of peptide expression from the ML to the H with highest expression in cells located in the outer 
GCL. D) CMV-EGFP transduction pattern in DIV-5 organotypic hippocampal slice cultures. Inset: higher magnification of 
the boxed area. The split panels at the bottom show the corresponding EGFP and NeuN signals from the same area. 
Note the almost complete lack of co-localization. Each image shown is representative of 5 animals independently 
injected. Scale bars: A, B and D: 100 μm; C: 10 μm. CA1: Cornu Ammonis 1, SR: Stratum Radiatum; ML: Molecular layer; 
GCL: Granule Cell Layer; H: Hilus; SGZ: Subgranular Zone.  
 
 Figure 3.5  Lentivirus-mediated EGFP delivery to the SR. Lentivirus-mediated delivery by stereotactic injections to the 
SR of the hippocampus does not result in substantial EGFP expression in the GCL, despite low (A) or high (B) EGFP 
expression, 1 week after injection. Right panels represent the boxed area in the left panels of the figure. Arrows (A) and 
arrowheads (B) indicate EGFP+ cells in the GCL. Scale bars: left panels 100 μm; right panels 20 μm. Each image shown is 
representative of 5 animals independently injected. SR: Stratum Radiatum; CA1: Cornu Ammonis 1; ML: Molecular layer; 
DG: Dentate Gyrus. 
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 Figure 3.7 Transduction pattern of the CMV-EGFP lentivirus in DG and CA3 by EGFP immunohistochemistry. A) 
Confocal microscope image and orthogonal projections onto the x–z (bottom) and y–z (right) planes showing co-
localization (yellow) of the native EGFP fluorescence (green) and EGFP immunohistochemistry signal (red) in GC somata, 
one week after injection. B) Higher magnification of the boxed area depicted in A showing partial co-localization in 
dendrites of GC (top). The split panels corresponding to the EGFP native fluorescence signal (488 nm, center) and the 
EGFP immunohistochemistry signal (594 nm, bottom) are shown. C and D) Composite of 5 confocal z-projected stacks 
combining EGFP’s native fluorescence and immunohistochemistry signal 5 weeks after injection, showing EGFP positive 
cells with their somata in the GCL (E) and projecting axons into the hilus (F) and the Stratum Lucidum of the CA3 field 
(G), were the synaptic boutons of these axons are evident (F and inset in G). Each image shown is representative of 5 
animals independently injected. Scale bars: A: 40 μm; B: 25 μm; C: 200 μm; E; F and G: 10 μm. GCL: Granule Cell Layer, 
H: Hilus. CA3: Cornu Ammonis 3.  
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Figure 3.8  Identification and quantification of different cell types targeted by injection of CMV-EGFP in the DG. See 
legend on the next page. 
 
 
Figure 3.9  Morphological analyses and three-dimensional reconstructions of EGFP+/NeuN+ cells in the GCL. See 
legend on the next page 
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 Figure 3.8  Identification and quantification of different cell types targeted by injection of CMV-EGFP in the DG. 
Examples of EGFP co-localization with different markers of neuronal differentiation within the GCL. The orthogonal 
projections onto the x–z (bottom) and y–z (right) planes of cells indicated by hairlines are shown to confirm double 
labelling throughout the extent of EGFP+ cells co-expressing DCX and NeuN (A); Ki67 (B); GFAP (C); NeuN (D) or Nestin 
and NeuN (E). Each image shown is representative of 5 animals independently injected. Scale bars: 20 μm. (F) Percentual 
distribution of EGFP+ cells expressing differentiation markers within the GCL, 1 week after the stereotactic injection 
normalized to the total number of EGFP+ cells.  
 
 Figure 3.9  Morphological analyses and three-dimensional reconstructions of EGFP+/NeuN+ cells in the GCL.  
Representative examples of EGFP+ neurons located in the GCL 1 week after the stereotactic injection of CMV-EGFP. A) 
Confocal image showing EGFP+ cells in the DG. The orthogonal projections onto the x–z (bottom) and y–z (right) planes 
are shown to confirm EGFP expression throughout the extent of the cells indicated with hairlines. B) Z-axis projection of 
EGFP+ neurons from the area depicted in A, showing their morphological features. C) and D) higher magnification of the 
areas boxed in B. E) three-dimensional reconstruction of the dendritic segment depicted in C, shown as example of those 
used for dendritic protrusion analyses. F) Three-dimensional reconstructions of two example EGFP+ GCL neurons, 
showing their dentritic arborization and length. Cell somata are shown in cyan and dendrites in red. Similar neurons 
were used for quantitative analyses. Scale bars: A: 50 μm; B, C, D, E: 10 μm; F: 100 μm. (Full-resolution animated 3D-
reconstructions are available at http://bio-imaging.liacs.nl/gallery). 
 
into the GCL, labelling Neuron-Specific Nuclear Protein (NeuN)+ cells present in all three sub-
layers of the supra-pyramidal blade, the hilus and reaching the infra-pyramidal blade of the DG 
(Figure 3.6C). These results demonstrated that our stereotactic injections to the SR can positively 
transduce neurons of the GCL, including those located on the GCL3 and therefore that no physical 
(anatomical) obstacles may preclude lentivirus transduction of granule cells.  
Although these findings support the conclusion that our lentiviral system is not able to induce 
transgene expression in GCL3 neurons, we tested once more this hypothesis in organotypic 
hippocampal slice cultures. Using this model, hippocampal cells are directly exposed to the virus-
containing solution, avoiding the need of stereotactic injection 67. During the first postnatal weeks 
neurons of embryonic origin are already present in the immature GCL, while progenitor cells that 
will eventually complete the neuronal layer are still present in the hilus 424. Four days after 
transduction with CMV-EGFP lentivirus the vast majority of the EGFP+ cells were negative for 
NeuN (Figure 3.6D), therefore substantiating our conclusions. This is in agreement with previously 
reported observations, where we demonstrated that the CMV-EGFP lentivirus transduces 
nestin/GFAP+ neuronal progenitor cells in early postnatal hippocampal slices 67. Moreover, others 
have shown that although transgene expression increases slowly with time after transduction of 
hippocampal slices with VSV-G pseudotyped lentivirus, it may remain restricted to CA1 and CA3 
pyramidal cells 425. 
Since we have used EGFP native fluorescence to directly detect transgene expression, one 
possible technical limitation in observing positive cells could have been a presumable low 
sensitivity of native EGFP fluorescence detection. Indeed, in the reference protocol for transgene 
delivery to granule cells the use of EGFP immunohistochemistry and subsequent indirect 
fluorescence detection is recommended 367. Therefore, we followed this approach to account for 
possible low detectability of EGFP-expressing cells. As shown in Figure 3.7A, 
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immunohistochemistry increased the detection of EGFP, as expected. Importantly, this increase 
was most evident in the dendritic arborizations and axonal extensions of the labelled cells. To 
account for this observation we used an Alexa 594-labelled secondary antibody to discriminate in 
between EGFP native fluorescence detected with an excitation wavelength of 488 nm and the 
immunohistochemistry signal detected with an excitation wavelength of 594 nm (Figure 3.7A). 
This approach showed a partial co-localization of the two signals, with highest co-localization 
detected in cell somata, and only partial co-localization in dendrites and axons (Figure 3.7A, boxed 
area and 3.7B). This phenomenon has been previously described and explained by partial 
antibody penetration under experimental conditions similar to ours 426. Therefore, in successive 
experiments we utilized a combination of native fluorescence and immunohistochemistry signal 
by using an Alexa 488-labelled secondary antibody. Following this approach, 5 weeks after 
injection the morphology of EGFP expressing cells transduced by the CMV-EGFP lentivirus was 
exposed with great detail. As recently described with other retroviruses 102;426, we were able to 
observe the axonal projections of EGFP labelled granule cells into the hilus and the stratum 
lucidum of the CA3 (Figure 3.7C-F). However, the distribution of EGFP+ cell somata within the GCL 
remained very similar to that observed using native fluorescence only, with almost no EGFP+ cells 
observed in the GCL3 (Figure 3.7G). Altogether these experiments further substantiate our 
conclusion that cells within the GCL3 are less permissive to lentivirus-delivered transgene 
expression.  
 
Identity of EGFP+ cells in the GCL after CMV-EGFP injection. 
To characterize the cell type(s) transduced by the CMV-EGFP lentivirus more accurately, we 
performed a series of immunohistochemical co-stainings for neuronal progenitor (nestin), glial 
(GFAP), immature neuron (DCX), proliferating (Ki67) and mature neuron (NeuN) cell markers 62 
(Figure 3.8). EGFP+ cells present in the GCL were analyzed for co-expression of these markers one 
week after lentivirus injection (Figure 3.8A-E). Quantitative analyses of these samples 
demonstrated that the majority of the EGFP+ cells were DCX+, with phenotypes ranging from 
putative dividing neuronal progenitors to early post-mitotic immature neurons (Figure 3.8). 
Nestin+, GFAP+ and NeuN+ cells accounted each for approximately one third of the EGFP+ cells, 
while Ki67 was co-expressed in a small proportion of the cells (Figure 3.8F). NeuN+ cells were 
further analyzed for neuronal features such as the presence of dendritic spines (Figure 3.9). We 
found that 11 4 % of the EGFP+ neurons present in the GCL had simple dendritic arbors with 
dendritic spines (Figure 3.9B-D), phenotypically resembling immature, most probably adult 
generated neurons 94;368. Quantitative analysis of spine density from EGFP+ neurons showed that 
these cells have relative low protrusion densities (Figure 3.9E; 7±2 protrusion/10 μm, n=5 
neurons, 420 protrusions counted) and present morphological features compatible with 
immature neurons 427. Three-dimensional reconstructions of EGFP+ cells revealed that these cells 
had narrow, low-complexity dendritic arbors, normally with one primary dendrite and relatively 
short secondary dendrites projecting into the ML (Figure 3.9F; mean maximal distance from soma 
203± 20 m, n=25 neurons), characteristics all compatible with being immature neurons 94;95. 
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DISCUSSION  
 
In the present study we have used lentiviral vectors expressing EGFP from three different 
promoters in the mouse hippocampus and have identified sub-field specific differences in 
transgene expression in various cell types of the GCL of the DG. Furthermore, we have 
characterized the cell types transduced by these lentiviral vectors, concluding that they target 
primarily NPC and immature neurons present in the SGZ and more immature layers of the GCL. 
Our observations suggest the existence of intrinsic differences in the permissiveness to lentivirus 
transduction among populations of granule cells of the GCL. In particular, we show for the first 
time that mature neurons of the outer granule cell layer do not express lentivirus-delivered 
transgenes, despite successful expression in other hippocampal cell types. Therefore, only adult-
generated neurons may be target for lentivirus-mediated transgene delivery within the GCL. 
The DG of the mammalian hippocampus is progressively constructed through a complex 
developmental program. Embryology studies have demonstrated that the GCL can be divided into 
an outer shell and an inner core, originated from separate embryonic progenitor pools. These 
progenitors generate first the outer shell followed by the development of the inner core by later-
born granule cells 428. Therefore, the outer shell of the GCL is partially assembled during 
embryogenesis and the majority of dentate granule cells, located in the inner shell are generated 
after birth 429-431. These and other observations have generated the hypothesis that, in contrast to 
the neocortex, the DG is built up following a life-long outside-in arrangement, where new cells are 
incorporated in the GCL following a downward gradient of positional cues 368.  
In rodents, proliferative cells become largely confined to the SGZ at the base of the GCL after 
postnatal day 30 430. Therefore, during the juvenile and adult periods the SGZ is the source of 
newly produced granule cells 62. 
Several groups have shown heterogeneous functional properties of granule cells in the adult 
hippocampus. In particular, new neurons generated by adult neurogenesis display increased 
synaptic plasticity and increased excitability suggesting that maturation of the neuronal 
phenotype includes changes in membrane excitability and morphology, as well as the 
establishment of appropriate connectivity 94;107;432. Interestingly, it has been proposed that 
functional and morphological differences among granule cells are a function of their location 
within the GCL rather than of their relative age 76;433. 
Herein we report that the three different lentivirus systems tested in this study, transduced 
mainly cells located in the SGZ and inner layers of the GCL. Cells expressing the reporter transgene 
EGFP one week after viral injection were mainly immature neurons expressing DCX. These 
observations resemble the EGFP expression profile achieved using MMLV-derived vectors that 
transduce only proliferating cells 94. Therefore, the initial cell population hit by the lentivirus was 
most probably a subpopulation of NPC that evolved into the neuronal lineage as judged by the 
predominance of DCX+ cells one week after transduction, similar to reports using MMLV-vectors 
94;95. Moreover, retro- and lenti-viral vectors have been shown to target similar, although not 
completely overlapping, populations in the hippocampus 368. Therefore, the use of adeno-
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associated virus-derived vectors may be more adequate to target mature neurons of embryonic 
origin in the adult dentate gyrus 434. An indubitable characterization of the cell type originally 
transduced by the lentiviral vector may request the use of cell type specific promoters restricted 
to NPCs 435. However, in the adult dentate gyrus, DCX is only expressed in cells contributing to 
adult neurogenesis and therefore can be used as a bona fide marker of newborn adult-generated 
neurons 100;436. 
Our observations are in agreement with the described ability of lentiviral vectors to transduce 
adult NPC in vivo 437. The presence of subpopulations of EGFP+ cells expressing the NPC marker 
nestin and Ki67, a cell proliferation marker expressed during the active phases of the cell cycle 438 
emphasize our conclusions.  
Moreover, the reduced numbers of EGFP+/NeuN+ cells found, their morphology and their 
location in the inner layers of the GCL, indicate that these EGFP+/NeuN+ cells have most probably 
originated from a population of immature cells originally hit by the virus. 
Crucial to sustain these conclusions are our experiments in which we delivered the lentiviral 
vector to the SR, situated between the CA1 and the outer shell of the GCL. If the pattern of EGFP 
expression restricted to the inner layers of the GCL would have been a mere mechanical effect of 
the steric hindrance generated by the tightly packed structure of the GCL 439, the lentiviral vector 
should have been able to transduce cells in the outer layers of the GCL, when delivered to the SR. 
Conversely, we observed strong EGFP expression in cells within the ML and CA1, demonstrating 
adequate diffusion of the lentivirus across different cellular structures. Moreover, EGFP+ cells 
were homogenously distributed within the CA1 layer, with profuse EGFP expression in the soma, 
axons and dendrites of cells phenotypically resembling mature pyramidal neurons. Our 
experiments using a peptide-cy5 conjugate, depicted in Figure 6, showed that this construct 
delivered into the SR, could effectively transduce the neurons located in the outer layers of the 
supra-pyramidal blade of the GCL and beyond into the hilus and the infra-pyramidal blade. These 
experiments demonstrated that stereotactic injection to the SR permits effective delivery to the 
GCL.  
Our data from the CA1 cells demonstrated as well that the CMV promoter is indeed able to 
promote transgene expression in mature post-mitotic neurons, as previously described 420. These 
observations made us to conclude that, although the use of different (cell-type specific) 
promoters is useful to promote different patterns of transgene expression in the GCL, cells 
present in the outer shell of the GCL only scarcely express transgenes delivered by lentiviral 
vectors. Interestingly, the Synapsin I promoter rendered an EGFP expression profile more similar 
to that of the CMV promoter than to that of the CaMKII promoter, in accordance to its expression 
in earlier neuronal developmental stages 383. Therefore, although further experiments to 
investigate transgene expression mediated by different promoters at later times post-injection 
seems important to address the relevance of differential promoter use, it escapes the objective of 
the present study.  
One potential drawback of the use of the CMV promoter may be its potential activation in 
astrocytes short time after injury, described in the cerebral cortex and caudate-putamen 440. 
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Nevertheless, this activation could be dependent on virus titers and other factors such as the 
particular CMV sequence used and the time after the injection 441. For the interpretation of the 
data presented herein it is worth to take into account that sections surrounding the injection site 
were routinely discarded. 
Specific transgene silencing after lentiviral vector-mediated delivery has been described before 
442. Although we cannot exclude from this set of experiments the possibility that transgene 
expression driven by the three promoters used in this study were selectively silenced in mature 
neurons present in the outer layers of the GCL, the fact that the CMV promoter was able to 
promote expression in cells of the CA1 makes this possibility unlikely.  
Overall, our observations are in agreement with previous reports showing that lentiviral vectors 
can successfully transduce mitotic and post-mitotic cells 420;437;443. However, the exact nature of 
the cell types and hippocampal sub-fields targeted by lentiviral vectors remains controversial. 
Previous reports did not find sub-field specific differences in GFP expression. This could be due to 
technical differences such as the use of different GFP variants and constructs, analysis of the 
samples at different time points after stereotactic injection or differences in the CMV promoter 
sequence used to control transgene expression 363;369. Nevertheless, the disparity in EGFP 
expression reported herein between cells located in the inner or outer layers of the GCL seems to 
be a function of intrinsic differences between cells generated by embryonic or adult neurogenesis. 
In this context, disparities in transgene expression in granule cells, depending on their relative 
location within the GCL and their progression into the neuronal differentiation program, 
emphasize the heterogeneity between newly adult-generated neurons and pre-existing ones, 
probably originated during embryonic and/or early postnatal development. 
Although further experiments will be required to clarify the exact nature of this heterogeneity 
among granule cells of the DG, regarding their permissiveness to lentivirus-delivered transgene 
expression, one possible explanation could be the differential expression of receptor proteins that 
recognize pseudotyping proteins by subpopulations of granule cells. However, VSV-G 
pseudotyped viruses have been shown to effectively transduce cells within the GCL of the DG 
363;369. This suggests that, although pseudotyping proteins can influence transduction efficiency 
and tropism to hippocampal cell types 384;419, the receptors for VSV-G glycoprotein are present in 
granule cells of the DG. Moreover, transgene expression from VSV-G pseudotyped lentivirus is 
pantropic in the rat brain, labelling a variety of glial and neuronal cell types depending on the 
promoter used to control transgene expression 443. 
Interestingly, even though cell mitosis is not a requisite for integration, transduction efficiency of 
lentiviral vectors is dependent on cell-cycle progression of target cells, with cells actively growing 
or arrested in phases other than G0 being more efficiently transduced in vivo 
420;444-446. As 
demonstrated here, lentivirus transduced EGFP+ cells are in their vast majority positive for 
progenitor (nestin), astrocyte (GFAP), proliferation (Ki67) and immature neuron (DCX) cell 
markers. Furthermore, Schmetsdorf et al 447 have demonstrated that cells from distinct 
hippocampal fields, including CA1, CA3 and DG, express completely different repertoires of cell 
cycle-related proteins. Therefore, although a more thorough elucidation of the factors regulating 
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lentivirus transduction of post-mitotic granule cells is beyond the scope of this article, our 
observations demonstrating lentivirus-mediated transgene expression in NPC and immature 
neurons suggest that cell-cycle progression is an important determinant in lentivirus transduction 
efficiency of hippocampal granule cells in vivo. 
 
Conclusion 
Herein, we report on sub-field specific differences in permissiveness to lentivirus-delivered 
transgene expression in the mouse hippocampus. Most interestingly, we observed transgene 
expression preferentially in NPC and immature neurons present in the SGZ and inner layers of the 
GCL, where adult neurogenesis takes place and different subpopulations of granule cells exist. 
Based on our results, we conclude that this disparity in transgene expression observed between 
cells located in the inner or outer layers of the GCL seems to be a function of intrinsic differences 
between cells generated by embryonic or adult neurogenesis and therefore favour the hypothesis 
that cell-cycle progression of target cells is an important determinant of lentivirus transduction 
efficiency. These differences could be exploited in utilizing lentivirus for transgene delivery to NPC 
and immature neurons of the mouse hippocampus in vivo.  
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ABSTRACT 
 
Stress is a major factor affecting adult hippocampal neurogenesis. However, the role of one of the 
major mediators of the stress response in neuronal progenitor cells (NPCs), the glucocorticoid 
receptor (GR), is unknown. Here, we show that specific GR knockdown in NPCs accelerated 
neuronal differentiation and migration. Strikingly, GR knockdown led to mis-positioning of adult 
newborn neurons, to altered dendritic arborization, to higher numbers of mature mushroom and 
thin spines and to larger mossy fiber boutons. In line with increased numbers of synaptic contacts, 
adult newborn neurons with GR knockdown exhibit increased mEPSC frequencies. Together, our 
data show a key role for GR expression levels in the appropriate formation of hippocampal neo-
circuits.  
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INTRODUCTION 
 
In the adult brain, neuronal progenitor cells (NPCs) exist in the sub-granular cell layer of the 
dentate gyrus, a subfield of the hippocampus that is involved in learning and memory formation. 
NPCs proliferate, and a subpopulation of these migrate and differentiate into granule neurons 
that are integrated into functional hippocampal networks (reviewed in 62). Together, this process 
takes approximately 4 weeks and is known as adult hippocampal neurogenesis. Previous 
pharmacological and physical 280;448 and recent genetic manipulations 98;406;449 aiming at blockade 
of neurogenesis have provided convincing evidence for a role of neurogenesis in hippocampus-
dependent memory formation.  
Among the most profound and best-studied regulators of neurogenesis are glucocorticoids (GC), 
which are one of the main mediators of the stress response. In the brain, GCs have profound 
effects on hippocampal networks that underlie behavioural adaption to stress. Prolonged periods 
of elevated GC levels, induced by e.g. chronic stress, have been associated with alterations in 
neuronal plasticity 371 and decreased levels of neurogenesis 139;244;450.   
GCs exert their effect by binding to two types of receptors i.e. glucocorticoid receptors (GR) and 
the mineralocorticoid receptor (MR) 14. Despite the wealth of information on the effect of stress 
and circulating GC levels on neurogenesis, very little is known on the role of GR and MR in 
individual NPCs. GRs are known to be expressed in NPCs but the MR is not 56;57. Two recent studies 
have suggested that tight GR regulation in NPCs is necessary for proper neurogenesis. Firstly, 
NPCs contain specialized retrograde transport mechanisms for GR translocation to the nucleus 67. 
Secondly, neuron-specific miR-124, a non-coding small RNA molecule regulating proper neuronal 
differentiation of NPCs in vitro and in vivo 60;61, down-regulates GR protein levels  59. Yet, how GR 
protein levels directly regulate adult-born NPC function is unknown.  
To study the in vivo role of the GR in NPCs of the sub-granular layer of the DG requires an 
experimental approach that is not based on traditional pharmacological or genetic manipulations 
of the GR. Therefore, we used previously characterized lentivirus-based vectors that preferentially 
transduce a population of DCX+ neuronal progenitor cells and immature dentate granule neurons 
in the DG (further referred to as NPCs) 109;451 (see also CHAPTER 3). In vitro, lentivirus-based 
vectors containing shRNAs directed against the GR (pm-shGR) were found to gain more than 70% 
GR protein knockdown (Van Hooijdonk et al., unpublished data (CHAPTER 2)). Using this 
technique for shRNA transgenesis to knockdown GR protein expression, we found that GR 
knockdown accelerates neuronal differentiation of NPCs. Moreover, GR knockdown induced 
aberrant positioning of adult newborn granule neurons in the outer layers of the DG, a higher 
number of cells with complex dendritic trees and a higher abundance of thin / mushroom-shaped 
mature spines at the cost of more immature stubby-shaped ones. Strikingly, this aberrant cellular 
phenotype was associated with enhanced basal neuronal excitability as measured by mEPSC 
frequencies.  
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MATERIALS AND METHODS 
 
Animals 
Male BALB/c mice (6 weeks, Janvier Bioservices, Genest st Isle, France) were individually housed 
for one week in filtertop cages before stereotactic surgery. The mice had free access to food and 
water and were kept under a 12 hour dark/light cycle (lights on at 8.00 hrs) in a temperature 
(20°C) and humidity controlled room. Experiments were performed between 8.00 and 13.00 hrs. 
All experiments were approved by the committee on Animal Health and Care from the Leiden 
University, The Netherlands and the Netherlands ministry of VROM and were performed in strict 
compliance with the European Union recommendations for the care and use of laboratory 
animals. 
 
Short hairpin (shRNA) constructs 
Perfect match (pm) and two nucleotide mismatch (mm) control short hairpin RNA (shRNA) 
expression vector and mismatch (mm) control directed against the consensus sequence of mouse, 
rat and human GR were designed according to the described criteria 373;374. The sequence for 
shRNA against mouse GR (NM_008173) was 
GATCCCCGAAAGCATTGCAAACCTCATTCAAGAGATGAGGTTTGCAATGCTTTCTTTTGGAAA for the pm, 
and GATCCCCGACAGCATTGCACACCTCATTCAAGAGATGAGGTGTGCAATGCTGTCTTTTGCAAA for the 
mm control (mismatch positions underlined). The sense and antisense oligonucleotides were 
annealed and cloned in BglII and HindIII sites of p-super vector (The Netherlands Cancer Institute, 
Amsterdam, The Netherlands). Insertion of the oligonucleotides was confirmed by sequencing. 
The knockdown of the GR by pm-shGR was confirmed by Western Blot in rat PC12 cells and 
functionally tested in N1E-115 mouse neuroblastoma cells by using a Dual Luciferase (Promega 
Corp. Madison, WI)- based GC response element reporter gene assay as previously described (see 
CHAPTER 2). 
 
Lentiviral vectors 
P-super vector derived pm-shGR and corresponding mm-shGR constructs were subcloned into a 
lentiviral vector downstream of the H1 promotor. The lentiviral vector also contained EGFP 
downstream of the CMV promoter. These replication incompetent and self-inactivating Advanced 
Generation Lentiviral vectors were produced and titrated as previously described 67 (see CHAPTER 
3). Titers of both viruses were comparable and ranged between 1x108 and 1x109 transducing 
U/ml. Virus suspensions were stored at -80°C until use and were briefly centrifuged and kept on 
ice immediately before injection.  
 
Stereotactic surgery  
Stereotactic injections were performed in the morning, following previously described methods 
451 (see CHAPTER 3). For all experiments, (LV-) pm-shGR or -mm-shGR constructs (titers ranged 
between 1x108 and 1x109 transducing U/ml) were injected bilaterally into the hilus of the DG (AP: 
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-2.00 mm, ML: +/-1.50 mm, DV: -1.90 mm, relative to Bregma). After surgery, animals were placed 
under a heating lamp until awakening and checked upon daily. For immunocytochemical 
experiments a group of 40 mice (N=20 for pm-shGR and N=20 for mm-shGR) was stereotactically 
injected and sacrificed one week post injection (N=10 for pm-shGR and N=10 for mm-shGR) or 
five weeks post injection (N=10 for pm-shGR and N=10 for mm-shGR). The results at the five week 
time point for neuronal makers and GFP positioning were confirmed in the mice that underwent 
context and cue fear conditioning- (see CHAPTER 5). For electrophysiological experiments, 20 
mice were stereotactically injected and sacrificed five weeks later (N= 10 pm-shGR and N= 10 
mm-shGR). In all experiments, mice were only included for analysis based upon post-mortum 
histological evidence of an appropriately targeted micro-injection as visualized by GFP expression 
in SGZ. Animals with low (<100 GFP+ cells per section), absent or mis-positioned GFP expression 
were excluded from the experiment and further assessment. 
 
Tissue preparation 
For the immunohistochemical experiments, one to five weeks post injection (PI), mice were 
sacrificed and brains were fixated by transcardial perfusion and processed as described previously 
451. Serial, coronal sections of 20 um thickness, were obtained using a cryostat (Leica CM 1900). All 
brain sections containing the hippocampus were collected either free-floating in eppendorf tubes 
containing anti-freeze, or thaw-mounted on SuperFrost object glasses. Superfrost slides were 
stored at -80°C till further use, whereas free floating sections were stored at -20°C.  
For the electrophysiology experiment, 5 week PI, mice at rest were sacrificed by decapitation (one 
mouse per day, between 9.00 and 9.30 am, when circulating levels of plasma corticosterone are 
low) Acute hippocampal slices (350 μM thick) for the electrophysiology recordings were made 
with a vibratome (model VT1000S; Leica, Germany) as described before 452 30. Hippocampal slices 
were stored at room temperature until recordings (for at least 1 h). 
 
Immunohistochemistry 
Immunofluorescent double and triple labelling staining procedures were performed following a 
standard procedure with thaw-mounted sections, and free floating as described 381;451 (see 
CHAPTER 3). Primary antibodies were from: Santa Cruz Biotechnology, Inc; Heidelberg, Germany 
(Doublecortin (C-18), used 1:200, Ki67 (M-19), used 1:100; GFAP, mouse monoclonal, used 
1:1000);  Chemicon-Millipore International BV, Amsterdam, The Netherlands (NeuN (A60), mouse 
monoclonal, used 1:200; GFP, mouse monoclonal, used 1:200), BD Biosciences, Breda, The 
Netherlands (Nestin, mouse monoclonal (556309), used 1:200), Abcam (Glucocorticoid receptor, 
(BuGR2), mouse monoclonal, used 1:500) or Molecular Probes/Invitrogen, Breda, The Netherlands 
(GFP, chicken polyclonal, used 1:500).  
 
Electrophysiology 
In acute hippocampal slices, GFP+ granule cells of both pm- and mm- shGR treatment groups and 
GFP- cells of both treatment groups were assessed for their physiological properties. Using patch 
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clamp techniques, spontaneous miniature excitatory postsynaptic currents (mEPSCs) were 
recorded as a measure of the resting membrane properties of newborn cells. Recordings of 
mEPSCs were performed as previously described 30. All values shown in the results section are the 
average ± SEM of the data. Statistical analysis between control and a single treatment on a given 
group of cells was carried out using a Student's t-test (paired when applicable). If more than two 
conditions were investigated on a given set of cells, we applied a general linear model for 
repeated measures (within-subjects contrast). Comparison of several conditions between sets of 
cells was performed with ANOVA, followed by post hoc multiple comparisons of the mean 
(Tukey). In all cases, P < 0.05 indicated significance. 
 
Histological analyses and confocal microscopy 
Quantification of EGFP+ cells and quantitative analysis of different classes of neuronal cells in the 
hippocampus of treated animals were performed using the optical fractionator sampling method, 
as described by Encinas and Enikolopov 81. Briefly, every tenth hippocampal section was collected 
starting at the DG following the fractionator scheme, to ensure that each slice is 200 nm apart 
from the next slice within each collected set of approximately 11 slices 67;451. For quantification of 
EGFP+ cells, three sets of slices from at least three independently injected animals from each 
experimental group were used. Sections surrounding the injection site were routinely discarded. 
For quantitative analysis of neuronal cell-types other three sets of slices from at least three 
independently injected animals from each experimental group were used. Confocal images were 
acquired using a Nikon C1si Spectral confocal microscope, as described 67. Expression of markers 
and cell-localization analyses were done counting more than 50 EGFP+ cells per animal. Co-
localization was assessed through the entire z-axis of each cell, using an optical slice of 0.3–0.6 
μm. Morphology was analyzed from three-dimensional reconstructions of series of sequential 
confocal images taken at 0.3–0.6 μm intervals in EGFP+ cells.  
 
Image analysis 
For EGFP+ cell-localization analyses within the DG or CA1 sub-fields, maximum intensity z-axis 
projections of series of sequential confocal images were constructed using ImageJ, as described 67. 
Using these projections, EGFP+ cells were automatically identified and counted using Cell Profiler 
(http://www.cellprofiler.org) 414. This procedure was validated by comparison to manual counting 
performed by an experienced operator using the optical fractionator method sampling scheme 
and unbiased stereology estimation of cell numbers as described by West and co-workers 415. The 
“pipeline” used to automate cell counting was composed of the following Cell Profiler’s modules, 
in the specified order: LoadSingleImage, ColorToGray, CorrectIllumination_Calculate, 
CorrectIllumination_Apply, IdentifyPrimAutomatic. By using this pipeline we routinely found a 
strong correlation between the manual unbiased stereology method and the automated 
procedure (r=0.985, Pearson’s correlation test performed with GraphPad Prism 4, GraphPad 
Software, Inc., La Jolla, CA). EGFP+ cells were individually pseudo-coloured to facilitated 
visualization and cell-localization maps were generated using Cell Profiler. Subsequently, based on 
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a previously described manual method to study granule cell location within the GCL 416 the GCL 
was subdivided in four 2-cell-body-wide sub-layers using ImageJ (http://rsb.info.nih.gov/ij/) to 
generate a superimposed grid, guided by Hoechst 33342 staining of cell nucleus. These sub-layers 
were denominated: sub-granular zone (SGZ) and granule cell layer (GCL) 1 to 3, as described by 
others 94;278;368. Then, the pseudo-coloured cell-localization maps generated with Cell Profiler were 
used to manually assign and count individual EGFP+ cells to the 4 sub-layers of the GCL of the DG. 
In all cases, EGFP+ cells present in the apex of the DG were excluded from the analyses. A similar 
procedure was used in experiments comprising EGFP+ cells in CA1. 
 
GR knockdown measurements 
Confocal images were analyzed by an operator blind to the treatment, using ImageJ 1.40 software 
for Windows (an open source public domain developed by NIH, USA). Clear-shaped and non-
overlapping EGFP+ cells in the granule cell layer of the DG of either perfect match- or mismatch 
shRNA groups were selected by using “free hand selection” mode, guided by Hoechst staining. 
Sections surrounding injection sites were discarded. The intensity of EGFP+ and mouse-anti-GR-
Alexa 594 immuno-labelling in these cells was measured by using Region of Interest (ROI) 
manager program. The degree of GR knockdown at protein level was estimated by normalizing 
expression levels in EGFP+ cells within the GCL and sub-granular zone (SGZ) to expression levels in 
equal numbers of GR+ CA1 neurons within the same hippocampus slice, which were not targeted 
by the lentivirus delivered to the hilar region. 
 
Quantification of different cell-type markers  
EGFP+ cells were automatically identified and counted using Cell Profiler from z-projected 
confocal images. From the same images, cells positive for each individual co-stained marker were 
also automatically identified and counted with Cell Profiler using the corresponding confocal 
channel. Cells positive for each marker analyzed were expressed as percentage of total EGFP+ 
cells per layer. All image analyses procedures were performed in hippocampal sections from at 
least three independently injected animals as described above. In all cases, image analyses were 
performed by an operator blind to the treatment. 
 
Quantification of GFP+ cell distribution among different DG sub-layers 
For each DG sub-layer, the number of GFP+ cells were counted –blind to treatment- using Image J 
Cell counter and ROI Manager program, respectively. Hoechst/GFP+ cells were counted separately 
for each DG sub-layer according to the following steps. At first, the DG in the photo was rotated to 
the horizontal or vertical position. After the rotation, the DG was divided by grids. Grids’ size was 
decided by blades’ width (only including dense area), which was fitted by 6 grids (2 grids for one 
layer: the GCL 1, 2&3). The blades’ width is not the same everywhere. Thus an average size of 
grids was chosen for each picture. The neurons outside the GCL1 but next to it (less than 2 grids 
distance) were counted as SGZ neurons. Then GFP+ cells were counted over all DG sub-layers. 
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Later same procedure was followed for quantification of Hoechst/GFP/DCX+ and 
Hoechst/GFP/NeuN+ neurons. 
 
Dendrite tracing and three-dimensional reconstructions. 
Three-dimensional reconstructions of dendritic arbors was performed as described previously 451, 
using TDR3D software package (http://bioimaging.liacs.nl/tdr3dbase.html), and using a simulated 
fluorescence process-based algorithm 418. Series of confocal images of EGFP+ neurons were taken 
at 0.3–0.6 μm intervals from at least three independently injected animals. All cells used for 
morphological analyses were positive for the neuronal marker NeuN. 
 
Sholl analysis 
Three-dimensional reconstruction of the entire dendritic processes of EGFP+ neurons was made 
from Z-series stacks of confocal images as described above. All EGFP+ dentate granule cells with 
largely intact dendritic trees were analyzed for total dendritic length and branch number. 
Measurements did not include corrections for inclinations of dendritic process and therefore 
should be considered to represent projected lengths 368. Sholl analysis for dendritic complexity 
was carried out using the Sholl Analysis Plugin for ImageJ (http://www- 
biology.ucsd.edu/labs/ghosh/software/ShollAnalysis_class). Data shown were from a 22 
individual EGFP+ dentate granule cells from at least 4 animals per experimental group. 
 
Dendritic spine three-dimensional reconstructions and shape classifications. 
Three-dimensional reconstruction of dendritic segments was done from Z-stacks of confocal 
images series of 100-200 confocal planes taken at 0.1 μm intervals using a 63x oil immersion 
objective. The confocal stacks were then deconvolved with Huygens Deconvolution Software 
(Scientific Volume Imaging b.v, Hilversum, the Netherlands). Spine density reconstructions and 
analysis were performed by automated three dimensional detection and shape classification 
based on a Rayburst sampling algorithm 453 using NeuronStudio software 
(http://www.mssm.edu/cnic/tools-ns.html).  
 
Confocal analysis of mossy ﬁber boutons.  
Mossy fiber boutons in the CA3 area were analyzed as described by others 102. Z-stacks of confocal 
images series of 100-200 confocal planes were acquired at 0.75 μm intervals with 40X oil lens 
(numerical aperture, 1.3; Nikon) and a digital zoom of 6. Confocal stacks were then deconvolved 
Huygens Deconvolution Software. 
 
Statistical analysis  
All comparisons of GR knockdown animals with control animals were statistically tested using 
unpaired Student’s t-test. When more than two groups were compared we used a one-way 
ANOVA test with Tukey’s post test if P<0.05, as described by van Hooijdonk et al 451. All values 
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shown in the results section are the average ± SEM of the data. In all cases, P < 0.05 indicated 
significance. 
 
 
RESULTS  
 
GR knockdown in vivo 
To knockdown the GR in NPC and their neurogenic progeny in vivo, lentivirus suspensions were 
delivered to the DG of the adult mouse hippocampus by stereotactic injections to the hilar region. 
Immunohistochemistry to detect the GR confirmed effective knockdown in LV-pm-shGR (further 
referred to as GR knockdown) EGFP+ cells, while LV-mm-shGR (further referred to as control) was 
ineffective on GR expression (Figure 4.1 B-G). After semi-quantification, we observed a significant 
GR knockdown of 85% in LV-pm-shGR EGFP+ cells, as compared to LV-mm-shGR EGFP+ analyzed 
in the same way (Figure 4.1 A). This partial knockdown, is comparable to that observed in vitro 
(>70%, see CHAPTER 2), and is consistent with previous in vivo observations 360. 
 
GR knockdown leads to accelerated neuronal differentiation of NPCs 
As different levels of GCs affect the fate of NPCs during embryogenesis 454 and in the adult brain 
123, we first investigated the effect of GR knockdown on neuronal differentiation one week after 
stereotactic delivery of our lentiviral constructs. We found a significantly increased proportion of 
EGFP+ cells positive for the mature neuron marker NeuN within the internal layers of the GCL, 
compared to LV-mm-shGR injected controls (Figure 4.1 H-J). This was accompanied by a 
concomitant increase in the proportion of EGFP+ cells positive for the immature neuron marker 
DCX in the same layers (Figure 4.1 K-M). Interestingly, the proportion of EGFP+ cells positive for 
the neuronal progenitor marker Nestin -exclusively located in the SGZ in both experimental 
groups- was unaffected by GR knockdown (Figure 4.1 N-P). These results strongly suggest that GR 
knockdown accelerates neuronal differentiation in newborn cells, without affecting survival of 
neuronal progenitors in the DG, as judged by the numbers of Nestin+ cells.  
 
 Figure 4.1 Effective GR knockdown in vivo regulates neuronal differentiation. (A to H) Validation of GR knockdown 
by lentiviral constructs in vivo. Semi-quantification of GR knockdown in EGFP positive cells of the dentate gyrus (A). GR 
expression levels detected by immunohistochemistry in EGFP+ cells within the GCL and SGZ were normalized to 
expression levels in equal numbers of individual GR+ cells in the CA1 area within the same hippocampal section, negative 
for EGFP (125 cells per experimental group, * p< 0.0001, unpaired Student’s t-test). The effective (LV-PM, B) or 
ineffective (LV-MM, E) lentiviral constructs were delivered by stereotactic injection into the hilus and GR knockdown was 
analyzed in cells expressing the enhanced green fluorescent protein (EGFP, green) by GR immunohistochemistry (red) 1 
week PI (post-injection). Orthogonal projections corresponding to boxed areas in B show a sample cell positive for GR 
expression (C) and a sample cell negative for GR expression (D). Cells with highest GR depletion were always found in the 
proximity or within the Molecular Layer (ML). Orthogonal projections corresponding to boxed areas in E show two 
sample cells positive for GR expression (F, G) irrespective of their relative positioning within the granule cell layer (GCL) 
or the sub-granular zone (SGZ). Sample orthogonal projections from confocal z-stack images corresponding to animals 
injected (1 week PI) with LV-PM (H, K, N) or LV-MM (I, L, O), showing EGFP and (H, I) NeuN, (K, L) DCX and (N, O) Nestin 
co-immunostainings. Distribution plots of EGFP and (J) NeuN, (M) DCX and (P) Nestin double-positive cells within four 
subdivisions of the GCL (SGZ, GCL1-3; Experimental Procedures). Values represent mean ± SD (n = 5 animals per group); * 
p< 0.05, unpaired Student’s t test. Nestin positive cells were only observed in the SGZ. Scale bars: 10 m.  
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GR knockdown in NPCs leads to an altered dendritic tree and dendritic spine profile  
During neuronal differentiation, new granule cells migrate from the sub-granular zone outwards, 
to the edge of the cell layer 368;455. This is accompanied by changes in the dendritic arborization of 
neurons in the DG, with cells in the outer layer showing more dendrites branching from the soma 
and more complex dendritic arborization than cells in the inner layer 433. Consistent with these 
observations we found that GR knockdown induced differential morphological features in EGFP+/ 
NeuN+ neurons (Figure 4.2 A-B). To characterize these differences, we reconstructed dendritic 
arborization of individual EGFP+ neurons in the DG. Compared to control animals, EGFP+ neurons 
in GR knockdown animals consistently showed more complex dendritic arbors (Figure 4.2 C-D).  
Consistent with previous observations 433, Sholl analyses demonstrated the existence of two 
different populations of EGFP+ neurons. We named these populations A and B cells. ‘A’ cells have 
simpler dendritic arbors than B cells (Figure 4.2 E-F).  Moreover, near the cell body, A cells present 
a unique primary dendrite with a smooth, a-spiny proximal dendritic domain and a spiny distal 
dendritic domain, while in B cells both the proximal and distal dendritic domains present 
abundant spines (Figure 4.2 C-D). Interestingly, the number of B cells was significantly increased in 
GR knockdown animals, with all B cells located in the most external third of the GCL (Figure 4.2 G). 
These observations are consistent with a premature progression into neuronal differentiation of 
newborn neurons in the adult hippocampus after GR knockdown.  
The morphological alterations after GR knockdown are likely regulated by GR-responsive genes 
219. In previous work, we have identified a number of genes like BDNF, LIM kinase 1(LIMK-1) and 
Calcineurin A, that also regulate spine dynamics as GR -responsive 22;456-458. Therefore, we 
reasoned that GR could be involved in regulating dendritic spine morphology in newborn neurons 
of the adult hippocampus. Multiple studies have demonstrated that newborn neurons in the adult 
hippocampus integrate into pre-existing circuits, receiving fully functional excitatory inputs and 
forming morphologically mature synapses, which is reflected in the shape of the dendritic spines 
95;427;459. Since mature granule neurons receive the majority of their synaptic input through 
dendritic spines, their numbers and morphology is indicative of their connectivity within 
hippocampal circuits 95. 
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Figure 4.2 GR regulates dendritic morphology of newborn neurons. Sample confocal images showing denditic 
morphology of EGFP+ cells and their location within the GCL from animals injected with LV-MM (A) or LV-PM (B). 3D 
confocal reconstruction of somas and dendrites of EGFP+ newborn neurons, obtained 1 week PI (C, Control; D, GR 
knockdown). Left panels show original images, center panels corresponding 2D projected dendritic trajectories and right 
panels show details of the distal (top) or proximal (bottom) to soma dendritic domains corresponding to boxed areas in 
the original image. Panels showing proximal domains were rotated 90 degrees clockwise. Only EGFP+ neurons with 
obvious dendritic spines were considered for analysis. Scale bar: 10 m. (E) Sholl analysis of dendritic complexity of 
EGFP+ neurons 1 week PI. Values represent mean  SD (n=5 animals per group), * p< 0.05, one-way ANOVA. (F) 
Dendritic properties of EGFP+ newborn neurons 1 week PI. Values represent mean  SD (same cells as in E, n=5 animals 
per group), * p< 0.05, unpaired Student’s t-test. (G) Presence of “B” cells (results section) in GCL3 (Experimental 
Procedures) as percentage of total EGFP+ cells in GCL in control vs. GR knockdown animals. * p< 0.05, unpaired 
Student’s t-test. 
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Figure 4.3 GR regulates dendritic spine maturation in newborn neurons. Sample deconvolved confocal images of spiny 
dendrites of newborn neurons in (A) Control or (B) GR knockdown animals and their corresponding 3D reconstructions 
(C, Control; D, GR knockdown). Scale bar: 10 m. (E) examples of 3D reconstructions of individual mushroom (top), thin 
(middle) or stubby (bottom) dendritic spines, indicated by arrows. Spine density measurements corresponding to (F) 
total, (G) mushroom, (H) thin and (I) stubby shaped spines in Control vs. GR knockdown animals. Values represent mean 
± SD (n = 5 animals per group), * p< 0.05, unpaired Student’s t-test.  
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Recently, we have shown that one week after stereotactic delivery of our lentiviral vector, only a 
small percentage of EGFP+ cells present in the GCL are positive for the mature neuron marker 
NeuN and have simple dendritic arbors with dendritic spines, whereas the vast majority of EGFP+ 
cells are positive for the immature neuron marker DCX, with phenotypes ranging from putative 
dividing neuronal progenitors to early post-mitotic immature neurons 451. Therefore, we analyzed 
the density and shape of dendritic spines from EGFP+/NeuN+ neurons in control and GR 
knockdown animals with visible spines in the proximal molecular layer (Figure 4.3 A-E). We found 
no significant difference in total spine density between EGFP+/NeuN+ cells in control and GR-
knockdown animals (Figure 4.3 F). The average spine densities that we found are consistent with 
spine densities previously observed in young newborn hippocampal neurons 95. 
Dendritic spines can be categorized into at least three different types based on their morphology: 
mushroom, thin and stubby 460;461. From these, stubby (headless) spines are associated with 
developing neurons while thin and mushroom spines, with increased head size, are more 
abundant in mature neurons 460;462. Strikingly, we found a significant increase in the percentage of 
mushroom and thin spines in EGFP+/NeuN+ cells from GR-knockdown compared to control 
animals (Figure 4.3 G-H). This increase in mushroom and thin spines was compensated by a 
significant decrease in stubby spines in GR-knockdown neurons (Figure 4.3 I). Overall, stubby 
spines were the predominant group of spines (59.2 1.5%) in control animals, while in GR-
knockdown animals mushroom spines slightly predominated (37.8 0.7%). Interestingly, although 
thin spines were the minority group, they constituted the group with the largest fold-change in 
GR-knockdown neurons (11.7 0.5% and 24.8 1.1 %, 2.11 fold, control vs. GR-knockdown, 
respectively). These results are again consistent with an accelerated maturation of newborn 
neurons after GR knockdown in NPCs. Moreover, as the size of spine head may correlate with the 
efficacy of the corresponding synapse 95, our results strongly suggest a role for GR protein levels in 
controlling synaptic efficacy in newborn granule neurons of the adult hippocampus. 
 
GR knockdown results in altered mossy fiber boutons 
The connectivity of neurons is determined by both afferent input through dendrites and efferent 
output through axons. As early as 10 days after new granule cells are born in the adult 
hippocampus they project their axon into the hilus and CA3 areas 95;105;439. The maturation of 
dendritic spines of newborn cells has been suggested to be matched with similar development of 
axonal output 102. Our observation that GR knockdown animals exhibit increased dendritic spine 
maturation suggests therefore that axonal synaptic output of newborn cells is also increased. 
These synaptic contacts, often visible as large mossy fiber synaptic boutons, constitute functional 
synapses of newborn granule cells with hilar interneurons and CA3 pyramidal neurons. The cross-
sectional area of mossy ﬁber boutons reflects the maturity of the corresponding synapse 102. 
Earlier it was reported that a relative increase in GR activation in the hippocampus, e.g. in 
mineralocorticoid receptor knockout animals 463 or after chronic stress 464, correlates with 
decreased mossy ﬁber projections, suggesting a role for corticosteroid receptors in the regulation  
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Figure 4.4 GR regulates mossy fiber boutons maturation. (A) Sample confocal images showing an overview of the 
hippocampus with a subpopulation of lentivirus-transduced cells in green (EGFP) in GR knockdown (top) or Control 
(bottom) animals, 1 week PI. Images are compositions of 5-6 individual images obtained at 40X and processed using the 
automatic Photomerge function of Adobe Photoshop CS2 (Macintosh version). Examples of mossy fiber axons labelled 
with EGFP in the CA3 corresponding to (B) Control or (C) GR knockdown. Insets show high magnification examples of 
giant boutons in the CA3. Scale bars: 10 m (A-C) and 2.5 m (insets). (D) Cross-sectional area of EGFP+ boutons at the 
largest section, calculated from 3D reconstructions of original images exemplified in B and C in Control vs. GR 
knockdown animals. (E) Frequency distribution plot of the size of mossy ﬁber boutons in Control vs. GR knockdown 
animals. Giant mossy ﬁber boutons in CA3 were grouped according to their size, and the percentage of boutons in each 
size group was calculated. In all cases values represent mean ± SD (n = 5 animals per group); *p< 0.05, unpaired 
Student’s t-test. 
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Figure 4.5 GR regulates positioning of newborn neurons within the GCL. See for legend next page. 
 
 
Figure 4.6 GR regulates resting membrane electrophysiological properties of newborn neurons (part 1). 
CHAPTER 4: CELLULAR EFFECTS OF GR KNOCKDOWN 
105 
 
 
Figure 4.6 GR regulates resting membrane electrophysiological properties of newborn neurons (part 2). Sample 
confocal images of EGFP+ (green) immunostaining from (A) GR knockdown or (B) Control animals 5 weeks PI, showing 
the persistent mis-location of EGFP+ cells after GR knockdown. The arrow in (A) shows a sample EGFP+ cell ectopically 
located in the ML. (C) Bar graphs showing the relative positioning of EGFP+ cells within four subdivisions of the GCL (SGZ, 
GCL1-3; methods section) normalized to total EGFP+ cell numbers 5 weeks PI in Control vs. GR knockdown animals. 
Values represent mean ± SD (n = 5 animals per group); * p< 0.05, unpaired Student’s t-test. (D) Examples of paired 
mEPSC recordings in GR knockdown (top) or Control (bottom) animals treated with LV-PM (top) or LV-MM (bottom), 5 
weeks PI. Inset shows a sample mEPSC. Scale bars represent 0.5s, 20 pA. mEPSC mean frequency (E) and amplitude (F) in 
animals in Control vs. GR knockdown animals. Values represent mean ± SD: n= 10 animals per group; * p< 0.05, unpaired 
Student’s t-test. 
 
 Figure 4.5 GR regulates positioning of newborn neurons within the GCL. Sample confocal images of EGFP (green) 
and NeuN (red) immunostainings in (A) GR knockdown or (B) Control animals, showing the differential positioning of 
EGFP+ neurons within the pre-existing granule neurons of the GCL, 1 week PI. Corresponding orthogonal projections (C, 
GR knockdown; D, Control) showing examples of EGFP/NeuN double-positive neurons. (E) Bar graphs showing the 
relative positioning of EGFP+ cells within four subdivisions of the GCL (SGZ, GCL1-3; Experimental Procedures) 
normalized to total EGFP+ cell numbers, 1 week PI. Values represent mean ± SD (n = 5 animals per group); * p< 0.05, 
unpaired Student’s t-test.  
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of mossy fiber connectivity. Therefore, we studied the layout of mossy fibers in GR-knockdown 
animals by analyzing axons and axon terminals in the CA3 area using confocal microscopy.  
We found that the mossy ﬁber boutons in CA3 were substantially larger in one week GR-
knockdown animals than those in the control group animals (Figure 4.4 A-C). The mossy fiber 
boutons in GR-knockdown animals had a significantly larger mean cross-sectional area than those 
in control animals (Figure 4.4 D, p=0.007; 2.4 0.1 m2 vs. 1.5 0.1 m2 GR-knockdown, n=109, and 
Control, n=102, respectively. p=0.007). Moreover, a frequency distribution analysis of mossy fiber 
bouton size showed that in control animals the majority (70.7 %) of the boutons had a cross-
sectional area smaller than 2 m2, while in GR-knockdown animals the majority (57.2 %) of the 
boutons had a cross-sectional area larger than 2 m2. In contrast, 6.3% of the boutons in GR 
knockdown animals had a cross-sectional area larger than 4 m2, which was not observed in 
control animals (Figure 4.4 E). These results suggest that, together with those presented in 
previous sections, GR-knockdown in adult-born granule cells induces a differential connectivity 
pattern to hippocampal circuits that may result in increased excitability. 
 
GR knockdown leads to altered positioning of adult newborn cells 
In our analysis of dendritic arborisation and spine morphology of newborn cells, we noted a 
marked dispersion of EGFP+ cells within the pre-existing granule cells of the granule cell layer 
(GCL) 1 week after treatment with LV-pm-shGR, which was nearly absent with LV-mm-shGR. 
Moreover, EGFP+ cells that retained high GR expression were located in the internal layers of the 
GCL, while EGFP+ cells with more profound GR knockdown were consistently located in more 
external layers of the GCL (Figure 4.5 A-D). These results suggest a role for the GR in the accurate 
positioning of newborn cells within the pre-existing GCL. In line with this are recent findings that 
excess glucocorticoids retard neuronal migration of NPCs during the cortical development 465. 
Therefore, we proceeded by comparing in detail the relative contribution of EGFP+ cells to the 
pre-existing GCL in groups of animals treated with LV-pm-shGR (GR knockdown) or LV-mm-shGR 
(control) and their progression into neuronal differentiation (Figure 4.5 E). We found that the 
proportion of EGFP+ cells located to specific GCL subdivisions, termed SGZ and GCL1-3 from the 
hilus to the Molecular Layer (Methods section), was significantly different in GR knockdown 
compared to control animals. The majority of the cells in control animals were located in the inner 
layers, which is in line with normal migration patterns of adult-born new neurons 76;94. Strikingly, 
in GR knockdown animals, the majority of the cells had progressed towards the outer layers, with 
a significant higher number of EGFP+ cells in GCL3 for GR knockdown animals (Figure 4.5 E). This 
seemed to be accompanied by a significant reduction of the number of EGFP+ cells in the SGZ. 
Thus, GR knockdown leads to an altered positioning of adult newborn neurons in the different 
layers of the DG. 
 
GR knockdown leads to sustained mis-positioning of NPCs and affects basal membrane 
excitability 
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To check if 5 weeks of GR knockdown also resulted in mis-positioning of newborn cells we have 
analysed the location of EGFP+ cells in the different DG layers (Figure 4.6 A-B). For the position of 
EGFP+ cells in the different layers, time was not significant for both treatment groups. In fact, 
significantly (p< 0,05) higher numbers of EGFP+ cells were found in GLC3 in GR knockdown 
animals compared to control animals, indicating long-lasting effects of GR knockdown on the 
formation of hippocampal neo-networks (Figure 4.6 C). 
To further test the contribution of newborn cells of GR knockdown animals in hippocampal 
circuitry we analysed the potential synaptic strength by recording spontaneous miniature 
excitatory postsynaptic currents (mEPSCs) as a measure of the spontaneous excitatory 
transmission (Figure 4.6 D), with whole cell voltage clamp (holding potential VH=-70 mV). EGFP+ 
cells within the granule cell layer were identified as neurons by the shape and location of their 
soma and dendritic tree. Consistent with the increased proportion of mature spines, EGFP+ cells 
in GR-knockdown animals presented a significant (p=0.03) increase in the frequency of mEPSCs, as 
compared to EGFP+ cells in control animals (Figure 4.6 E). The mean frequency of mEPSCs in 
control EGFP+ cells was highly comparable to that of neighbouring non-EGFP cells. No differences 
in mEPSC amplitude were detected between GR-knockdown and control EGFP+ cells (Figure 4.6 F) 
or neighbouring EGFP- cells. Collectively, these data corroborate that GR-knockdown in newborn 
hippocampal neurons induces drastic increases in basal membrane excitability, thus suggesting 
their participation in hippocampal circuitry.  
 
 
DISCUSSION 
 
Here we show that GR protein levels in NPCs are a key determinant for functional integration of 
adult born granule cells in hippocampal neo-networks. Firstly, GR knockdown leads to an 
accelerated neuronal differentiation of newborn cells. Secondly, downregulation of GR leads to a 
significant change in the relative positioning of newborn cells in the external layers of the GCL, or 
even in the molecular layer. Thirdly, lowering GR protein levels results in a clear shift in spine 
morphology, with more mature thin and mushroom spines and less immature stubby spines. 
Fourthly, EGFP+ neurons exhibited increased neuronal activity after GR knockdown, a finding with 
possible consequences for hippocampal circuitry.  
Several studies showed that aberrant GC signalling impairs neurogenesis in the sub-granular zone 
of the adult dentate gyrus 109;123. However, the role of the main mediator of glucocorticoids action 
in NPCs, i.e. the glucocorticoid receptor, remains elusive. This role may be direct or indirect since 
GRs are expressed in virtually every cell type in the DG, which confounds the interpretation of 
studies aiming to unravel the contribution of the GR in NPCs using classical transgenesis models. 
Therefore, we here used lentiviral vectors to specifically knockdown GR in the neurogenic niche of 
the dentate gyrus 451. Our data clearly indicate that aberrant GC signalling may target directly the 
fate of NPCs and that GR, expressed in NPCs, has a key role in proper integration of newborn 
neurons into existing hippocampal neuronal circuits. 
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The process of adult hippocampal neurogenesis comprises of several stages: proliferation, 
survival, migration, neuronal differentiation and functional integration into the hippocampal 
trisynaptic circuitry. Thus far, stress, and aberrant GC signalling have been mainly associated with 
antineurogenic effects at the initial stages (reviewed in CHAPTER 1.3.2); cell proliferation 
82;137;158;466 and cell survival 92;122. These stages are mainly associated with quantitative aspects of 
neurogenesis. 
In this study, we have found several lines of evidence that GR is involved in later stages of 
neurogenesis. GR knockdown in NPCs resulted in accelerated differentiation. In addition, our 
study revealed morphological alterations in dendritic arborisation, dendritic spines and boutons. 
Perhaps most importantly, our study showed that GR in NPCs controls correct positioning of NPCs 
as well a physiological evidence for an aberrant functional integration of NPCs into hippocampal 
networks. Our results indicate therefore GR knockdown in NPCs might have possible implications 
for the functioning of the hippocampus.  In a study by Herbert and Wong (2006), a first indication 
for an involvement of GR in later stages of neurogenesis was observed. Systemic injections with 
high concentrations of GCs, thus activating GR, “discouraged” the acquisition of neuronal fate in a 
time-dependent fashion 123. GCs given during the post-mitotic interval were shown to reduce the 
differentiation of newly formed cells into mature neurons as determined 1 and 4 weeks after 
treatment. Together, these data imply that GR’s are not only involved in regulating the number of 
newborn neurons (referred to as “quantitative” aspects), but also in controlling several aspects of 
neuronal development, such as spine and bouton formation of newborn neurons (referred to as 
“qualitative” aspects).  
How to explain these qualitative aspects of neurogenesis upon GR knockdown? One possible 
explanation is underlying the molecular function of GR as a transcription factor. This implies a 
more or less direct GR-mediated effect on differentiation, migration and integration. However, 
the signalling pathway downstream of the GR is not yet resolved. A first indication as to the 
nature of these signals comes from a study showing that the phenotype of newborn cells after 
knockdown of Disrupted-In-Schizophrenia 1 (DISC1; 368, a gene of which genetic variants have 
been implicated in the pathogenesis of schizophrenia 467, is strikingly reminiscent of what we 
observed after GR knockdown. Similarly as in our study, DISC1 knockdown in NPCs leads to 
enhanced excitability, accelerated neuronal maturation and synapse formation and to aberrant 
integration of newborn cells into hippocampal neo-networks. This similarity in phenotype after GR 
and DISC1 knockdown suggests that both proteins may be involved in the same signalling cascade 
directing newborn granule cells to their destination. One such potential converging pathway 
might be GSK3beta, a kinase involved in the control of cell proliferation and direct target of the 
anti-depressant lithium, as both both DISC1 and GR have been shown to control GSK3beta activity 
in neuronal progenitor cells 56;468.  
A second indication can be inferred from the observation that GR knockdown leads to a significant 
increase in the frequencies of spontaneous mEPSCs as well as in the numbers of mature-type 
mushroom and thin spines, indicative of increased glutamatergic neurotransmission 469. This may 
be the result of overall acceleration of neuronal differentiation by increased neuronal activity 
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caused by GR knockdown. Neuronal activity is a major determinant for the maturation rate of 
newborn cells. Alternatively or in combination with other factors, the GR may control more 
directly synapse formation and glutamatergic neurotransmission. Indeed, we have reported that 
the expression of several important components affecting spine formation, such as BDNF 456, 
LimK-1 and calcineurin A 22, is controlled by GRs at the genomic level. More recently, synaptic GR-
dependent glutamate receptor clustering has been reported by us and others 470;471. In addition, 
GRs are known to alter glutamate signalling 89;132-136. Also, a number of excitatory stimuli are 
known to be influenced by GR-mediated transcriptional regulation. Excitatory stimuli of NPCs are 
thought to release BDNF and also activate glutamatergic signalling via NMDA receptors, calcium 
entry, and activation of transcription factors like CREB and AP-1 64;472-476. Activated GR is well-
known to dampen these excitatory stimuli, for example by downregulation of BDNF 456;477 or by 
repression of AP-1 and cAMP signalling 478-480. However, the signalling pathways downstream of 
GR are a matter requesting further investigations. 
Either way, our data indicate a crucial role for appropriate GR expression levels in NPCs for 
progression of neuronal differentiation and functional integration into existing networks. The 
question therefore arises to what extent endogenous factors affect GR expression. Recently we 
showed that GR protein levels are down-regulated by microRNA-124 59, a non-coding RNA that is 
endogenously highly expressed specifically in neuronal cells. Interestingly, recent in vivo 
experiments identified microRNA-124 as a master switch that turns on a neuronal differentiation 
program in neuronal progenitor cells 61 suggesting that reduced GR protein levels are necessary to 
keep neuronal differentiation within physiological range, a notion that is in line with our data. 
Equally interesting, several risk factors for the pathogenesis of psychiatric disorders have been 
shown to result in reduced GR protein levels.  To illustrate, decreased maternal care in early life in 
rats, a rodent model for depression, reduces GR protein levels in the hippocampus 273; chronic 
stress, a major risk factor for several psychiatric disorders, is associated with reduced GR protein 
and mRNA levels in the hippocampus 51;302;481 and aging impairs negative feedback action of 
glucocorticoids on the HPA-axis that is associated by reduced hippocampal GR protein levels 482. 
Extrapolating, our data indicate that reduced GR protein levels under these circumstances can 
impair hippocampal function by re-organizing hippocampal neo-networks. 
 
In conclusion, we have demonstrated a crucial role for GR expression levels in migration, 
differentiation and integration of newborn granule cells into hippocampal networks. As the GR is 
a target for stress-induced elevation in glucocorticoids and for a broad range of pharmacological 
steroid-based agents, our data suggest that these factors may affect correct integration of 
newborn cells with possible consequences for neuroplasticity and hippocampal function.  
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ABSTRACT  
 
In a previous study, we found evidence for a regulating role of glucocorticoid receptors (GRs) in 
the development of newborn dentate granule neurons. To what extent GRs in these cells 
contribute to hippocampus-dependent memory processes, has yet to be investigated.  
In this study, we examined the role of GRs in a population of neuronal progenitor cells (NPCs) and 
immature dentate granule neurons for the formation of contextual fear memory. Lentiviral 
vectors expressing perfect match-shRNA for the GR were applied by microinjections into the 
dentate gyrus of male BALB/c mice to specifically knockdown glucocorticoid receptor proteins in 
the newborn granule neurons. Mismatch-shRNA injections served as control. Four weeks later, 
when immature dentate granule neurons were matured, mice were trained and tested in a 
Pavlovian fear conditioning task. This task was designed to allow measurement of fear memory 
(expressed as freezing) for both context and cue within the same procedure.  
Our data demonstrate dependency of GR signalling in newborn dentate granule cells for 
facilitation of consolidation of fear memories. Knockdown of GR destabilized memory 
consolidation to the conditioned context, resulting in a less strong expression of fear behaviour; 
i.e less “passive” freezing and more “active” scanning coping style. In line with our previous study 
(see CHAPTER 4), these data suggest a key role for GR in the formation of hippocampal neo-
networks that coordinate hippocampal memory formation.    
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INTRODUCTION 
 
The dentate gyrus (DG) of the hippocampus is implicated in memory processes involving 
discrimination between similar contexts 483 and the encoding of spatial information 73;184-186;484. 
The granule cell layer of the dentate gyrus is a heterogenous structure formed by granule neurons 
of different ages, morphologies and electrophysiological properties 76;402. The sub-granular zone of 
the DG also contains neuronal progenitor cells (NPCs). During a process called adult neurogenesis, 
NPCs proliferate and a subpopulation of these differentiate, migrate to the granular cell layer and 
mature into functionally active granule neurons that are incorporated in the hippocampal 
trisynaptic circuit. This process takes about four weeks. Previous pharmacological and physical 
280;366;448 and recent genetic manipulations 98;406;449 have provided convincing evidence that these 
adult born granule neurons also play a role in hippocampus-dependent memory formation. At 
least four weeks after modulation or elimination of NPCs for example, hippocampal function was 
affected as shown by weakening of contextual fear conditioning 296;366;449;485-487.  
Both hippocampus-dependent cognitive functions as well as neurogenesis are regulated by 
glucocorticoids (GCs) 5. These stress hormones affect memory consolidation 149;209, and 
neurogenesis 122;123. GCs exert their action via high affinity mineralocorticoid and low affinity 
glucocorticoid receptors (MRs and GRs respectively). MR and GR are known to be abundantly 
expressed in the granule neurons of the DG 54. In NPCs, GRs but not MRs are expressed 56;57. 
However, the GR role in NPCs is largely unknown which might be due to technical limitations to 
specifically manipulate its expression in this cell population.  
We hypothesize that GCs via GR may affect hippocampal-dependent cognitive performance by 
regulating the development of NPCs. To examine this in detail, in a previous study we have 
applied lentiviral vectors using stereotactic injections targeted at the sub-granular zone of the DG. 
We showed successful transduction of a specific population of DCX+ NPCs and immature dentate 
granule neurons (further referred to as NPCs) 451 (see CHAPTER 3). We used this technique to 
knockdown GR protein expression by RNA-interference technology (GR knockdown; Van 
Hooijdonk et al., unpublished data (CHAPTER 2) and indeed found evidence for an orchestrating 
role of GR in the formation of hippocampal neo-networks (Van Hooijdonk and Fitzsimons et al., 
submitted (CHAPTER 4)). GR knockdown was shown to have major impact on NPC differentiation, 
positioning, morphology and physiology. In fact, specific GR knockdown in NPCs accelerated 
neuronal differentiation and migration. Strikingly, GR knockdown led to mis-positioning of adult 
newborn neurons, to altered dendritic arborization, to higher numbers of mature mushroom and 
thin spines and to larger mossy fiber boutons. In line with increased numbers of synaptic contacts, 
adult newborn neurons with GR knockdown exhibit increased mEPSC frequencies. This suggests 
GR knockdown in NPCs might affect neuronal signalling and thereby result in a destabilized 
cognitive performance. To what extent GRs in NPCs contribute to hippocampus-dependent 
cognitive processes is topic of further investigation. Here, we assessed the effects of GR 
knockdown in NPCs on context and cue fear conditioning. For our experiments, we have selected 
the Balb/c mouse strain. Balb/c mice are known for their increased stress susceptibility, high 
CHAPTER 5: COGNITIVE EFFECTS OF GR KNOCKDOWN 
114 
 
emotional expression and superior cognitive performance in hippocampal-dependent tasks such 
as context and cue fear conditioning 308;484;488. We found that GR knockdown resulted in a 
destabilized memory consolidation to the conditioned context. This resulted in a less strong 
expression of fear behaviour; i.e less “passive” freezing and more “active” scanning coping style. 
Our data demonstrate dependency of GR signalling in newborn dentate granule cells for 
facilitation of consolidation of fear memories. In line with our previous study (see CHAPTER 4), 
these data suggest a key role for GR in the formation of hippocampal neo-networks that 
coordinate hippocampal memory formation.    
 
 
MATERIALS AND METHODS 
 
Animals 
We chose for BALB/c mice as this mouse strain expresses strong context- and cue-related fear 
memories in fear conditioning 484;489. Male BALB/c mice (6 weeks, Janvier Bioservices, Genest st 
Isle, France) were individually housed for one week in filtertop cages before stereotactic surgery. 
The mice had free access to food and water and were kept under a 12 hour dark/light cycle (lights 
on at 8.00 hrs) in a temperature (20°C) and humidity controlled room. Experiments were 
performed between 8.00 and 13.00 hrs. All experiments were approved by the committee on 
Animal Health and Care from the Leiden University, The Netherlands and the Netherlands 
ministry of VROM and were performed in strict compliance with the European Union 
recommendations for the care and use of laboratory animals. 
 
Small interference (siRNA) constructs 
Perfect match (pm) short hairpin RNA (shRNA) expression vector and mismatch (mm) control 
directed against the consensus sequence of mouse, rat and human GR were designed. The 
sequence for shRNA against mouse GR (NM_008173) was 
GATCCCCGAAAGCATTGCAAACCTCATTCAAGAGATGAGGTTTGCAATGCTTTCTTTTGGAAA for the pm, 
and 
GATCCCCGACAGCATTGCACACCTCATTCAAGAGATGAGGTGTGCAATGCTGTCTTTTGCAAA for the mm 
control. The sense and antisense oligonucleotides of 64 bp long were annealed and cloned in BglII 
and HindIII sites of p-super vector (The Netherlands Cancer Institute, Amsterdam, The 
Netherlands). Insertion of the oligonucleotides was confirmed by sequencing. The knockdown of 
the GR by GR knockdown was tested by Western Blot and quantitative PCR in rat PC12 cells (Van 
Hooijdonk et al., unpublished (CHAPTER 2); Van Hooijdonk and Fitzsimons et al., submitted 
(CHAPTER 4)) and functionally tested in N1E-115 mouse neuroblastoma cells by using a Dual 
Luciferase (Promega Corp. Madison, WI)- based GC response element reporter gene assay as 
previously described 67. 
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Lentiviral vectors 
P-super vector GR knockdown and corresponding control constructs were subcloned into a 
lentiviral vector downstream of the H1 promotor. The lentiviral vector also contained EGFP 
downstream of the CMV promoter. These replication incompetent and self-inactivating Advanced 
Generation lentiviral vectors were produced and titrated as previously described 451 (CHAPTER 3). 
Titers of both viruses were comparable and ranged between 1x108 and 1x109 transducing U/ml. 
Virus suspensions were stored at -80°C until use and were briefly centrifuged and kept on ice 
immediately before injection.  
 
Stereotactic surgery  
Stereotactic injections were performed in the morning, following previously described methods 
(CHAPTER 3) 367;451. LV-pm-shGR knockdown (n=25 GR knockdown mice) and LV-mm-shGR (n=25 
control mice) constructs were injected bilaterally into the hilar region of the DG (AP: -2.00 mm, 
ML: +/-1.50 mm, DV: -1.90 mm, relative to Bregma). After surgery, animals were placed under a 
heating lamp until awakening and checked upon daily. Four weeks after injection, mice were 
subjected in the context and cue fear conditioning procedure to assess their learning and memory 
capacities for a fearful event. This fear conditioning experiment was repeated with another cohort 
of injected mice (N=20 GR knockdown mice and N=20 control mice) with similar results. In 
addition, the brains of these mice were used for the morphological analysis of NPCs described in 
CHAPTER 4. 
 
Fear conditioning apparatus 
Fear conditioning was conducted in a conditioning chamber (25 cm x 25 cm) enclosed by 4 black 
Plexiglas walls (35 cm high), one embedded with a speaker (25 cm high) connected to a tone 
generator (70 dB). A 3 cm plastic rim covered the top of the walls. The floor consisted of 37 
stainless steel bars 5 mm in diameter spaced 0.5 cm apart, connected to a shock generator (0.4 
mA). Underneath the stainless steel bars, tissues were placed to collect faeces and urine. A white 
light source (260 Lux) was placed 20 cm above the conditioning chamber together with a camera 
for later behavioural analysis from video tape.  
A radio on the other side of the experimental room produced 20 dB of background noise. The 
light intensity of the experimental room was 90 Lux. After each animal the chamber was cleaned 
with tap water and the tissues in the container replaced by clean ones. 
 
Fear conditioning procedure 
Our fear conditioning paradigm allows to differentiate between context and cue related 
behavioural responses in the same setting 484;490. During conditioning (day 1), three minutes of 
baseline recording was followed by 6 light/tone (CS) + shock (US) pairings with a one minute 
interval. Pairings were as follows; light and tone were given simultaneously for 20 seconds; an 
electric foot shock (0.4 mA) was administrated during the last two seconds. Two minutes after the 
last pairing, the mice were returned to their home cage. At 48 (day 3) and 72 hrs (day 4) after the 
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initial conditioning, the same procedure was repeated without shocks to test memory and 
extinction of fear behaviours during alternating context and additional cue episodes. The 
procedure lasted 12 minutes per mouse on each testing day. At the end of the testing session of 
Day 4, animals were sacrificed, and upon a fixation procedure, sections of the hippocampus were 
assessed for EGFP expression in the dentate gyrus around the injection site. Animals with low 
(<100 EGFP+ cells per section), absent or mis-positioned EGFP expression were excluded from the 
experiment and further behavioural assessment. 
 
Corticosterone radio immune assay 
At 4 time points before, during and after the fear conditioning procedure blood was collected via 
tail incision or after decapitation. Under resting conditions, two days before the fear conditioning 
experiment, blood samples were taken by tail incision during the morning (7.00 hrs, circadian 
nadir) and evening (18.00 hrs, circadian peak), i.e. one hour after light on and before light off 491. 
A third, peak stress blood sample was collected 30 minutes after the start of conditioning at Day 
1. A fourth, habituated stress blood sample was collected 60 minutes after the last memory 
testing session on Day 4. Corticosterone concentrations were measured in blood plasma using a 
commercially available radio immune assay kit (ICN Biomedicals, Inc), as described before 308. 
 
Behavioural assessment 
Fear can elicit multiple behavioural responses, for example encompassing behavioural inhibition 
such as freezing in response to threatening contexts. We registered freezing as expression of fear 
behaviour during alternating context and cue episodes. Freezing is defined as complete 
immobility of the body and head, being devoid of interaction with the environment. For a more 
precise evaluation of fear behaviour we additionally analysed scanning. Scanning is defined as 
immobility of the body, while the head is moving horizontally from side to side. Although being 
immobile, the animal is still actively interacting with its environment. Scanning and freezing are 
interdependent behaviours that express a different quality of fear. With automatic scoring they 
are often measured together as “total immobility” 194. To ease comparison of our work with 
others, we also calculated the total immobility score. All behaviours were scored from video tape 
using a semi automatic scoring program (The Observer 4.1, Noldus, Wageningen, The 
Netherlands). Videotaped behaviour was analysed by an experimenter blind to the treatment.  
 
Statistical analysis 
Endocrine and behavioural analysis of selected GR knockdown and control mice was performed 
after testing, based upon two criteria: 1) post-mortem histological evidence of an appropriately 
targeted micro-injection as visualized by EGFP expression in SGZ, and 2) indication of an 
appropriate, average acquisition of fear conditioning at Day 1. Data are shown as mean ± SEM and 
p < 0.05 was accepted as level of significance for all statistical testing. Endocrine analysis consisted 
of a General Linear Model (GLM)-Repeated Measures for comparing blood plasma corticosterone 
concentrations between the different treatment groups over the four time points. In addition, 
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Students T-test statistics were used to compare corticosterone concentrations of GR knockdown 
and control groups at each time point. Fear behaviour is expressed as percentage of e.g., freezing 
per Day for context and cue on episodes. A comparison in average freezing behaviour was 
determined first by a GLM-Repeated Measures analysis for all treatment groups: 1) uni- and 
bilateral injected mice, (2) sham and mm-shGR control groups, and 3) mm-shGR and GR 
knockdown injected mice. Difference in average freezing behaviour and progression over 
episodes/ Days between GR knockdown and control mice was subsequently determined by GLM-
Repeated Measures statistics. Difference in context only and cue on induced freezing behaviour 
between GR knockdown and control mice were determined with a two-way ANOVA. 
Furthermore, a two-way ANOVA was performed to determine on which episodes GR knockdown 
and control mice differ in freezing behaviour. Significant treatment difference between GR 
knockdown and control mice in fear (freezing, scanning and total immobility) and other behaviour 
was determined with a GLM multivariate analysis followed by an ANOVA to determine which 
specific behaviours differed. A GLM-Repeated Measures was subsequently done to determine 
differences in total immobility or scanning behaviour and progression over Days between GR 
knockdown and control groups for context as well as cue on episodes. A Paired Samples T-test 
was done to compare freezing to context and cue for both GR knockdown and control groups for 
Day 3 and Day 4. A Students T-test for independent variables was used to compare the 
percentage of freezing or scanning for context and cue on episodes between groups per Day. 
Factor analysis was subsequently performed to determine a treatment specific behavioural 
structure. The factor analysis uses cross-mouse comparisons to distinguish the relation between 
behavioural parameters. It includes as much data as possible in each factor to minimize residual 
variance from the original dataset. The Principal Component Analysis (PCA) was performed with a 
Varimax rotation on variables with communalities over 0.65, that is, of which at least 65 % of the 
variance is explained by the Factors extracted. The number of extracted Factors was not pre-
defined; as described before 489, Factors with an Eigenvalue over 1 were accepted. Factor scores 
were subjected to a one-way ANOVA to determine treatment differences.  
 
 
RESULTS  
 
Assessment of treatment groups for EGFP expression, HPA activity and freezing. 
Mice with appropriate EGFP expression at the injection site and freezing behaviour during 
conditioning on day 1 were selected for the two experimental groups: GR knockdown and control. 
Twenty-one out of N= 25 GR knockdown mice showed EGFP expression in the SGZ of the DG in at 
least one brain hemisphere (N= 17 mice bilateral EGFP expression and N= 4 unilateral EGFP 
expression). Eleven out of N= 25 control mice were selected for further analysis (of which N= 7 
bilateral EGFP expression and N= 4 unilateral EGFP expression). One mouse from the control 
group was not selected because of a complete lack of freezing behaviour. 
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We further assessed whether unilateral or bilateral EGFP expression differentially affected 
corticosterone secretion and freezing behaviour. We found no differences between the groups 
(corticosterone: GR knockdown F(89,91) 3.093, p=0.082); control F(38,40) 2.305, p= 0.137; 
freezing: for GR knockdown F(1,39) 0.88, p= 0.354); for control F(1,15) 0.66, p= 0.428). Therefore, 
we pooled the data of mice with unilateral or bilateral EGFP expression in the GR knockdown (n= 
21) or control groups (n= 10). This is also in line with earlier reports on the connectivity between 
hippocampi, indicating there is a strong connectivity by  contralateral commissural projections of 
mossy cells in the hilus, and lesion studies in mice and humans (Amaral et al., 1990, 2007; Hoz et 
al., 2005; Groticke et al., 2008; Batchelor et al., 2008) 70;72;492-494. 
Some of the mice (n= 14) did not show EGFP labelling of the cells indicating that no lentivirus was 
injected, i.e, “sham-injected” control geroup. One mouse did not freeze during acquisition and 
was discarded from further analysis. Comparison of the sham and EGFP expressing control groups 
revealed comparable corticosterone secretion (F(83,85) 1.53, p= 0,220) and freezing over the 
three testing days (F(1, 65) 3.15, p= 0.081), excluding an effect of the lentiviral microinjection.  
Because the mm-shRNA construct differs only two nucleotides from the pm-shRNA construct, we 
consider the control group as the most appropriate control group. Therefore, we continued our 
endocrinological and behavioural analysis by comparing control and GR knockdown groups.  
 
GR knockdown in dentate granule neurons does not affect plasma corticosterone   
GR activation in the hippocampus after stress exposure is known to limit further activation of the 
stress system via facilitation of behavioural adaptation 9;11;495. Knockdown of hippocampal GR 
might therefore affect HPA activity, and thereby indirectly influencing cognitive performance. To 
control for this, we measured plasma corticosterone concentrations at four time points. Basal 
plasma corticosterone concentrations were determined the morning and evening two days prior 
to the start of fear conditioning. Compared to these basal morning and evening corticosterone 
levels, there was an expected robust corticosterone response 30 min following acquisition on Day 
1 (Figure 5.1). In line with previous studies from our group 489;491, this indicates that plasma 
corticosterone levels had increased enough to activate the GR during the fear conditioning 
paradigm. The corticosterone levels of the fourth sample were low and similar to basal. At all 
measured time points, corticosterone concentrations were comparable between mm- and GR 
knockdown groups. GR-knockdown in NPCs therefore did neither affect the level nor the 
rhythmicity of corticosterone secretion. This suggests that newborn dentate granule cells are not 
involved in hippocampal inhibition of the HPA axis. In addition, this indicates that the behavioural 
effects are due to the selective downregulation of GR expression and not indirectly, due to 
differences in ligand availability.  
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Figure 5.1. Plasma corticosterone concentrations in GR knockdown and control at four time points (mean ± SEM). 
Basal morning and evening blood samples were taken two days before the start of fear conditioning. A third blood 
sample was taken 30 min after the start of conditioning on Day 1 and the fourth sample 60 minutes after the start of 
memory testing on Day 4. 
 
Freezing during context and cue episodes per testing day 
Context and cue fear conditioning is a form of Pavlovian conditioning elicited by pairing a neutral 
stimulus (CS: light and tone = cue) with an aversive unconditioned stimulus (US: e-shock) in a 
distinctive context. Acquisition of the CS-US association is known to require the amygdala 496. 
Acquisition of a context-US association is regarded as a hippocampus-dependent task, involving a 
spatial/ contextual component that involves the dentate gyrus and amygdala 497;498. Proper 
acquisition elicits fear behaviours for the expected aversive stimulus, such as freezing, which is 
regarded as an adaptive species-specific defence behaviour 499. This is emotionally arousing as 
well as stressful, triggering GC secretion as well as subsequent GR activation and thus making it 
suitable for investigating GR function. After 48 (day 3) and 72 hours (day 4), mice were tested for 
their fear memory related to alternating cue-on and context episodes. Freezing is the 
predominant expression of fear. 
Perfect match-shGR and control treated mice differed significantly in freezing behaviour over the 
three testing days (Figure 5.2; main effects of treatment: F(1,85) 20.483 p<0.0001; day: F(2,85) 
9.908 p<0.0001; interaction treatment-day: F(2,85) 3.391 p=0.038). Both, freezing during context 
and cue differed significantly between treatments over the Days (cue / context: main effect 
treatment: F(1,91) 17.519, p<0.0001 / F(1,85) 19.588 p<0.0001; Day F(2,85) 9.439, p<0.0001 / 
F(2,85) 11.517, p<0.0001; interaction treatment-Day: F(2,85) 3.975, p=0.022 / F(2,85) 3.205, 
p<0.046).  
During acquisition on Day 1, freezing behaviour was comparable between GR knockdown and 
control groups for cue and context episodes. During memory testing on Day 3, GR knockdown 
treated mice showed about 50 % less context-related freezing (F(1,30) 7.322, p=0.011) while on 
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Day 4 both, context and cue-related freezing were decreased by 50 % (context: F(1,30) 15.456, p< 
0,001; cue: F(1,30) 18.026, p<0.0001) (figure 5.2) compared to control mice. Mismatch-shGR mice 
expressed similar high cue-related freezing on Days 3 and 4. Perfect match-shGR treated mice 
discriminated between freezing to context (less) and cue (more) on Days 3 and 4 (both p<0.01). 
Mismatch-shGR treated mice showed significantly less freezing to context than cue on Day 4 
(p<0.0001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. Percentage of freezing during context (A) and cue (B) episodes per testing day (mean ± SEM). (A) freezing 
to context. B) freezing to cue on. Dark bars: GR knockdown, light bars: control. Between groups ** p< 0.011 GR 
knockdown compared to control. Within groups # p< 0.01 context freezing compared to cue freezing. 
 
Progression of freezing behaviour over alternating context and cue episodes 
During acquisition of fear on day 1, mm- and pm- shGR injected mice significantly increased 
freezing over context and cue episodes (context: F(5,145) 47.291, p< 0.0001; cue: F(5,145) 54.779, 
p<0.0001; Figure 5.3). This pattern was similar in both groups, indicating a proper learning curve 
independent of treatment. During memory testing on day 3, context-related freezing decreased 
over time, comparably in both groups (F(5,140) 6.779, p<0.0001), while cue-related freezing did 
not change over time. On testing day 4, context-related freezing changed over time (F(5,140) 
12.416 p<0.0001), with a different time course in both groups: freezing is low with little change 
over time in the GR knockdown groups, while there is a significant decrease of context freezing in 
the control group (interaction F(5,140) 2.604, p=0.028). Cue-related freezing decreases in both 
groups (F(5,140) 2.846 p=0.018).  
On day 3, significant differences in freezing behaviour were observed for several context and the 
first cue episodes (all p < 0.05; figure 5.3). Perfect match-shGR treated mice showed less freezing 
than control mice during the initial 3 minutes in the box before the first cue (F(1,111) 10.35, p< 
0.002). This shows that GR knockdown treated mice freeze less when first exposed to the context 
previously associated with a shock, and also freeze less when the cue is presented for the first 
time. 
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During testing for memory on day 4, freezing behaviour during all cue and context episodes was 
significantly less expressed in GR knockdown than control mice (ANOVA for all episodes: p < 0.05; 
GLM for context: F(5,155) 2.79, p= 0.019; GLM for cue: F(5,155) 4.97, p<0.0001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Percentage of freezing to context (A) and cue on (B) over the alternating episodes per testing day (mean ± 
SEM). From episode 0-3 onwards paired context and cue on episodes are separated in this graph for better distinction of 
the freezing patterns between the two groups. Dark bars: GR knockdown; light bars: Control. The lines indicate the 
context or cue on episodes with significant differences between treatment groups. Freezing to the context was 
significant at Day 3 for episodes 0-1 to 0-3 and 1 to 4 (p<0.05). For Day 4 context freezing was significant for episodes 1-
6 (p<0.05). Freezing to cue on was significant at Day 3 only for the first episode (p<0.05), while on Day 4 episodes 1 to 6 
were significant between GR knockdown and control groups (p<0.05). 
 
Scanning: a more active fear behaviour  
In addition to freezing, we also assessed another fear-related behaviour: scanning. Freezing and 
scanning are often represented together as “total immobility”. Throughout the 3 days of the 
context and cue fear conditioning paradigm, the percentage of time in which mice displayed 
“total immobility” was comparable to GR knockdown and control mice. Comparable to the 
differences found for freezing, scanning differed significantly between GR knockdown and control 
mice and changed over days (main effect of treatment: F(4,81) 2.835, p=0.03; day: F(8,164) 9.071 
p<0.0001). During conditioning, scanning in context and cue episodes was comparably high 
between the groups. Perfect match-shGR mice keep the same level of scanning behaviour shown 
during conditioning also on the memory testing days, while scanning decreases in the control 
mice. Thus, on testing Days 3 and 4, scanning behaviour was increased in GR knockdown mice 
      Conditioning Day 1        Memory/ extinction Day 3   Memory/ extinction Day 4 
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during context and cue episodes (context: F(1,84) 5.613 p=0.02; cue: F(1,84) 8.484 p=0.005) 
compared to control mice (figure 5.4).  
 
 
 
Figure 5.4. Percentage of scanning during context (A) and cue (B) episodes per testing day (mean ± SEM). Dark bars: 
GR knockdown, light bars: control. Between groups: * p<0.05 and ** p<0.005 compared to control. Within groups: not 
significant. 
 
Factor analysis 
Factor analysis resulted in the extraction of two factors explaining 83 % of total variance (table 
5.1). Factor 1 was classified as passive fear, factor 2 was classified as fear activity. Further ANOVA 
showed a significant treatment effect (F(1,1349) 12.466, p<0.0001) on factor 1, indicating less 
passive fear behaviour in GR knockdown treated mice. 
 
 Factor 1: Passive fear Factor 2: Fear activity 
Total immobility 0.890  
Freezing 0.828  
No. Scan  0.978 
No. Freeze  0.943 
 
Table 5.1. Principal component analysis over all data, with Varimax rotation and Kaiser normalisation. Behavioural 
parameters are represented as factor loading per factor. Factor loadings with equal value are positively correlated, 
while loadings with opposing values are negatively correlated. Loadings < 0.7 are not included in this table.  
 
 
 
 
CHAPTER 5: COGNITIVE EFFECTS OF GR KNOCKDOWN 
123 
 
DISCUSSION 
 
In this study we have shown that four weeks of RNAi-mediated GR knockdown (GR knockdown) in 
NPCs resulted in a destabilized memory consolidation during context and cue fear conditioning. 
Specifically, GR knockdown resulted in less context- dependent freezing during memory testing on 
Day 3, and lower context- and cue- induced freezing on Day 4, despite a comparable acquisition 
during Day 1. Furthermore, analysis of all fear behaviour showed a shift from a passive coping 
strategy (freezing) to a more active coping strategy (scanning) in GR knockdown injected mice. 
This was verified by factor analysis. Supported by the lack of effects on circulating plasma 
corticosterone, these data confirm the involvement of hippocampal GR expression levels in NPCs 
in cognitive performance.  
Several studies have shown the involvement of glucocorticoids and GR activation in fear 
conditioning 149;209. However, the role of GR in specific hippocampal cell populations, i.e. neuronal 
progenitor cells, remains elusive. Thus far, it has been difficult unravelling GR function in the 
different cell types, because of a lack of discriminating techniques. Therefore, we here used 
lentiviral vectors to specifically knockdown GR in the neurogenic niche of the dentate gyrus 451. 
Our data add to the growing evidence that NPCs are important substrates underlying 
hippocampal cognitive performance. In addition, we show for the first time that GR expression in 
NPCs is involved in memory consolidation for a fearful event. 
 
GR knockdown in NPCs is not involved in appraisal or acquisition 
Hippocampal-dependent learning and memory can be separated into distinct phases; on the one 
hand appraisal (evaluation of the situation) and acquisition (learning), on the other hand 
consolidation (memory formation) and retrieval (memory recollection) 183. Extinction occurs when 
a conditioned response to a stimulus decreases when a reinforcer is omitted 500. A lack of memory 
as “end product” can be caused by a disruption in each of these phases. For the GR, its role in 
memory during contextual fear conditioning has been observed in several studies using systemical 
loss of GR expression, inhibited GR activation by adrenalectomy or GR 199;200;209;501-504. In our study 
we aimed for a more specific investigation of the function of the GR in NPCs in relation to a 
specific phase of memory. To this end, we used a 4-day paradigm for context and cue fear 
conditioning. Although it is difficult to discriminate between phases, this paradigm gives more 
insight in the memory phases affected by GR knockdown in NPCs.  
Interestingly, the acquisition of fear behaviour in GR knockdown mice was comparable to control 
mice during conditioning on day 1. During the initial minutes in the fear conditioning apparatus 
and the following episodes of alternating context and cue pairings followed by a footshock, we did 
not observe any difference between GR knockdown and control mice. Freezing increased during 
each subsequent episode in a similar fashion for both GR knockdown and control mice. These 
learning curves suggest the mice learned equally well and therefore may imply that appraisal and 
acquisition are not affected by adult born neurons and more specifically not by GR knockdown in 
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NPCs. This supports the finding of others, that altering GR activation by GR (ant-) agonist 
treatment before acquisition does not affect fear behaviour to a shock 489;505.  
Also, upon a non-GR related genetic manipulation of NPCs, no effects of acquisition could be 
found 487. In this study, the expression of the pro-differentiative gene PC3 (Tis21/BTG2) was 
induced specifically in nestin-positive cells, which is in line with the GR knockdown data 
described in Chapter 4. In line with the data described in this chapter, the authors also found 
that an accelerated differentiation of NPCs did not affect acquisition. This suggests that 
acquisition was not affected by GR knockdown in NPCs, and consequently, that different 
hippocampal circuits and signalling pathways are involved in acquisition of context and cue fear 
conditioning. 
 
GR knockdown in NPCs leads to destabilized memory consolidation for the context 
In contrast to a role for GR knockdown in NPCs in appraisal and acquisition, a role in memory 
consolidation is more likely. Memory consolidation is the process by which a fragile short term 
memory trace is transferred into stable long term memory. Stress-mediated activation of GRs, has 
been strongly associated with a facilitative effect on memory consolidation 149;209. Specifically, GCs 
have been shown earlier to enhance memory consolidation of emotionally arousing experiences 
506, a situation we tested in context and cue fear conditioning.  
Fourty-eight hours after conditioning, during first minutes of memory testing, GR knockdown 
treated mice showed less freezing response when placed in the fear conditioning chamber 
(context) and the first cue. This strongly indicates that for context, mice seem to have 
remembered less about the fearful foot shock on Day 1. After the first cue exposure, a number of 
subsequent context episodes still showed decreased freezing of GR knockdown mice as well. 
Freezing in response to the cue however, was comparably high to control mice and also 
significantly higher from context freezing in GR knockdown mice. This indicates mice are able to 
differentiate between context and cue episodes.  
Processing context and cue information is known to take place in different brain areas. The cue 
related fear response is related to the amygdala 498. This explains well the lack of effect on cue 
freezing upon GR knockdown in the dentate granule neurons. In contrast, in the dorsal 
hippocampus, the DG together with the CA3 serves to encode spatial and contextual information 
187;245, so less GR function in the DG might affect encoding of context information during memory 
testing. Another explanation for less contextual freezing during (initial) memory testing might be a 
loss of the facilitative effects of GR activation on memory consolidation; i.e. a destabilized 
consolidation 507. In line with this, a hippocampal GR modulatory effect on contextual fear 
memory has been shown 489;508;509, although not specific for the DG.  
GR-mediated facilitation of memory consolidation of emotionally arousing experiences such as 
fear conditioning is also critically dependent upon GC induction of sympathic activity in the 
amygdala. In our study, GC levels were high during conditioning, thus also able to activate GRs 
throughout the brain, including the amygdala. GR knockdown however was restricted to NPCs in 
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the DG. It would therefore be interesting to further investigate the link between NPCs and 
amygdala activation in context and cue fear conditioning. 
Indeed, the involvement of NPCs in processing contextual information has been shown previously. 
Similar to our study, Farioli-Vecchioli et al for example showed that accelerated differentiation of 
NPCs by conditionally expressing the PC3 transgene specifically affected contextual memory for 
fear conditioning (but not acquisition) 487. Also, focal X-irradiation, and genetic ablation of GFAP+ 
NPCs impaired contextual fear conditioning but not cued conditioning 366;510. These studies 
support our evidence that GR in NPCs is involved in contextual memory consolidation. 
 
GR knockdown in NPCs facilitates extinction of fear memory and leads to a shift from passive 
fear coping to active fear coping 
Overall freezing seems to decrease during memory testing days 3 and 4. Interestingly, total fear 
memory (total immobility= freezing + scanning) does not differ between groups on both day 3 and 
4. This suggests that mice indeed remember the negative event, although expressing a different 
quality of fear: scanning. In fact, the reduction of freezing behaviour seems to be compensated by 
a relative increase in scanning. On both memory testing days scanning is relatively increased in GR 
knockdown compared to control mice during both context and cue episodes.  
This can be due to (i) lower fear memory or (ii) better memory for the new “safe” situation or (iii) 
better retrieval. It is difficult to distinguish between these alternative explanations in our 
paradigm. However, we can conclude that the process(es) that underlie less freezing behaviour on 
day 4 probably take place between the two memory testing days and thus involves memory 
consolidation. Therefore this is also in line with the evidence for a role of GR knockdown in 
destabilization of memory consolidation: Possibly, less consolidation of the fearful event lowers 
(not extinguishes) fear perception for the adverse context during later memory testing and 
induces a more active coping mechanism to the fearful environment.  
Perfect match-shGR treated mice do not differ in freezing behaviour at the end of memory testing 
day 3, while they do show less overall freezing from the beginning of the memory testing day 4. 
Furthermore, progression of freezing behaviour on day 4 is not similar compared to controls, 
although a significant lowering of freezing behaviour is present in both GR knockdown and control 
treatment groups. This additionally shows that short term extinction is similar between GR 
knockdown and control mice, and that only absolute freezing levels differ.  
Thus, GR knockdown in NPCs seems to affect memory consolidation. Several studies have shown 
impaired GR function disrupts consolidation 509;511-513, thus excluding the argument that in mice 
with GR knockdown consolidation of memory for the new “safe” situation is improved. In this line 
of reasoning, the hypothesis regarding decreased fear memory is most likely due to impaired 
consolidation in GR knockdown treated mice.  
Still, a careful consideration of our GR knockdown animal model is necessary. Firstly, this study is 
the first to show GR knockdown in NPCs, therefore far more specific than any other 
pharmacological or genetical animal models thus far. Nevertheless, in our study we have 
manipulated the GR irreversibly four weeks before memory testing. Therefore our shGR mice 
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were already different from the start of the fear conditioning procedure, even though at the time 
of acquisition equally high GC levels were present. Keeping in mind that GCs and GR activation 
need a narrow time window to affect any of the individual memory phases 183;514, an 
supplementary experiment would be necessary. In addition to the GR knockdown and control 
mice in which during conditioning high GC levels were observed, a group of ADX mice should be 
investigated. ADX mice are depleted of GC secretion and therefore are expected to have similar 
memory impairments to GR knockdown mice. However, GC treatment just after acquisition 
should rescue this phenotype; mimicking the control group. Although not specific for NPCs, such 
an experiment would present final evidence that GR is critical for memory consolidation. 
 
Destabilization of memory consolidation in Balb/c mice is adaptive  
BALB/c mice represent an emotional and stress sensitive mouse strain and good spatial learners 
489. Similar to wild type BALB/c mice our control mice lack discrimination of context and cue. This 
indicates a generalised and even potentiated fear response 484. In contrast, during memory 
testing, GR knockdown results in a pattern of fear behaviour that indicates discrimination 
between the context and cue. As discussed above, this indicates GR knockdown in NPCs affects 
context information processing in the DG and shows a relatively more pronounced fear response 
to the cue. Recognizing the cue as a threat, and respond with freezing in anticipation of the shock, 
can be considered as an adaptive response. The decrease in freezing to the context was 
compensated by an increased scanning which indicates a shift to a more active coping strategy 
that might allow possibilities to escape the expected aversive event (Brinks et al., 2008). 
Therefore, a lowered fear response secondary to GR knockdown in BALB/c mice seems an 
adaptive response rescuing emotionally overwhelmed BALB/c mice from a generalised fear 
response.  
The long term blocking of GR by RNAi and the acute behavioural results we have seen for memory 
consolidation of a fearful event, suggests that in newborn dentate granule neurons GR is 
especially important to deal with stressful challenges of the hippocampus. This is also in line with 
GRs function as a sensor of salient and/ or threatening stimuli 3.  
 
How do NPCs contribute to memory consolidation for context and cue fear conditioning? 
Opposed to a direct role of GR in memory consolidation, an alternative possibility is a rather 
indirect role of GR. In a previous study, we have shown GR knockdown in NPCs affected proper 
differentiation and positioning, morphology, physiology and synaptic plasticity of adult born 
dentate granule neurons (see CHAPTER 4). This evidence strongly suggests that GR knockdown in 
NPCs affects functional incorporation of newborn dentate granule neurons into the hippocampal 
neo-circuitry and thereby affecting hippocampal function.  
Adult born dentate granule neurons have indeed been shown to contribute to the hippocampal 
circuitry as well as pre-existing dentate granule cells 95;98;103-108. In fact, they display plastic 
properties making them exceptionally suited for contribution to hippocampus-dependent 
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cognitive performance. Kee et al demonstrated that newborn granule cells are preferentially 
activated in hippocampus-dependent learning tasks.  
In numerous studies of eliminating or genetically modulating NPCs, the involvement of adult born 
dentate granule neurons in hippocampus-dependent memory formation and contextual fear 
conditioning has been stressed  296;366;449;468;485-487;515;516. However, not all studies uniformly report 
an involvement of NPCs in context fear conditioning 98;406. These conflicting data can be explained 
by differences in experimental design and NPC targeting techniques 110.  
As there is at present no indication that these NPC manipulations affect GRs, it is likely that both 
GR and NPCs in combination are the substrate underlying our behavioural findings. This is 
underlined by the observations that successful memory consolidation are dependent on de novo 
protein synthesis, long term changes in synaptic plasticity 517 and the fact that the GR is a 
transcription factor that is involved in dentate gyrus neurogenesis and synaptic plasticity 
(CHAPTER 4). 
 
Conclusions 
All together, our data demonstrate dependency of GR signalling in newborn dentate granule cells 
for facilitation of consolidation of fear memories. Knockdown of GR destabilized memory 
consolidation to the conditioned context, resulting in a less strong expression of fear behaviour; 
i.e less “passive” freezing and more “active” scanning coping style. These results, in combination 
with the evidence for a role of GR in the maturation of NPCs (see CHAPTER 4), are in line with our 
hypothesis that GR knockdown in NPCs affects neuronal function and may thereby modulate 
cognitive performance. The precise mechanisms underlying this exciting phenomenon, is a matter 
for additional experimentation.  
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6.0 INTRODUCTION TO GENERAL DISCUSSION 
 
Impaired GR signalling has been associated with hippocampal dysfunction and stress-related 
diseases. The underlying mechanisms are still unknown and therefore necessitate the 
development of animal models in which these processes can be carefully manipulated and 
investigated. Previously, GR has been investigated in various pharmacological and genetic models. 
While often mutually consistent, the available models sometimes show a conflicting or 
contradictory phenotype. As the GR is involved in a pleiotropy of functions in different cell types 
of the hippocampus 3, it is important to scale down and to carefully dissect GR function at discrete 
hippocampal subfields.  
The objective of my thesis was therefore to investigate in detail the role of the GR in a specific 
subfield of the hippocampus: the dentate gyrus. For this purpose, we developed a novel mouse 
model to specifically knockdown GR expression using RNA-interference. To our surprise we 
observed that GR knockdown occurred selectively in a population of DCX+ neuronal progenitor 
cells the SGZ of the DG. Hence, this unexpected finding allowed to focus the objective on the role 
of GR in the neurogenic niche of the hippocampus. In the second part of my PhD project I have 
used this model to test the hypothesis that GRs in these newborn cells in the DG contribute to 
aspects of cognitive performance. For this purpose, the (sub-) cellular morphology and physical 
properties of GR knockdown cells were investigated. Subsequently, the effects of GR knockdown 
were characterized in a hippocampal-dependent task: context and cue fear conditioning.  
We have described the design and selection of potent GR-shRNA constructs in CHAPTER 2 and a 
new strategy for specifically targeting neural progenitors in the SGZ by lentivirus-mediated 
delivery of shRNAs in CHAPTER 3. Using this strategy, we achieved GR knockdown of 
approximately 85% specifically in a population of newborn granule neurons. Also, we discovered a 
new role for GR in the development and functional integration of newborn granule neurons 
(CHAPTER 4). Finally, pharmacological experimentation suggested evidence for the involvement of 
GR in contextual fear memory and my data strongly suggest that this action of glucocorticoids, at 
least partly, is executed by GR expressed in NPCs.  Our RNAi mouse model further revealed that 
basal and stress-induced plasma corticosterone concentrations were not different from the values 
observed in control mice, suggesting that GR in NPCs is not involved in hippocampal inhibition of 
the HPA axis (CHAPTER 5). 
In this chapter I will discuss these experimental results in a broader context. I will compare the 
functional results of the RNAi mouse model with other GR animal models. I also will propose a 
mechanism for the involvement of granule cell GR in the new findings of GR in neurogenesis and 
hippocampal function. Furthermore I will discuss the possible consequences and implications of 
the new insights gained in the present study. 
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6.1 LOCAL APPLICATION OF LV-RNAI-MEDIATED GR KNOCKDOWN  
 
6.1.1 A comparison of our shGR mouse model with other transgenic animal models for GR 
In this thesis, I have described a novel mouse model in which GR expression was specifically 
reduced by 85% using RNAi. Short hairpin RNAs were delivered into the hippocampus using 
stereotactic injections of lentiviral vectors. In fact, to our surprise we found lentiviral vectors to 
transduce a specific population of DCX+ NPCs and their progeny of newborn dentate granule 
neurons (further referred to as NPCs). This LV-shGR mouse model enabled us to investigate the 
hypothesis that GRs in NPCs in the DG underlie hippocampal features of cognitive processes.  
GR function has been investigated already for decades in various animal models using 
pharmacological and genetic approaches (see CHAPTER 1.6). For investigating our hypothesis, our 
newly developed LV-shGR mouse model has several advantages over these conventional 
approaches. A major advantage for example is that our LV-shGR mouse model seems specific for 
DCX+ NPCs, while more conventional strategies target GR more widely in numerous cell 
populations. The GR is expressed in almost all brain cell types and is associated with an enormous 
diversity in functions 3. Therefore, conventional models could mask the cell-specific effects and 
thereby confound the interpretation of GR function in individual cell populations 113. Equally 
important, even subtle differences affecting GC signalling through GR may affect the phenotype. 
As described in CHAPTER 1, GC signalling in the hippocampus depends not only on factors such as 
GR expression and GC concentrations, but also on receptor-specific characteristics, timing, and 
importantly, on cellular context. This context is critical in the dentate gyrus, since it is a very 
heterogeneous environment consisting of different cell types and cell populations from different 
origin and age 62;70. Therefore, compared to more conventional approaches such as classical 
transgenesis, more cell-specific GR manipulations are required to give new insight in cell type-
specific GR functions.  
A second advantage of our LV-shGR mouse model is the lack of possible developmental 
disruptions. Several transgenic GR mice are associated with developmental disruptions and/or 
compensation mechanisms. For example, the GR appears to be critical for embryonic 
development and absence leads to lethality or severe hyper-adrenalism and wasting 319. As 
mentioned before, GR is expressed in virtually every brain cell, executing different functions. Cell-
specific GR manipulation by viral delivery in the adult brain circumvents possible developmental 
problems by preventing compensation and confounding effects. As I showed specific targeting of 
lentivirusses to NPCs (CHAPTER 3), our LV-shRNA mouse model seems ideal to investigate the role 
of GR in newborn dentate granule neurons in adult mice. 
A third advantage is that RNAi-mediated GR manipulation allows for a partial knockdown and not 
a complete knock-out of GR protein expression. On average, we found a 85% knockdown of GR 
protein expression in NPCs. This is critical, since the extent to which the GR expression is 
manipulated has consequences for the phenotype. GR can be over-expressed or knocked out fully 
in transgenic animals, but can also have a partial knockdown of function or expression as for 
example mediated by antagonists or RNAi. Since GR is an essential transcription factor, full 
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ablation is developmentally lethal. However, reductions of GR mRNA and protein expression and 
function have been shown in physiological conditions such as chronic stress, early life stress, aging 
and elevated GC concentrations 51;273;481;518-520. Also in line with our findings, previously reductions 
in GR expression have been associated with cognitive and neurogenic and physiological effects in 
vivo 312;313;318;321. GR protein levels are also endogenously determined by RNAi. Recently our group 
showed that GR protein levels are down-regulated by microRNA-124 59, a non-coding RNA that is 
endogenously highly expressed specifically in neuronal cells, such as NPCs 61. The approach of a 
(RNAi-mediated) reduction of GR expression is therefore considered more resembling naturally 
occuring, physiological circumstances.  
 
Despite these advantages of our shGR mouse model, there are more differences between 
different GR animal models that might be more a drawback or disadvantage. Each approach 
comes with its own pros and cons (see CHAPTER 1, Table 1.1). A first potential disadvantage of our 
shGR mouse model is associated with the delivery of shRNA constructs; the stereotactic injections 
into the brain. Every intrusion, may involve a potential hazard, since neuronal damage or 
inflammations secondary to neuronal damage may interfere with the phenotype. Also, since the 
small and restricted location of NPCs in the sub-granular zone of the dentate gyrus, injections 
have to be very precise. Minor variations can lead to a mis-positioned injection. This is reflected in 
the relatively high numbers of experimental animals we have used for each experiment. Also 
pharmacological experiments may be influenced by variations in technique or individual 
differences between experimental animals. This is not the case with genetic animal models 
(although breeding costs a lot of animals, effort and money).  
A second potential disadvantage of our approach is the use of exogenous materials in the brain; 
lentiviral vectors and shRNA constructs. As extensively discussed in CHAPTER 2, this may lead to 
non-specific effects or off-target effects. These non-specific effects may be difficult to circumvent. 
However, it is possible to adapt the experimental design with appropriate controls. We therefore 
used mismatch-shRNA constructs that were only different from perfect match shRNA in two 
nucleotide point mutations.  
For our experiments aimed at investigating the role of GR with respect to adult hippocampal 
neurogenesis and cognition, our LV-shGR mouse model has proved to be an excellent approach. 
Nevertheless, it is important to keep in mind that investigating the different aspects of GC/GR 
signalling may require different approaches. For example, genetic approaches alter gene 
expression at the level of the DNA. Posttranscriptional RNAi alters gene expression at the level of 
mRNA. Both methods have in common that both mRNA and protein expression is altered. In 
contrast, pharmacological methods alter GR function -but not expression- at the level of the 
protein. The availability of all different models is also necessary to confirm experimental data and 
obtain robust evidence for GR function. In this respect, the best proof is when a certain result is 
established using different methods. This also accounts for our LV-shGR model, as the phenotype 
of RNAi-mediated reduction of GR was at the behavioural level in support of other studies using 
antagonists and adrenalectomy with hormone substitutions (see CHAPTER 5) 200;209;489;504. Our 
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model therefore has the important advantage of high target specificity combined with flexibility 
and easiness of use.  
 
6.1.2 Lentiviral vectors target neuronal progenitor cells and immature dentate granule neurons 
In CHAPTER 3, I described how lentiviral vectors target a specific population of adult born dentate 
granule neurons referred to as NPCs. This evidence was based on the analysis of cell-lineage 
specific markers. In CHAPTER 4 we studied the effects of GR knockdown during the development 
of these cells. Several lines of evidence in this study indicated GR knockdown results in an 
accelerated neuronal differentiation. This hypothesis was based on the analysis of the expression 
of cell-lineage specific markers and the examination of morphological parameters such as 
dendritic arborisation, dendritic spines and boutons. One remarkable observation was that one 
week PI GR knockdown in NPCs resulted in a significant increase of the percentage of a more 
mature and stable type of spines compared to control. Typically, spine formation in adult born 
neurons takes place during the third and fourth week of neuronal development 64;102;427. How is 
this finding to be explained in the light of the cell population targeted by the lentiviral vector? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Proposed development of newborn neurons in the dentate gyrus (see also CHAPTER 1). Six stages of 
neuronal development in the adult hippocampus can be readily identified on the basis of morphology, proliferative 
ability, and expression of markers such as nestin, GFAP, DCX, calretinin, calbindin and NeuN. The gray line indicates the 
developmental stages that are suggested to be transduced by the lentivirus. Figure modulated from references 57;62-64.  
 
One possibility is that lentiviral vectors do not target NPCs around the stage of cell division, but in 
a later stage. The development of a newborn neuron takes about four weeks during which the cell 
passes several stages. Each of these stages has its own characteristics (see figure 6.1). According 
to Kempermann et al (2004) neuronal development is hypothesized to originate from a putative 
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stem cell (called a type-1 cell) 62. This cell has radial glia and has astrocytic properties, such as 
GFAP expression. Neuronal development then progresses over three stages of putatively 
transiently amplifying progenitor cells (Type-2a, type-2b and type-3 cells), which appear to be 
increasingly determined to the neuronal lineage to an early post-mitotic stage.  Type-1, Type-2a 
and type-2b cells for example express Nestin. Type-2b and type-3 cells express DCX during the 
second and third week after cell division. DCX is therefore regarded as a marker for immature 
neurons 100;135. During the third and fourth week spine formation appears 64;102;427. From the post-
mitotic stage onwards, cells express the mature neuron marker NeuN in the fourth week.  
In our study (CHAPTER 3), the majority of the cells targeted by the lentivirus (> 50%) was DCX+ 
already one week PI. Cells positive for NeuN constituted 15%. These cells were characterized by 
their morphology and dendritic spine profile as probably late stage immature neurons. Cells 
positive for a very early neuronal marker Nestin constituted 11%. Four percent of the LV-targeted 
cells were positive for the neuronal proliferative marker Ki67. The remaining 16% of the cells were 
positive for GFAP, a marker for putative stem cells and glial cells. In addition, the cell population 
targeted by the lentivirus was typically located in the sub-granular zone and inner layers of the 
granule cells layer. As discussed in CHAPTER 3, these data suggest that the lentivirus targets 
newborn neurons of several developmental stages; i.e. early neuronal progenitors (KI67+ and 
Nestin+), as well as later stage DCX+ immature neurons. This finding is confirmed using three 
different lentiviral systems and is in line with studies by others showing that in the CNS, 
lentiviruses may target both dividing as well as type 2b, type-3 and/or (some) type-5 cells in vivo 
353;355;369;370;437.  
This hypothesis may explain why in CHAPTER 4 dendritic spines were observed to be present on 
NPCs in such a short time as 1 week PI. We suggest that the NPCs in which the spines were 
present, the lentivirus transduced these respective cells in stage type-3 or stage 5. Of course, 
more research is necessary to clarify this issue. However, the differences between spine 
morphology and other morphological characteristics between GR knockdown and control are 
likely not explained by the lentivirus but by treatment. Therefore we hypothesised in CHAPTER 4 
that GR knockdown results in accelerated differentiation of newborn neurons.  
The term “neuronal progenitor” has been used in literature to loosely describe all dividing cells 
with some capacity to differentiation into neurons 64. For the purpose of describing the 
population of newborn cells targeted by the lentiviral vector we have used the term NPC to cover 
the cells targeted by the lentivirus from the KI67+ and Nestin+ early stages to immature neurons 
expressing DCX and the early NeuN expressing stages. Other studies of neurogenesis in vivo have 
often used retroviral vectors, Murine Maloney Leukemia Viruses (MMLV) for example, that target 
a similar but smaller population of NPCs. These retroviruses transduce proliferating cells only 94. 
The low numbers of cells transduced at a certain time point in an animal may be a drawback for 
certain studies. Often, high numbers of cells are necessary for behavioural studies and 
comparison between several treatments (in my case GR knockdown versus control). By targeting 
cells of a more broad developmental stage, as lentiviruses do, a higher number of cells can be 
analysed. 
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CONCLUSION: The ability to study GR function in a specific cell population of newborn dentate 
granule neurons -NPCs- using LV-RNAi, makes our model unique compared to other existing 
animal models. Therefore the shGR mouse models may provide a valuable new approach to 
study gene function in restricted brain regions. 
 
 
6.2 GR MAY CONTRIBUTE TO HIPPOCAMPAL PLASTICITY BY MODULATING 
NEUROGENESIS  
 
In this thesis I have characterized a new mouse model in which NPCs have been targeted by LV-
delivered shRNAs directed against the GR. I found significant effects of GR knockdown on 
neurogenesis, neuroplasticity and hippocampal-dependent memory. Here, I will further discuss 
how neurogenic alterations may contribute to cognitive performance. Subsequently, I will discuss 
how GRs may modulate hippocampal function by controlling the maturation and proper 
integration of newborn neurons into the hippocampal neo-network. 
 
6.2.1 Are neurogenic alterations a substrate for cognitive processes? 
Although described in separate chapters, the cognitive effects of GR knockdown in NPCs (chapter 
5) were observed in the same animals of which the morphology of NPCs has been analysed 
(chapter 4). Therefore, the accelerated neuronal differentiation and aberrant positioning and 
connectivity of newborn dentate granule neurons are associated with the impaired memory 
consolidation for a fearful event. This anatomical co-localization of neurogenic alterations and 
impaired memory consolidation in the NPCs of the dentate gyrus seems to be interdependent. 
Whether altered neurogenesis is causally underlying the observed changes in memory 
consolidation is a tempting speculation. However, the causal relationship between neurogenesis 
and hippocampal function is as yet still not fully established. Since this possibility was first 
outlined by Barnea and Nottebohm (1994) 521, a number of intriguing correlations has been 
described. Recently, a number of publications provided evidence for a causal relationship:  
Firstly, NPCs are important for hippocampus-dependent cognition, since ablation of NPCs by 
different methods has shown detrimental effects for hippocampus-dependent cognition 
98;280;406;449;522. In fact, the relevance of NPCs for memory consolidation in fear conditioning has 
been shown by others. At least four weeks after modulation or elimination of NPCs for example, 
hippocampal function was affected as shown by weakening of contextual fear conditioning 
296;366;449;486;523;524.  Remarkably, these results were obtained with different methods. Neurogenesis 
could for example be disrupted with whole brain or focal (directed to hippocampal region) 
fractionated ionizing/ X irradiation 296;366;486;524; genetically targeted ablation 365;449 of neurogenesis 
by over-expressing pro-aptoptic genes in NPCs; or by reducing neurogenesis with the toxin 
methylazoxymethanol acetate (MAM) 523. Our data extend these observations by selectively 
manipulating one gene by RNAi in newborn granule cells in the sub-granular zones.  
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Secondly, NPCs exhibit unique physiological properties during certain critical periods of 
maturation, which make them suitable for neuroplasticity and signalling underlying hippocampal 
memory 104;524. It has been established with a variety of different techniques that newborn 
neurons become within a month functionally integrated in the trisynaptic circuit where they 
construct long-lasting connections 92;94;95;103;105-107;439;525;526. In fact, Kee et al demonstrated that 
newborn granule cells are preferentially activated in hippocampus-dependent learning tasks, 
suggesting they uniquely contribute to memory formation in the dentate gyrus 527. Also, in line 
with our findings, this study shows that these granule cells are mature, contain more 
mushroom/thin spines, have increased excitatory electrical firing capacity and form altered 
functional synapses with their target cells in the CA3 region (see figure 6.2).  
 
Thirdly, aberrant neurogenesis underlies hippocampal dysfunction. Recent evidence has 
suggested that correct coordination of hippocampal memory tasks is critically dependent on the 
correct timing of the initial stages of NPC maturation and on connection to pre-existing circuits 487. 
In this study, the pro-differentiative transgene PC3 was conditionally expressed in Nestin+ NPCs. 
This resulted in an accelerated differentiation of NPCs combined with profound morphological 
changes. Three to four weeks later, these mice exhibited impairments in spatial and contextual 
memory in several hippocampus-dependent tasks. Similar observations have also been observed 
by others studying pathological conditions in the brain. It has been found that in mouse models 
for epilepsy 516 or schizophrenia 368;468, alterations in neurogenesis are also correlated with 
impairments in hippocampal memory formation. Seizure-induced malformation of dendritic 
outgrowth of newborn cells has for example been associated with impaired hippocampal memory 
formation 528. 
DISC1 knockdown in the dentate gyrus also results in impaired performances of mice in several 
hippocampus-dependent tasks as well as comparable aberrant placement in hippocampal neo-
circuits 368;468. In our study we found that GR knockdown in NPCs resulted in accelerated neuronal 
differentiation and aberrant positioning and connectivity of newborn dentate granule neurons. 
These morphological and physiological alterations are associated with the impaired memory 
consolidation. In fact we delivered the LV-shRNAs into the dorsal section of the hippocampus, an 
area of the hippocampus that is particularly associated with cognitive functions 245;529.  
Above discussed publications indeed suggest a causal link between neurogenesis and certain 
aspects of hippocampal function. Aberrant neurogenesis as a substrate seems therefore the most 
likely explanation of our behavioural findings.  
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Fig 6.2 GR knockdown- mediated alterations in NPCs of the dentate gyrus (see also CHAPTER 1).  
Summary of the main cellular findings in NPCs. Orientation of the dentate gyrus (black dots) and cornu ammonis (black 
triangles) and their connections with the trisynaptic circuit. Abbreviations: CA1-3 = cornu ammonis 1-3; DG = dentate 
gyrus; EC = entorhinal cortex; pp = perforant pathway; mf = mossy fibers; sc = Schaffer collaterals; ff = fimbria fornix. 
(Adapted from Kim et al., 2002) 71 
 
6.2.2 Are GRs modulating cognitive performance by regulating neurogenesis?  
As outlined above, a causal relationship between adult hippocampal neurogenesis and 
hippocampal function seems evident. If this hypothesis holds true and new neurons in the adult 
hippocampus are indeed involved in the formation of new memory 448, the GR knockdown-
induced accelerated neuronal differentiation, aberrant positioning and functional integration of 
newborn dentate granule neurons may account for the cognitive deficits observed in context and 
cue fear conditioning. This is in line with our hypothesis proposed in CHAPTER 1: that 
hippocampal GRs may affect hippocampal function by modulating neurogenesis. So, what role 
plays GR in this relationship? 
The neurogenic actions of glucocorticoids mediated by GR are likely to be direct 123, since newly-
formed cells express GR at birth and the expression of these receptors increases over time 57. 
Also, NPCs in the sub-granular zone of the DG are closely associated with the vasculature, 
indicating that factors from the blood (such as GCs) may have a direct impact on NPCs 124;530. An 
intriguing argument for this hypothesis comes from a study of the effects of diabetes on 
neuroplasticity and cognition 172. Diabetes is known to influence the HPA-axis. In this study it was 
demonstrated in two independent animal models, that diabetes impairs hippocampus-dependent 
memory, perforant path synaptic plasticity and adult neurogenesis, AND that glucocorticoids 
contribute to these adverse effects. The diabetic animal models suffered from reduced insulin, 
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hyperglycemia, increased corticosterone, impairments in neurogenesis, synaptic plasticity and 
learning. Typically, these changes in neuroplasticity and hippocampal function could be reversed 
when physiological levels of corticosterone were maintained. In a similar study, aberrant effects 
on neurogenesis and hippocampal function of diabetes-induced hypercorticism could even be 
attenuated by treatment with the GR-antagonist mifepristone 148. The authors of both studies 
suggested therefore convincingly that the cognitive impairment in diabetes may result from 
glucocorticoid-mediated deficits in neurogenesis and synaptic plasticity. 
However, our findings on accelerated neuronal differentiation and aberrant functional integration 
after GR knockdown might be secondary effects; e.g. GR-mediated effects on cell proliferation or 
cell survival/ cell selection. It is known that spatial learning depends on both the addition and 
removal of newborn neurons in the hippocampus (Dupret et al., 2007) 98. Neuronal networks 
seem to be sculpted by a tightly regulated selection and suppression of different populations of 
newborn neurons. GR may play a role in this selection process by affecting the numbers of 
newborns cells in certain developmental stages. GCs are implicated in cell proliferation  
82;137;158;466, as well as apoptotic cell death 5 and cell survival of newborn neurons 92;122. Immature 
DCX+ cells have for example been shown to undergo apoptosis when they were also GR+ 57. In this 
line of reasoning, it could be that because of GR knockdown in the neuronal progenitors more 
cells survive which are not destined to become functionally mature. Speculatively, this could be 
an interesting explanation for the further aberrant path of altered migration, neuronal maturation 
and inappropriate integration of shGR targeted newborn neurons underlying impaired memory 
consolidation in our study. However, in our study the proportion of EGFP+ cells positive for the 
neuronal progenitor marker Nestin was unaffected by GR knockdown. A finding which suggests 
that GR knockdown accelerates neuronal differentiation in newborn cells, without affecting 
survival of neuronal progenitors in the DG.  
Alternatively to cell survival/ death, GR may also play another role in cell selection during 
neuronal development. Newborn neurons need to be adequately connected into the hippocampal 
circuitry to function 531. In our study we found several morphological alterations that suggest an 
altered functional integration of newborn neurons upon GR knockdown. GR knockdown resulted 
in mis-positioned cells, a more complex dendritic arborization of NPCs, an increased number of 
spines of a mature phenotype, an altered synaptic bouton profile, and an increased frequency of 
mEPSCs (see Figure 6.2). Combined with the memory impairments observed, these results could 
explain a possible role of GR in appropriate pruning and modulation of morphological 
characteristics of newborn neurons. This is again very suggestive, although GCs already previously 
have been associated with altered dendritic morphology and synaptic transmission 5.  
An alternative explanation for GR involvement in neurogenesis and hippocampal function –or 
perhaps in combination- may be that GR function was reduced during memory formation due to 
GR knockdown in NPCs, regardless of the position or maturation stage of the newborn cells. 
Indeed, loss of GR function by adrenalectomy or pharmacological inhibition of GR activity has 
been shown to impair memory for contextual fear conditioning in rats 200;209;504. However, in these 
studies the function of GR in NPCs was not studied in detail like in our study.  
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The above discussed theories and their underlying mechanisms need to be investigated further. 
However, a role of GR in hippocampal function by modulating the development of NPCs is 
plausible in respect to the hippocampal function in behavioural adaptation. The unique 
physiological properties of newborn neurons make them particularly suited to respond to and 
integrate stimuli during memory formation 92;110. The enhanced plasticity of newborn neurons has 
been suggested to allow preferential association of representations that are closely related in 
time 404. As there is a continuous cycle of neurogenesis in the adult hippocampus, this implies 
distinct age-cohorts of which the different populations of neurons might also be distinct in their 
modulated history during their development. This phenomenon might underlie the appreciation 
of different experiences or memories labelled in context and time, which precisely reflects the 
cognitive function of the hippocampus 282. Strikingly, newborn neurons of the hippocampus only 
constitute a very small part of the whole neuron population. It may therefore well be that the 
adult granule neurons are part in existing circuits underlying learned behaviours and that the 
newborn neurons function more in challenging conditions when new strategies need to be 
learned and applied which need a higher level of cellular plasticity. At this level, stress, and GCs 
through GR likely play a role as a functional modulator in the sensitivity and adaptation of NPCs 
for future situations 466.  
 
CONCLUSION: There is a clear relationship between GC signalling and neurogenesis on one 
hand, and GC signalling and hippocampal function on the other hand. Although the involvement 
of newborn neurons in hippocampal functioning is still not fully established, our evidence 
suggests that adult born dentate granule neurons contribute to contextual memory for a fearful 
event. GR knockdown in this cell population results in altered quantitative properties of 
neurogenesis and simultaneously impaired memory for a task associated with DG function. Our 
findings therefore strongly suggest that GR-mediated neurogenic alterations are indeed a 
substrate for hippocampal-dependent cognitive processes. Speculatively, GR signalling in NPCs 
contributing to hippocampal-dependent memory may promote behavioural adaptation. 
 
 
6.3 IN VIVO KNOCKDOWN OF GR IN NPCS: IMPLICATIONS FOR STRESS-RELATED-
BRAIN DISORDERS 
 
If, as discussed above, GR is indeed critical for maturation, migration and functional integration of 
newborn dentate granule neurons to adaptive hippocampal functioning; aberrant GR signalling in 
NPCs may contribute to hippocampal pathology and disease. Similar to our results, studies of 
others have shown aberrant neurogenesis in relation to hippocampal dysfunction and 
neuropathologies. Epileptic seizures for example, have been shown to induce dispersion of at 
least some of the newborn neurons to ectopic locations. The granule cell layer of the dentate 
gyrus in patients with temporal lobe epilepsy (TLE) is often abnormal due to dispersion and the 
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presence of ectopic granule like cells in the hilus and inner molecular layer 92;532;533. Hilar-ectopic 
granule-like cells are also observed in several animal models of TLE and may persist for months 
516;533;534. Similar to our findings, these aberrantly integrated cells display and accelerated 
functional maturation resulting in persistent hyperexcitability, and exhibit a much higher 
percentage of persistent basal dendrites than is normally found 526;535;536. Therefore, it is 
suggested that hilar-ectopic granule cells integrate abnormally and might contribute to seizure 
generation and propagation 533. 
As reviewed above, schizophrenia-associated gene DISC1 knocked down by RNAi results in a 
phenotype in which newborn dentate granule neurons were ectopically located. In addition, 
DISC1 knockdown was also shown to lead to soma hypertrophy, accelerated dendritic outgrowth 
with appearance of ectopic dendrites, enhanced intrinsic excitability, and accelerated synapse 
formation of new neurons 368. The results from Duan et al suggest that DISC1 orchestrates the 
tempo of functional neuronal integration in the adult brain and demonstrates essential roles of a 
susceptibility gene for major mental illness in neuronal development including adult 
neurogenesis.  
In respect to the GR, aberrant GC signalling before has been linked with damage to hippocampal 
integrity and cognitive function, as well as reductions in cell proliferation and newborn cell 
survival 1. In fact, there is strong evidence that the alterations in GR expression and activity (“GR 
resistance”) 52;537;538 are implicated in the pathogenesis and course of stress-related-
neuropsychiatric disorders, such as depression 4;113;219;230;232;238-240;304;539-541. Although the 
underlying molecular mechanisms are still far from clear (discussed in CHAPTER 4), “natural” 
reductions of GR in the hippocampus have been observed. To illustrate, decreased maternal care 
in early life of rats, a rodent model for depression, reduces GR protein levels in the hippocampus 
273; chronic stress, a major risk factor for several psychiatric disorders, is associated with reduced 
GR protein and mRNA levels in the hippocampus 51;481;520 and aging impairs negative feedback 
action of GCs on the HPA-axis that is associated by reduced hippocampal GR protein levels 482. 
 
At the level of newborn dentate granule cells, our shGR animal model could represent an 
endophenotype of GR-resistance. This is an interesting possibility since the DG is known to be 
exquisitely sensitive to circulating GCs and therefore may likely be one of the primary regions 
where GR-resistance could occur.  
HPA-targeted therapy could be beneficial to resolve the stress-associated hippocampal 
dysfunction. Antidepressants, although not specifically targeting the stress system 542, have been 
found to resolve HPA hyperactivity 543 and improve neurogenesis and cognition (reviewed in 109). 
Similar findings have been reported for anti-glucocorticoids 150;151. It would be interesting to 
investigate this. In particular, since recent evidence points out that just increasing neurogenesis is 
not sufficient 293;294. New therapies should suppress aberrant integration of newborn neurons or 
enhance the correct integration. Our shGR animal model may be instrumental to study the effects 
of such (antidepressant) drugs (whether or not specifically targeting GR). In addition, our shGR 
mouse model seems suitable to study the effects of several risk factors of hippocampal pathology 
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and stress-related-diseases, such as chronic stress. Therefore, our RNAi mouse model may be 
useful to investigate and explain the neurological alterations resulting from GR reductions and 
associated hippocampal dysfunctions and pathology. 
 
CONCLUSION: GR knockdown in NPCs resulted in a phenotype of aberrant neurogenesis that is 
possibly associated with hippocampal dysfunction and neuropathologies. Down-regulation of 
GR expression has been observed under several natural (pathological) circumstances. Our shGR 
animal model may therefore be useful to study a specific endophenotype: the effects of GR –
mediated alterations in the development of newborn neurons underlying hippocampal (dys-) 
function. Using this animal model, the sensitivity for stress-related brain disorders involving the 
hippocampus can be investigated.  
 
 
6.4 PERSPECTIVES 
 
The studies described in this thesis have yielded a wealth of information on GR function in 
modulating neurogenesis and fear memory. The results discussed fit well together in the concept 
of how GCs modulate the brain by regulating cellular processes. Further characterization of our 
shGR animal model will give more insight in the underlying molecular and cellular mechanisms.  
To further understand the alterations of newborn neuronal differentiation and aberrant 
incorporation in the dentate gyrus, it would for example be informative to study the cellular 
consequences of GR manipulation on a shorter time interval. In our experiments we have 
investigated the effects of GR knockdown 1 and 5 weeks PI. As these results were comparable, the 
aberrant process likely starts before one week PI. I suggest therefore in a future study to 
investigate a shorter time point such as 3 days PI. An alternative approach for such as study could 
be the use of a selective GR antagonist in combination with GFP-labelled NPCs by lentiviral 
delivery. Also, birth dating studies of NPCs with BrdU are important to obtain further insights in 
the characteristics of the cell population targeted by lentiviral vectors and at which time points of 
neuronal development GR plays a role. 
Then, it may be useful to investigate the quantitative effects (e.g. proliferation and survival of 
NPCs) in our shGR mouse model as well. For example, proliferation rate en cell death/ cell survival 
numbers could give necessary information to compare our GR knockdown phenotype with that of 
other models. 
In addition, it would be informative to further investigate the electrophysiological properties of 
the newborn cells with GR knockdown. The experiments described in CHAPTER 4, investigated 
signalling of GR knockdown neurons in resting state by measuring mEPSCs. However, how these 
adult born neurons would underlie cognition, could be better understood by investigating the LTP 
properties.  
To further characterize our shGR animal model it is relevant to study its behavioural and 
physiological response in the context of both chronic and acute stress. In my thesis, I have 
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reported the effect of GR knockdown on NPCs under “basal” conditions. Although I tested 
cognition under acute stress conditions (context and cue fear conditioning), I did not address the 
effects of chronic stress. Chronic stress however, is associated with disease states. As GR (dys-) 
function is also associated with stress-related disease states, e.g. “GR resistance”, our shGR 
animal model may provide a useful addition to the already known animal models for anxiety and 
depression. And as discussed above, it could be a valuable addition to study the biological 
mechanism of and/ or sensitivity for stress-related-brain disorders in respect to neurological and 
cognitive disturbances. 
This is especially relevant since so many drugs used in clinic affect GC/GR signalling. Extensive use 
of such GR antagonistic or agonistic drugs may have prominent effects on neurogenesis and 
hippocampal function. Recently the antiglucocorticoid RU38486 has been shown for example to 
relief psychotic and depressive symptoms within one week of treatment 544-546 as well as boost 
neurogenesis in animals 150;151. Vice versa, high systemic doses of prednisolone (GR agonist) may 
have adverse effects on the hippocampus, while suppressing autoimmune disease. Using our 
shGR animal model we can further study the neurological and molecular mechanisms underlying 
such effects. On the long run, more insight could therefore possibly lead to more cell specific 
therapeutics or even an important new drug target.  
 
CONCLUSION: Further characterization of our shGR animal model is necessary in the pursuit of a 
better understanding of how GCs modulate the brain by regulating cellular processes.  
 
 
6.5 CONCLUSIONS 
 
The shGR mouse model characterized in this thesis is a valuable addition to the current animal 
models for the investigation of GR function in the brain. The approach using LV-shRNA to 
specifically knockdown GR in a specific cell population, the neural progenitor cells (NPC) in the 
dentate gyrus is unique and validated in this thesis. In respect to the phenotype of this model, my 
study has led to the following conclusions: 
Knockdown of GR in NPC’s accelerates neuronal differentiation and migration. GR knockdown 
alters positioning of newborn neurons in the dentate gyrus. The altered dendritic and synaptic 
organization corresponds to the enhanced excitability measured in de dentate circuit. 
Knockdown of GR in NPC’s destabilized memory consolidation in a fear conditioning paradigm. 
The data suggest a key role for GR in the formation of hippocampal neo-circuitry that 
coordinates the function of the hippocampus in memory formation for an aversive experience. 
This conclusion leads me to argue in favour of the hypothesis that hippocampal GRs may affect 
hippocampal function by modulating neurogenesis.  
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SUMMARY 
 
Glucocorticoid stress hormones and their glucocorticoid receptors (GRs) have a profound 
influence on the brain by modulating processes such as neuronal plasticity and cognition. 
Aberrant glucocorticoid signalling negatively affects cognitive performance and the integrity of 
neuronal structures and therefore, has been implicated with several stress-related 
neuropsychiatric disorders. In addition, many known drugs affect glucocorticoid signalling. This 
makes an in dept understanding of the effects of glucocorticoid signalling in the brain very 
important. 
Particularly sensitive to stress hormones is the dentate gyrus of the hippocampus, a brain 
structure implicated in memory processes and encoding of spatial information. The dentate gyrus 
is a very heterogeneous structure, consisting of different cell types, of different age, origin and 
physiological properties. Of particular interest are the neuronal progenitor cells (NPCs), known to 
express GR. These cells are located in the sub-granular zone and are the substrate for adult 
hippocampal neurogenesis. Neurogenesis is a form of neuroplasticity. It involves the continuous 
process of development of new functional neurons from NPCs. Studies in rodents suggest that 
these newborn neurons may contribute to the function of the dentate gyrus in spatial and 
contextual memory. 
 
The finding that newborn granule cells contribute to memory formation and that NPCs express GR 
has culminated in the hypothesis that hippocampal GRs may affect hippocampal function by 
modulating neurogenesis. The underlying mechanism is not clear and needs detailed study. The 
main objective of my thesis was therefore to investigate the role of the GR in hippocampal NPCs 
in relation to neuroplasticity (described in CHAPTER 4) and learning and memory processes 
(described in CHAPTER 5). Thus far, technical limitations have prevented the study of the function 
of GR in individual cell types. Because of this, the second objective of my PhD project was to 
investigate the applicability of a new refined technique to study GR in NPCs in vivo: lentiviral-
shRNA injections in the dentate gyrus (described in CHAPTER 2 and 3). This approach makes it 
possible to down-regulate GR expression specifically in NPCs. The mouse model in which this 
approach was developed is further referred to as the shGR mouse model.  
 
In CHAPTER 2 the design and optimization of effective RNA-interfering constructs targeting the 
glucocorticoid receptor were described. To achieve potent knockdown of the GR, we have 
designed four different sequence-specific short interfering RNA constructs. These constructs were 
cloned into pSuper vector in a short hairpin (sh) format. Subsequently, pSuper-shRNA constructs 
were transfected into a neuronal cell line and assessed for their potency to down-regulate GR 
protein levels. Using Western Blot analysis we determined the efficacy of the different constructs 
compared to sham, empty vector and corresponding mismatch shRNA. We found four effective 
pm- shRNAs, one (pm-GR3) with high potency to yield more than 90% GR protein knockdown, 
whereas the 3 others were less potent (pm-GR2 ~ 60%, pm-GR1 ~ 46% and pm-GR4 ~ 25% 
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respectively). Pm-GR3 was subsequently cloned into a lentiviral vector and its potency was 
verified, gaining > 70% GR protein knockdown. Using shRNA constructs it was possible to 
specifically down-regulate GR expression both via plasmid- and lentiviral vectors in a neuronal cell 
line. Therefore, this lentiviral vector was used in further studies to deliver shRNA into the dentate 
gyrus.  
 
In CHAPTER 3 the cell types are described that are effectively transduced in vivo by the lentiviral 
vector. In contrast to the CA1 subfield of the hippocampus, lentiviral injection in the granule cell 
layer of the dentate gyrus revealed sub-field specific differences in transgene expression. 
Furthermore, lentiviral vectors were found to target primarily NPCs and immature neurons 
present in the sub-granular zone and more immature layers of the granule cell layer. The targeted 
cell population was further referred to as NPCs. Also, lentiviral vectors in the granule cell layer do 
not target mature granule neurons. These observations suggest the existence of intrinsic 
differences in the permissiveness to lentiviral transduction among various hippocampal cell types. 
Therefore, it was concluded that amongst hippocampal granule cells, only adult-generated 
neurons are target for lentivirus-mediated transgene delivery. These properties make lentiviral 
vectors excellent systems for over-expression or knockdown of genes in neuronal progenitor cells, 
immature neurons and adult-generated neurons of the mouse hippocampus in vivo.  
 
In CHAPTER 4 the new approach of lentiviral-shRNA injections in the dentate gyrus was 
successfully used to study the effects of GR knockdown on neurogenesis. It was observed that 
specific GR knockdown in NPCs accelerated neuronal differentiation. Also, GR knockdown in NPCs 
led to altered morphological properties of the newborn neurons, as reflected by altered dendritic 
arborization, higher numbers of mature mushroom and thin spines and larger mossy fiber 
boutons. Strikingly, GR knockdown led to mis-positioning of adult newborn neurons, suggesting 
aberrant migration into the granule cell layer. In line with increased numbers of synaptic contacts, 
adult newborn neurons with GR knockdown exhibited increased mEPSC frequencies. Therefore 
we suggested that GR protein levels play a key role in the development of NPCs and the 
appropriate formation of hippocampal neo-circuits.  
 
In CHAPTER 5 we further characterized the phenotype of the shGR mouse model at the 
behavioural level. The role of GRs in NPCs was studied in respect to the formation of contextual 
fear memory. To this aim, four weeks after lentiviral injections when NPCs were matured and 
expected to be functionally incorporated into the hippocampal circuitry, GR knockdown and 
control mice were trained and tested in a Pavlovian fear conditioning task. This task was designed 
to allow measurement of fear memory (expressed as freezing) for both context and cue within the 
same procedure. Results demonstrated the dependency of GR signalling in NPCs for facilitation of 
consolidation of fear memories. Knockdown of GR destabilized memory consolidation to the 
conditioned context, resulting in a less strong expression of fear behaviour; i.e relatively less 
“passive” freezing and more “active” scanning coping style. In line with the results described in 
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CHAPTER 4, these data suggest a key role for GR in the formation of hippocampal neo-networks 
that coordinate hippocampal-dependent memory formation.   
 
In CHAPTER 6 the results are discussed leading me to argue in favour of the hypothesis that 
hippocampal GRs may affect hippocampal function by modulating neurogenesis. The data also 
demonstrate the validity of the newly developed shGR mouse model for further study on 
glucocorticoids and neurogenesis in adaptation to stress. 
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SAMENVATTING 
 
Stresshormonen (glucocorticoïden) oefenen grote invloed uit op de hersenen. Hormonen die in 
het bloed circuleren, kunnen de hersencellen binnendringen en daar hun effect uitoefenen. Dit 
doen zij voornamelijk door middel van binding aan specifieke glucocorticoïdreceptoren (GR). Op 
deze manier beïnvloeden glucocorticoïden verschillende processen waarbij de hippocampus 
betrokken is, zoals cellulaire neuroplasticiteit en leer- en geheugenprocessen, die als doel hebben 
de aanpassing aan stress te bevorderen. Echter, in sommige situaties kan er sprake zijn van een 
verstoorde glucocorticoïdwerking, bijvoorbeeld bij langdurige stress of ziekte. Een verstoorde 
glucocorticoïdwerking heeft niet alleen een negatieve invloed op deze processen, maar ook een 
beschadigend effect op de hersenen zelf. Dit fenomeen wordt zelfs in verband gebracht met de 
ontwikkeling en het verloop van stressgerelateerde ziekten zoals depressie. Op dit moment weten 
we nog te weinig over het mechanisme dat hieraan ten grondslag ligt. Het is daarom erg relevant 
om te weten wat precies de effecten van glucocorticoïden in de hersenen zijn en hoe deze 
effecten via de GR tot stand komen. 
 
Bijzonder gevoelig voor stresshormonen zijn de neuronen in de gyrus dentatus van de 
hippocampus. Het neuronale circuit dat deze neuronen vormen is betrokken bij 
geheugenprocessen, vooral wat betreft de tijd, plaats en context van met name emotionele 
ervaringen. De gyrus dentatus is een zeer heterogene structuur. Het bestaat uit verschillende 
celtypen en cellen van verschillende leeftijd en herkomst. Deze groepen neuronen hebben ieder 
hun specifieke eigenschappen. Interessant voor deze studie zijn vooral neuronale 
progenitorcellen. Deze cellen beschikken over de GR en zijn daarom gevoelig voor 
glucocorticoïden. Bovendien, in tegenstelling tot de meeste hersencellen, is dit celtype in staat 
zich te delen. Hierbij ontstaan nieuwe functionele neuronen die onderdeel worden van het 
neuronale circuit in de gyrus dentatus. Dit proces, neurogenese genoemd, duurt ongeveer een 
maand en bestaat uit verschillende ontwikkelingsfasen: celdeling, -selectie, -migratie, -
differentiatie, -rijping en de daadwerkelijke functionele integratie van het volwassen neuron in 
het circuit. Er wordt daarom aangenomen dat deze nieuwe neuronen bijdragen aan de functie van 
de gyrus dentatus in het geheugen voor de context. 
 
Deze achtergrond heeft geleid tot de hypothese die in dit proefschrift onderzocht is: het 
glucocorticoïdhormoon beïnvloedt via GR in neuronale progenitorcellen de functie van de gyrus 
dentatus door modulatie van neurogenese. Omdat het precieze mechanisme nog onduidelijk is, 
was het onderzoek naar de rol die GR speelt in neurogenese (Hoofdstuk 4) en gedrag (Hoofdstuk 
5) de voornaamste doelstelling van mijn proefschrift. Voorheen was het technisch niet mogelijk 
om de functie van een gen (zoals de GR) te onderzoeken in verschillende celtypen in de muis. 
Omdat de GR tot expressie komt in verschillende celtypen en waarschijnlijk verschillende functies 
in deze cellen heeft, is het voor deze studie essentieel dat de GR alleen in neuronale 
progenitorcellen onderzocht wordt. Om deze reden was de tweede doelstelling van mijn 
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proefschrift het ontwikkelen van een nieuwe techniek (RNA-interferentie) om de expressie van de 
GR in neuronale progenitorcellen van muizen te manipuleren. Om RNA-interferentiemoleculen in 
de neuronale progenitorcellen te brengen zijn lentivirussen gebruikt als vector (Hoofdstuk 2 en 3). 
De lentivirussen zijn met behulp van een stereotact in de gyrus dentatus van muizen geïnjecteerd. 
Dit muismodel is het shGR-muismodel genoemd. 
 
In Hoofdstuk 2 is de ontwikkeling en de effectiviteit van de shRNA-constructen beschreven. Om 
een goede downregulatie (verlaging) van GR-expressie te verkrijgen, zijn in eerste instantie vier 
verschillende constructen ontworpen. Deze constructen zijn vervolgens in een plasmidvector 
ingebouwd en getest in een neuronale cellijn. Met Western Blot zijn de GR-concentraties bepaald 
bij het toepassen van de verschillende constructen en specifieke controles. Alle vier constructen 
gaven enige downregulatie van de GR. Construct “pm-GR3” had de hoogste effectiviteit met een 
verlaging van meer dan 90% van de GR-expressie. Dit construct werd dan ook geselecteerd en 
ingebouwd in de lentivirale vector. Opnieuw werd de effectiviteit getest in de neuronale cellijn. 
Het lentivirus met het pm-GR3-construct gaf meer dan 70% downregulatie van GR. Daarom werd 
deze combinatie gebruikt in het vervolgonderzoek om de GR te verlagen in de neuronen van de 
muis.  
 
In Hoofdstuk 3 werd eerst gekeken naar de soort celtypes in de gyrus dentatus die het lentivirus 
infecteert. Een week na stereotactische injecties in de gyrus dentatus van de muis werden de 
cellen gelabeld door het lentivirus, bestudeerd. In tegenstelling tot neuronen van een andere 
hippocampale structuur, bleek er in de gyrus dentatus een verschil te zijn tussen verschillende 
cellagen. Sommige cellagen werden geïnfecteerd, andere niet. Nadere bestudering van deze 
cellagen en hun cellen gaf aan dat het lentivirus vooral neuronale progenitorcellen en 
onvolwassen neuronen infecteert. Deze celpopulatie, bestaande uit neuronale progenitorcellen 
en nieuwgeboren neuronen in verschillende ontwikkelingsstadia, werd verder aangeduid als NPC. 
Het lentivirus infecteert geen volwassen neuronen in de gyrus dentatus. De mogelijke 
verklaringen voor deze eigenschap van het lentivirus werden geëvalueerd. Er werd bovendien 
geconcludeerd dat dit lentivirus erg geschikt is als vector om RNA-interferentie over te brengen in 
NPC’s. Door deze eigenschap kunnen lentivirussen goed gebruikt worden in onderzoek naar de 
functie van genen in NPC’s. 
 
In Hoofdstuk 4 werd deze lentivirus-RNA-interferentie-aanpak succesvol toegepast. Er werd 
onderzocht wat de effecten van GR-downregulatie in NPC’s zijn op neurogenese. Een week van 
GR-downregulatie in NPC’s resulteerde al in een versnelde neuronale differentiatie. Bovendien 
bleek GR-downregulatie een effect te hebben op de morfologie van de NPC’s. Dit kwam onder 
meer tot uiting in een veranderde structuur van de dendrieten-“boom”, een toegenomen aantal 
dendritische spines met een volwassen fenotype, en een vergrote doorsnede van zogenaamde 
mossy fiber boutons. Opvallend was dat ook de positie van de NPC’s met GR-downregulatie in de 
granulaire cellaag verschilde van de controlemuizen. Dit duidt op een foutieve migratie. De 
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effecten van GR-downregulatie waren in overeenkomst 1 en 5 weken na injectie. De 
morfologische resultaten wekken de indruk dat de synaptische contacten - de manier waarop 
neuronen contact leggen met andere neuronen in het neuronale circuit - toegenomen zijn. In 
overeenstemming met deze bevindingen, vonden we ook een toegenomen frequentie van 
mEPSC’s wat wijst op een verhoogde excitabiliteit. Op basis van deze resultaten, samen met de 
veranderde migratie suggereerden we dat de GR-expressie mogelijk een cruciale rol speelt in de 
ontwikkeling van nieuwgeboren neuronen en de correcte integratie van deze neuronen in het 
neuronale circuit van de hippocampus. Ook werden de moleculaire mechanismen bediscussieerd 
die mogelijk ten grondslag liggen aan deze functie van GR. 
 
In Hoofdstuk 5 is vervolgens angstgemotiveerd gedrag van de shGR-muis onderzocht. Hiertoe 
werd onderzocht hoe GR’s in NPC’s betrokken zijn bij het geheugen voor een stressvolle en 
angstige gebeurtenis. ShGR-muizen en controlemuizen werden vier weken na injectie met het 
lentivirus (waarbij werd verondersteld dat de door het lentivirus geïnfecteerde NPC’s inmiddels 
volledig ontwikkeld waren) getest in een Pavloviaanse taak die “context and cue fear 
conditioning” heet. Tijdens context and cue fear conditioning is het mogelijk het angstgeheugen 
van de muizen te meten door herhaaldelijk de gedragsrespons op de omgeving (context) en op de 
geconditioneerde stimulus te meten. Angstgedrag bij muizen wordt gekenmerkt door immobiliteit 
en kan zowel door “freeze”- als door “scan”-gedrag tot expressie gebracht worden. Uit de mate 
van het angstgemotiveerd gedrag enkele dagen later kan een indruk worden verkregen van het 
verloop van de leer- en geheugenprocessen. Uit de resultaten bleek dat glucocorticoïdwerking via 
GR in NPC’s belangrijk is voor de bevordering van de consolidatiefase van het geheugen. shGR-
muizen leken een minder goed geheugen te hebben voor de angstige gebeurtenis. 
 
In Hoofdstuk 6 werd de mogelijke betekenis van de resultaten uit de verschillende experimenten 
bediscussieerd. De resultaten lijken de hypothese te ondersteunen dat de GR in neuronale 
progenitorcellen de functie van de gyrus dentatus beïnvloedt door modulatie van neurogenese. 
Bovendien ondersteunen de resultaten de validiteit van dit nieuw ontwikkelde shGR-diermodel 
voor verder onderzoek naar glucocorticoïden en neurogenese in aanpassing aan stress. 
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